<!DOCTYPE html> <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Intermediate acting versus long acting insulin for type 1 diabetes mellitus - Vardi, M - 2008 | Cochrane Library</title> <meta property="og:title" content="Intermediate acting versus long acting insulin for type 1 diabetes mellitus - Vardi, M - 2008 | Cochrane Library" /> <meta property="og:url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006297.pub2/references" /> <meta property="og:type" content="article" /> <meta property=”og:image” content=”https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png” /> <meta content="initial-scale=1.0, width=device-width" name="viewport" /> <meta name="dc.identifier" scheme="DOI" content="10.1002/14651858.CD006297.pub2" /> <meta name="citation_title" content="Intermediate acting versus long acting insulin for type 1 diabetes mellitus" /> <meta name="citation_author" content="Moshe Vardi" /> <meta name="citation_author_institution" content="Carmel Medical Center" /> <meta name="citation_author_email" content="MosheVa3@clalit.org.il" /> <meta name="citation_author" content="Eyal Jacobson" /> <meta name="citation_author_institution" content="Clalit Health Services, Haifa and Western Galilee District" /> <meta name="citation_author" content="Asaph Nini" /> <meta name="citation_author_institution" content="Sheba Medical Center" /> <meta name="citation_author" content="Haim Bitterman" /> <meta name="citation_author_institution" content="Carmel Lady Davis Medical Center" /> <meta name="citation_journal_title" content="Cochrane Database of Systematic Reviews" /> <meta name="citation_publisher" content="John Wiley &amp; Sons, Ltd" /> <meta name="citation_issue" content="3" /> <meta name="citation_doi" content="10.1002/14651858.CD006297.pub2" /> <meta name="citation_date" content="2008" /> <meta name="citation_online_date" content="2008/07/16" /> <meta name="citation_abstract_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006297.pub2/abstract" /> <meta name="citation_fulltext_html_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006297.pub2/full" /> <meta name="citation_pdf_url" content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006297.pub2/pdf/CDSR/CD006297/CD006297.pdf" /> <meta name="citation_issn" content="1465-1858" /> <meta name="citation_language" content="en" /> <meta name="citation_keywords" content="Diabetes Mellitus, Type 1 [blood, *drug therapy]; Glycated Hemoglobin A [analysis]; Hypoglycemic Agents [adverse effects, *therapeutic use]; Insulin [adverse effects, *therapeutic use]; Insulin, Long‐Acting [adverse effects, therapeutic use]; Randomized Controlled Trials as Topic" /> <script type="text/javascript" src="//script.crazyegg.com/pages/scripts/0056/6375.js" async="async"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <script type="text/javascript">var o={auth:{customerIds:["P#DRAAEAC","EAL00000056729","DRAA3TITLES","TSINGH009S","EAL0001468","EAL00000045347"],individualId:null,brandedCustomer:"EAL0001468",roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=UTF-8" http-equiv="content-type" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/favicon.ico" rel="Shortcut Icon" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" rel="canonical" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-CN" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;zh_TW&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="zh-TW" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;hr&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="hr-HR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="x-default" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="en-US" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fr&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fr-FR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;de&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="de-DE" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ja&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ja-JP" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ko&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ko-KR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ms&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ms-MY" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;fa&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="fa-IR" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pl&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pl-PL" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;pt&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="pt-PT" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ru&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ru-RU" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;es&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="es-ES" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;ta&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="ta-IN" rel="alternate" /> <link href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;th&#x2f;content&#x3f;templateType&#x3d;references&#x26;urlTitle&#x3d;&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;doi&#x3d;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x26;type&#x3d;cdsr&#x26;contentLanguage&#x3d;" hreflang="th-TH" rel="alternate" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581423095000" rel="stylesheet" type="text/css" /> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;aui&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581423095000" rel="stylesheet" type="text/css" /> <link href="&#x2f;html&#x2f;css&#x2f;main&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1559916431000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581717708000" rel="stylesheet" type="text/css" /> <link href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1581717784000" rel="stylesheet" type="text/css" /> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 13},getRevision:function(){return"605.1"},getVersion:function(){return"13.0"},isAir:function(){return false},isChrome:function(){return false},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return false},isMac:function(){return true},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="y8F68iId";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dreferences\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD006297\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD006297\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006297\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006297\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article References"},article:{availableLanguage:["en","ja","ms"],languageCode:"en",accessStatus:"licensed",doi:"10.1002/14651858.CD006297.pub2",title:"Intermediate acting versus long acting insulin for type 1 diabetes mellitus",firstPublishedDate:"Jul 16, 2008 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Metabolic and Endocrine Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;cochrane-theme&#x2f;css&#x2f;custom&#x2e;css&#x3f;browserId&#x3d;other&#x26;themeId&#x3d;cochrane_WAR_cochranetheme&#x26;minifierType&#x3d;css&#x26;languageId&#x3d;en_US&#x26;b&#x3d;6210&#x26;t&#x3d;1581423095000" rel="stylesheet" type="text/css" /> <style type="text/css"></style> <script src="//assets.adobedtm.com/6e626c9ec247e474f6b98eb15a79a185cf7e26a5/satelliteLib-b0f13d7a13ebe8b0b1b00a9f0730a084926e292f.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1581423095000" type="text/javascript"></script> <![endif]--> </head> <body class=" yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div id="js-cookie-message" class="cookie-message cookie-message--hidden system-message-container"> <div class="container"> <a href="#" class="fa fa-times js-cookie-close pull-right" aria-label="Close cookies message"></a> <div class="system-message-wrapper container"> <i class="fa fa-exclamation-triangle" aria-hidden="true"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7XGCZUQPW4C675JNSTYTLUDN7XB/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a href="#" class="btn secondary js-cookie-close js-cookie-accept">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/"> <span class="brand-name">The Cochrane Library</span> <img class="brand-logo" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/en-US_logo.png" alt="Cochrane Library logo" title="Cochrane Library" /> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="owel__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_auth=y8F68iId&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=references&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006297.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006297.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a href="/en/browse-by-topic" class="btn secondary">Browse</a>
<a href="/en/advanced-search" class="btn primary advanced-search-button">Advanced search</a>
</div>
</div>
<a href="#" class="toggle-menu-switch"><i class="fa fa-bars" aria-hidden="true"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<p class="auxiliary-menu-item access">Access provided by: <strong>Tsinghua University</strong></p>
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="bvrs__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh, za]"> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="open-language-modal" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="language-selector-modal-content" style="display: none;" data-modal-title="Language selection" data-size="large"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh" class="content-language-selector " data-languagecode="zh">简体中文</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=za" class="content-language-selector " data-languagecode="za">繁體中文</a> </div> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div> <a href="/en/cdsr/doi/10.1002/14651858.CD006297.pub2/references/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD006297.pub2/references/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <button class="btn primary btn-cancel" type="button">Cancel</button> <a class="btn secondary ok-btn pull-right" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006297.pub2%2Freferences" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
</a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
<div class="access-provider-mobile">
<p class="access">Access provided by: <strong>Tsinghua University</strong></p>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class=" nav-root-item parent">
<a href="#">Cochrane Reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_14" role="presentation">
<a aria-labelledby="layout_14" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews" role="menuitem">
Search Reviews (CDSR)
</a>
</li>
<li class=" child-nav-item" id="layout_15" role="presentation">
<a aria-labelledby="layout_15" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;reviews&#x2f;topics" role="menuitem">
Browse Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_18" role="presentation">
<a aria-labelledby="layout_18" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;table-of-contents" role="menuitem">
Issues
</a>
</li>
<li class=" child-nav-item" id="layout_17" role="presentation">
<a aria-labelledby="layout_17" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;editorials" role="menuitem">
Editorials
</a>
</li>
<li class=" child-nav-item" id="layout_19" role="presentation">
<a aria-labelledby="layout_19" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;special-collections" role="menuitem">
Special Collections
</a>
</li>
<li class=" child-nav-item" id="layout_20" role="presentation">
<a aria-labelledby="layout_20" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;supplements" role="menuitem">
Supplements
</a>
</li>
<li class=" child-nav-item" id="layout_13" role="presentation">
<a aria-labelledby="layout_13" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cdsr&#x2f;about-cdsr" role="menuitem">
About the CDSR
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_22" role="presentation">
<a aria-labelledby="layout_22" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central" role="menuitem">
Search Trials (CENTRAL)
</a>
</li>
<li class=" child-nav-item" id="layout_114" role="presentation">
<a aria-labelledby="layout_114" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;central&#x2f;about-central" role="menuitem">
About CENTRAL
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_29" role="presentation">
<a aria-labelledby="layout_29" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca" role="menuitem">
Browse Clinical Answers
</a>
</li>
<li class=" child-nav-item" id="layout_91" role="presentation">
<a aria-labelledby="layout_91" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;cca&#x2f;about" role="menuitem">
About Clinical Answers
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_116" role="presentation">
<a aria-labelledby="layout_116" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-library" role="menuitem">
About the Cochrane Library
</a>
</li>
<li class=" child-nav-item" id="layout_34" role="presentation">
<a aria-labelledby="layout_34" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochrane&#x2e;org&#x2f;about-us" role="menuitem">
About Cochrane
</a>
</li>
<li class=" child-nav-item" id="layout_121" role="presentation">
<a aria-labelledby="layout_121" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;about-cochrane-reviews" role="menuitem">
About Cochrane Reviews
</a>
</li>
<li class=" child-nav-item" id="layout_92" role="presentation">
<a aria-labelledby="layout_92" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;author-information" role="menuitem">
Information for authors
</a>
</li>
<li class=" child-nav-item" id="layout_188" role="presentation">
<a aria-labelledby="layout_188" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;releases" role="menuitem">
What&#039;s new
</a>
</li>
</ul>
</li>
<li class=" nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class=" child-nav-item" id="layout_177" role="presentation">
<a aria-labelledby="layout_177" href="https&#x3a;&#x2f;&#x2f;www&#x2e;wiley&#x2e;com&#x2f;network&#x2f;cochranelibrarytraining" role="menuitem">
Cochrane Library Training
</a>
</li>
<li class=" child-nav-item" id="layout_44" role="presentation">
<a aria-labelledby="layout_44" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;access" role="menuitem">
Access options
</a>
</li>
<li class=" child-nav-item" id="layout_150" role="presentation">
<a aria-labelledby="layout_150" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;permissions" role="menuitem">
Permissions and reprints
</a>
</li>
<li class=" child-nav-item" id="layout_93" role="presentation">
<a aria-labelledby="layout_93" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;media" role="menuitem">
Media information
</a>
</li>
<li class=" child-nav-item" id="layout_97" role="presentation">
<a aria-labelledby="layout_97" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;help&#x2f;contact-us" role="menuitem">
Contact us
</a>
</li>
<li class=" child-nav-item" id="layout_125" role="presentation">
<a aria-labelledby="layout_125" href="https&#x3a;&#x2f;&#x2f;www&#x2e;cochranelibrary&#x2e;com&#x2f;en&#x2f;about&#x2f;terms-and-conditions" role="menuitem">
Terms and conditions
</a>
</li>
<li class=" child-nav-item" id="layout_176" role="presentation">
<a aria-labelledby="layout_176" href="https&#x3a;&#x2f;&#x2f;hub&#x2e;wiley&#x2e;com&#x2f;docs&#x2f;cochrane-library&#x2f;cochrane-library-known-issues-DOC-16221&#x3f;referrer&#x3d;cochrane" role="menuitem">
Known issues
</a>
</li>
</ul>
</li>
<li class="about-link"><a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img id="etlj__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <section class="content-language-banner system-message-container" data-content-language="en" data-portal-language="en" style="display: none"> <div class="container"> <a href="#0" class="fa fa-times content-language-banner-close pull-right" aria-label="Close"></a> <i class="fa fa-globe" aria-hidden="true"></i> <div class="system-message-title">Content Language Selection</div> <div class="system-message-description">Your language preference is set to <strong class="language">English</strong>. Where translations are available, article sections will display in this language. Return to <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=reset-content-language&p_p_cacheability=cacheLevelPage" class="language secondary">English</a>.</div> </div> </section> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div id="content" class="">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="rjus__column1__0" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools"> <li class="cdsr-nav-link pulldown-menu readcube-menu closed"> <a href="#0" class="pulldown-menu-trigger"> <i class="icon fa fa-file-pdf-o"></i>View PDF <i aria-hidden="true" class="fa fa-caret-up"></i> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/pdf/full/en" class="download media pdf-link-full pdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/epdf/full/en" class="download media pdf-link-full readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Full </span> <span class="readcube-description "> All content </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/pdf/standard/en" class="download media pdf-link-standard pdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/epdf/standard/en" class="download media pdf-link-standard readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Standard </span> <span class="readcube-description "> Excludes data and analyses, and appendices </span> </a> </li> <li class=""> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/pdf/abstract/en" class="download media pdf-link-abstract pdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/epdf/abstract/en" class="download media pdf-link-abstract readcube-epdf-link" title="Article in PDF format"> <span class="readcube-label "> Summary </span> <span class="readcube-description "> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="cdsr-nav-link cite-article-link" data-article-id="CD006297.PUB2" data-modal-title="Cite this Review"> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/#"> <i class="icon fa fa-share"></i>Cite this Review </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-english-only-message="Please note, that requesting permissions is available in English only. Apologies for any inconvenience." href="/cdsr/doi/10.1002/14651858.CD006297.pub2/#" data-copyright="Copyright © 2010 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false"> <span class="request-permissions-icon"></span> Request Permissions </a> </li> <li class="cdsr-nav-link comment-on-review"> <a id="comment-on-review" class="js-old-version-modal-trigger" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/comment" data-new-version="" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience."> <i class="icon fa fa-comment"></i>Comment on Review </a> </li> <li class="cdsr-nav-link comment-on"> <span>Read comments on this Review(0)</span> </li> </ul> <ul class="share clearfix"> <li class="cdsr-nav-link print-cdsr-link" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD006297.pub2/print" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;アブストラクト&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Data and analysis&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;}]}]"> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/#"> <i class="icon fa fa-print"></i>Print </a> </li> <li class="cdsr-nav-link share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD006297.pub2/full"> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/#"> <i class="icon fa fa-share-alt"></i>Share </a> </li> <li class="cdsr-nav-link"> <a href="/c/portal/login" class="article-not-followed cochrane-link signin"> <span class="article-follow-display"><i class="icon fa fa-plus"></i>Follow</span> </a> </li> </ul> <ul id="linked-articles" data-type="cdsr" class="linked-content tools clearfix linked-content-trigger"> <li> <a href="#0"> <span class="linked-to-this"> Linked to this Review <span class="linked-content-count"></span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> </li> </ul> <ul class="linked-content-dropdown"> <li data-type="cca" class="linked-cca"> <p>Cochrane Clinical Answers</p> </li> <li data-type="editorial" class="linked-editorials"> <p>Editorials</p> </li> <li data-type="podcast" class="linked-podcasts"> <p>Podcasts</p> </li> <li data-type="sc" class="linked-sc"> <p>Special Collections</p> </li> </ul> <ul class="nav-long-form"> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/full#CD006297-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/full#CD006297-sec1-0006"> Authors' conclusions </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/full#CD006297-sec1-0001"> Background </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/full#CD006297-sec1-0002"> Objectives </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/full#CD006297-sec1-0003"> Methods </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/full#CD006297-sec1-0004"> Results </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/full#CD006297-sec1-0005"> Discussion </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/appendices#CD006297-sec1-0011"> Appendices </a> </li> </ul> <ul> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/information"> Information </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/information#authors"> Authors </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/information#history"> History </a> </li> <li class="cdsr-nav-link article-section-link"> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/information#keywords"> Keywords </a> </li> </ul> <ul> <li class="cdsr-nav-link bold-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/#"> <i class="icon fa fa-globe"></i>Translation notes </a> </li> </ul> <ul> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references"> References </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link references-link"> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#dataAndAnalyses"> Data and analyses </a> </li> </ul> <ul class="tools"> <li class="cdsr-nav-link "> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/#"> <i class="icon fa fa-line-chart"></i>Figures and tables </a> </li> <li class="cdsr-nav-link download-stats-data-link " data-download-href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/table_n/CD006297StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/table_n/CD006297StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <i class="icon fa fa-download"></i>Download statistical data </a> </li> <li class="cdsr-nav-link "> <a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i>Related content <span class="note podcast-indicator">Podcast available</span> </a> </li> </ul> </nav> </div> <article class="information" data-article-id="CD006297.PUB2"> <header> <h1 class="publication-title"><h1 lang="en" class="publication-title">Intermediate acting versus long acting insulin for type 1 diabetes mellitus</h1></h1> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div><h2 class="title section-collapse-title"> References <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <section class="references bibliographies" id="references"> <section> <div class="section-header" id="CD006297-bbs1-0001"> <h3 class="title">References to studies included in this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD006297-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD006297-bbs1-0003">ongoing studies</a></li> <li><a class="jump-to" href="#CD006297-bbs1-0004">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_includedStudies" id="CD006297-bbs2-0001"> <div class="reference-title-banner"> <h4 class="title">Ashwell 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0001"> <div class="citation-journal">Ashwell SG, et al. <span class="citation-title">Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross‐over trial in people with Type 1 diabetes</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2006</span>;<span class="volume">23</span>(3):285‐92. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1464-5491.2005.01781.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16492212" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Improved+glycaemic+control+with+insulin+glargine+plus+insulin+lispro:+a+multicentre,+randomized,+cross%E2%80%90over+trial+in+people+with+Type+1+diabetes+&author=SG+Ashwell&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD28Xjs1OgtLc%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000235370500011&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 56</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006297-bbs2-0002"> <div class="reference-title-banner"> <h4 class="title">Chatterjee 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0002"> <div class="citation-journal">Chatterjee S, Jarvis‐Kay J, Rengarajan T, Lawrence IG, McNally PG, Davies MJ. <span class="citation-title">Glargine versus NPH insulin: Efficacy in comparison with insulin aspart in a basal bolus regimen in type 1 diabetes—The glargine and aspart study (GLASS). A randomised cross‐over study</span>. <span class="citation"> Diabetes Research and Clinical Practice </span><span class="pubYear">2006</span>;<span class="volume">77</span>:215‐22. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2Fj.diabres.2006.11.002" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17141354" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glargine+versus+NPH+insulin:+Efficacy+in+comparison+with+insulin+aspart+in+a+basal+bolus+regimen+in+type+1+diabetes%E2%80%94The+glargine+and+aspart+study+(GLASS).+A+randomised+cross%E2%80%90over+study+&author=S+Chatterjee&author=J+Jarvis%E2%80%90Kay&author=T+Rengarajan&author=IG+Lawrence&author=PG+McNally&author=MJ+Davies&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2sXkvFGjs7k%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000246924100010&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 9</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006297-bbs2-0003"> <div class="reference-title-banner"> <h4 class="title">De Leeuw 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0003"> <div class="citation-journal">De Leeuw, et al. <span class="citation-title">Insulin detemir used in basal‐bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin</span>. <span class="citation"> Diabetes, Obesity &amp; Metabolism </span><span class="pubYear">2005</span>;<span class="volume">7</span>(1):73‐82. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1463-1326.2004.00363.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15642078" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+detemir+used+in+basal%E2%80%90bolus+therapy+in+people+with+type+1+diabetes+is+associated+with+a+lower+risk+of+nocturnal+hypoglycaemia+and+less+weight+gain+over+12+months+in+comparison+to+NPH+insulin+&author=Leeuw+De&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXhsFGhtLc%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000225956600009&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 63</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006297-bbs2-0004"> <div class="reference-title-banner"> <h4 class="title">Francis 1986 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0004"> <div class="citation-journal">Francis AJ, Hanning I, Alberti KGMM. <span class="citation-title">Human ultralente insulin: A comparison with porcine lente insulin as a twice‐daily insulin in insulin‐dependent diabetic patients with fasting hyperglycaemia</span>. <span class="citation"> Diabetes Research </span><span class="pubYear">1986</span>;<span class="volume">3</span>(5):263‐8. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3527523" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Human+ultralente+insulin:+A+comparison+with+porcine+lente+insulin+as+a+twice%E2%80%90daily+insulin+in+insulin%E2%80%90dependent+diabetic+patients+with+fasting+hyperglycaemia+&author=AJ+Francis&author=I+Hanning&author=KGMM+Alberti&publication_year=1986&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaL283pvFentQ%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1986D364800008&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 10</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006297-bbs2-0005"> <div class="reference-title-banner"> <h4 class="title">Fulcher 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0005"> <div class="citation-journal">Fulcher GR, Gilbert RE, Yue DK. <span class="citation-title">Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy</span>. <span class="citation"> Internal Medicine Journal </span><span class="pubYear">2005</span>;<span class="volume">35</span>(9):536‐42. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1445-5994.2005.00902.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16105155" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glargine+is+superior+to+neutral+protamine+Hagedorn+for+improving+glycated+haemoglobin+and+fasting+blood+glucose+levels+during+intensive+insulin+therapy+&author=GR+Fulcher&author=RE+Gilbert&author=DK+Yue&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXhtVyhtr%2FI" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000231147300007&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 34</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006297-bbs2-0006"> <div class="reference-title-banner"> <h4 class="title">Hermansen 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0006"> <div class="citation-journal">Hermansen K, et al. <span class="citation-title">Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: a randomized open crossover trial in type 1 diabetic subjects on basal‐bolus therapy</span>. <span class="citation"> Diabetes Care </span> 24;<span class="volume">2</span>:296‐301. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/116831" target="_blank"> <span>PubMed</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006297-bbs2-0007"> <div class="reference-title-banner"> <h4 class="title">Hermansen 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0007"> <div class="citation-journal">Hermansen K, et al. <span class="citation-title">Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal‐bolus therapy for patients with type 1 diabetes</span>. <span class="citation"> Diabetologia </span><span class="pubYear">2004</span>;<span class="volume">47</span>(4):622‐9. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1007%2Fs00125-004-1365-z" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15298338" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+analogues+(insulin+detemir+and+insulin+aspart)+versus+traditional+human+insulins+(NPH+insulin+and+regular+human+insulin)+in+basal%E2%80%90bolus+therapy+for+patients+with+type+1+diabetes+&author=K+Hermansen&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2cXjtlOqsL0%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000220987900003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 135</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006297-bbs2-0008"> <div class="reference-title-banner"> <h4 class="title">Home 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0008"> <div class="citation-journal">Home P, et al. <span class="citation-title">Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2004</span>;<span class="volume">27</span>(5):1081‐7. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.27.5.1081" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15111525" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+detemir+offers+improved+glycemic+control+compared+with+NPH+insulin+in+people+with+type+1+diabetes:+a+randomized+clinical+trial+&author=P+Home&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2cXks1Sgu7g%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000221157100012&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 120</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006297-bbs2-0009"> <div class="reference-title-banner"> <h4 class="title">Home 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0009"> <div class="citation-journal">Home PD, et al. <span class="citation-title">A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes</span>. <span class="citation"> Diabetes/Metabolism Research Reviews </span><span class="pubYear">2005</span>;<span class="volume">21</span>(6):545‐53. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2Fdmrr.572" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+randomized+multicentre+trial+of+insulin+glargine+compared+with+NPH+insulin+in+people+with+type+1+diabetes+&author=PD+Home&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXhtlSrtbjJ" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000233352500007&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 22</span></a></li> </ul> </div> </div> <div class="bibliography-section" id="CD006297-bib-0010"> <div class="citation-journal">Witthaus E, Stewart J, Bradley C. <span class="citation-title">Treatment satisfaction and psychological well‐being with insulin glargine compared with NPH in patients with Type 1 diabetes</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2001</span>;<span class="volume">18</span>:619‐25. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1046%2Fj.1464-5491.2001.00529.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11553198" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Treatment+satisfaction+and+psychological+well%E2%80%90being+with+insulin+glargine+compared+with+NPH+in+patients+with+Type+1+diabetes+&author=E+Witthaus&author=J+Stewart&author=C+Bradley&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3MXntFGmsLw%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000171186300003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 54</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006297-bbs2-0010"> <div class="reference-title-banner"> <h4 class="title">Kolendorf 2006 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0011"> <div class="citation-journal">Kolendorf K, et al. <span class="citation-title">Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2006</span>;<span class="volume">23</span>(7):729‐35. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1464-5491.2006.01862.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/16842476" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+detemir+lowers+the+risk+of+hypoglycaemia+and+provides+more+consistent+plasma+glucose+levels+compared+with+NPH+insulin+in+Type+1+diabetes+&author=K+Kolendorf&publication_year=2006&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD28XptVKjsLY%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000238618400004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 42</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006297-bbs2-0011"> <div class="reference-title-banner"> <h4 class="title">Murphy 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0012"> <div class="citation-journal">Murphy NP, et al. <span class="citation-title">Randomized cross‐over trial of insulin glargine plus lispro or NPH insulin plus regular human insulin in adolescents with type 1 diabetes on intensive insulin regimens</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2003</span>;<span class="volume">26</span>(3):799‐804. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.26.3.799" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12610040" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Randomized+cross%E2%80%90over+trial+of+insulin+glargine+plus+lispro+or+NPH+insulin+plus+regular+human+insulin+in+adolescents+with+type+1+diabetes+on+intensive+insulin+regimens+&author=NP+Murphy&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3sXisVCltL4%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000185505100040&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 68</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006297-bbs2-0012"> <div class="reference-title-banner"> <h4 class="title">Pieber 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0013"> <div class="citation-journal">Pieber TR, Eugene‐Jolchine I, Derobert E. <span class="citation-title">Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. The European Study Group of HOE 901 in type 1 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2000</span>;<span class="volume">23</span>(2):157‐62. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.23.2.157" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10868824" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+and+safety+of+HOE+901+versus+NPH+insulin+in+patients+with+type+1+diabetes.+The+European+Study+Group+of+HOE+901+in+type+1+diabetes+&author=TR+Pieber&author=I+Eugene%E2%80%90Jolchine&author=E+Derobert&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3cXnvVymtrw%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000085037300006&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 115</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006297-bbs2-0013"> <div class="reference-title-banner"> <h4 class="title">Porcellati 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0014"> <div class="citation-journal">Porcellati F, et al. <span class="citation-title">Better long‐term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal‐time lispro insulin</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2004</span>;<span class="volume">21</span>(11):1213‐20. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1464-5491.2004.01323.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15498088" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Better+long%E2%80%90term+glycaemic+control+with+the+basal+insulin+glargine+as+compared+with+NPH+in+patients+with+Type+1+diabetes+mellitus+given+meal%E2%80%90time+lispro+insulin+&author=F+Porcellati&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2cXhtVaktrvF" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000224593000008&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 61</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006297-bbs2-0014"> <div class="reference-title-banner"> <h4 class="title">Raskin 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0015"> <div class="citation-journal">Raskin P, et al. <span class="citation-title">A 16‐week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2000</span>;<span class="volume">23</span>(11):1666‐71. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.23.11.1666" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11092290" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+16%E2%80%90week+comparison+of+the+novel+insulin+analog+insulin+glargine+(HOE+901)+and+NPH+human+insulin+used+with+insulin+lispro+in+patients+with+type+1+diabetes+&author=P+Raskin&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3cXot1ahs7k%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000090106300011&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 119</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006297-bbs2-0015"> <div class="reference-title-banner"> <h4 class="title">Ratner 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0016"> <div class="citation-journal">Ratner RE, et al. <span class="citation-title">Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2000</span>;<span class="volume">23</span>(5):639‐43. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.23.5.639" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10834423" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Less+hypoglycemia+with+insulin+glargine+in+intensive+insulin+therapy+for+type+1+diabetes.+U.S.+Study+Group+of+Insulin+Glargine+in+Type+1+Diabetes+&author=RE+Ratner&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3cXnvVymsLY%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000087022800016&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 208</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006297-bbs2-0016"> <div class="reference-title-banner"> <h4 class="title">Robertson 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0017"> <div class="citation-journal">Robertson KJ, Schoenle E, Gucev Z, Mordhorst L, Gall MA, Ludvigsson J. <span class="citation-title">Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes</span>. <span class="citation"> Diabetic medicine </span><span class="pubYear">2007</span>;<span class="volume">24</span>:27‐34. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1464-5491.2007.02024.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17227321" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+detemir+compared+with+NPH+insulin+in+children+and+adolescents+with+Type+1+diabetes+&author=KJ+Robertson&author=E+Schoenle&author=Z+Gucev&author=L+Mordhorst&author=MA+Gall&author=J+Ludvigsson&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2sXisVKhsb4%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000243403200005&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 39</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006297-bbs2-0017"> <div class="reference-title-banner"> <h4 class="title">Rosenstock 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0018"> <div class="citation-journal">Rosenstock J, et al. <span class="citation-title">Basal insulin glargine (HOE 901) versus NPH insulin in patients with type 1 diabetes on multiple daily insulin regimens. U.S. Insulin Glargine (HOE 901) Type 1 Diabetes Investigator Group</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2000</span>;<span class="volume">23</span>(8):1137‐42. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.23.8.1137" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10937511" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Basal+insulin+glargine+(HOE+901)+versus+NPH+insulin+in+patients+with+type+1+diabetes+on+multiple+daily+insulin+regimens.+U.S.+Insulin+Glargine+(HOE+901)+Type+1+Diabetes+Investigator+Group+&author=J+Rosenstock&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3cXnvV2js7k%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000088376300015&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 99</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006297-bbs2-0018"> <div class="reference-title-banner"> <h4 class="title">Rossetti 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0019"> <div class="citation-journal">Rossetti P, Pampanelli S, Fanelli C, Porcellati F, Costa E, Torlone E, et al. <span class="citation-title">Intensive replacement of basal insulin in patients with type 1 diabetes given rapid‐acting insulin analog at mealtime: a 3‐month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2003</span>;<span class="volume">26</span>(5):1490‐6. [Intensive replacement of basal insulin in patients with type 1 diabetes given rapid‐acting insulin analog at mealtime: a 3‐month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime. Diabetes Care. 2003 May;26(5):1490‐6. Rossetti P, Pampanelli S, Fanelli C, Porcellati F, Costa E, Torlone E, Scionti L, Bolli GB. Related Articles, Links Intensive replacement of basal insulin in patients with type 1 diabetes given rapid‐acting insulin analog at mealtime: a 3‐month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime. Diabetes Care. 2003 May;26(5):1490‐6.] <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.26.5.1490" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12716810" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Intensive+replacement+of+basal+insulin+in+patients+with+type+1+diabetes+given+rapid%E2%80%90acting+insulin+analog+at+mealtime:+a+3%E2%80%90month+comparison+between+administration+of+NPH+insulin+four+times+daily+and+glargine+insulin+at+dinner+or+bedtime+&author=P+Rossetti&author=S+Pampanelli&author=C+Fanelli&author=F+Porcellati&author=E+Costa&author=E+Torlone&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3sXjvVegsbw%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000185505400027&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 63</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006297-bbs2-0019"> <div class="reference-title-banner"> <h4 class="title">Russell‐Jones 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0020"> <div class="citation-journal">Russell‐Jones D, et al. <span class="citation-title">Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal‐bolus regimen</span>. <span class="citation"> Clinical Therapeutics </span><span class="pubYear">2004</span>;<span class="volume">26</span>(5):724‐36. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2FS0149-2918%2804%2990072-0" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15220016" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effects+of+QD+insulin+detemir+or+neutral+protamine+Hagedorn+on+blood+glucose+control+in+patients+with+type+I+diabetes+mellitus+using+a+basal%E2%80%90bolus+regimen+&author=D+Russell%E2%80%90Jones&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2cXlsFCisL0%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000221891700009&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 94</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006297-bbs2-0020"> <div class="reference-title-banner"> <h4 class="title">Schober 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0021"> <div class="citation-journal">Schober E, et al. <span class="citation-title">Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2001</span>;<span class="volume">24</span>(11):2005‐6. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.24.11.2005" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11679478" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparative+trial+between+insulin+glargine+and+NPH+insulin+in+children+and+adolescents+with+type+1+diabetes+&author=E+Schober&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DC%2BD3MrntF2itw%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000171937800033&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 29</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006297-bbs2-0021"> <div class="reference-title-banner"> <h4 class="title">Tunbridge 1989 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0022"> <div class="citation-journal">Tunbridge FK, et al. <span class="citation-title">A comparison of human ultralente‐ and lente‐based twice‐daily injection regimens</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1989</span>;<span class="volume">6</span>(6):496‐501. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1111%2Fj.1464-5491.1989.tb01216.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/2527130" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+comparison+of+human+ultralente%E2%80%90+and+lente%E2%80%90based+twice%E2%80%90daily+injection+regimens&author=FK+Tunbridge&publication_year=1989&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaL1MzjslCnsQ%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1989AH64300005&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 15</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006297-bbs2-0022"> <div class="reference-title-banner"> <h4 class="title">Vague 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0023"> <div class="citation-journal">Vague P, Selam JL, Skeie S, Leeuw I, Elte JW, Haahr H, Kristensen A, Draeger E. <span class="citation-title">Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal‐bolus regimen with premeal insulin aspart</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2003</span>;<span class="volume">26</span>(3):590‐6. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.26.3.590" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12610006" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+detemir+is+associated+with+more+predictable+glycemic+control+and+reduced+risk+of+hypoglycemia+than+NPH+insulin+in+patients+with+type+1+diabetes+on+a+basal%E2%80%90bolus+regimen+with+premeal+insulin+aspart+&author=P+Vague&author=JL+Selam&author=S+Skeie&author=I+Leeuw&author=JW+Elte&author=H+Haahr&author=A+Kristensen&author=E+Draeger&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3sXisVClt74%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000185505100006&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 125</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_includedStudies" id="CD006297-bbs2-0023"> <div class="reference-title-banner"> <h4 class="title">Zinman 1999 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0024"> <div class="citation-journal">Zinman B, et al. <span class="citation-title">Effectiveness of human ultralente versus NPH insulin in providing basal insulin replacement for an insulin lispro multiple daily injection regimen. A double‐blind randomized prospective trial. The Canadian Lispro Study Group</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1999</span>;<span class="volume">22</span>(4):603‐8. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.22.4.603" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10189539" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effectiveness+of+human+ultralente+versus+NPH+insulin+in+providing+basal+insulin+replacement+for+an+insulin+lispro+multiple+daily+injection+regimen.+A+double%E2%80%90blind+randomized+prospective+trial.+The+Canadian+Lispro+Study+Group+&author=B+Zinman&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK1M3gsFGgtQ%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000079317900012&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 13</span></a></li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD006297-bbs1-0002"> <h3 class="title">References to studies excluded from this review</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD006297-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD006297-bbs1-0003">ongoing studies</a></li> <li><a class="jump-to" href="#CD006297-bbs1-0004">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006297-bbs2-0024"> <div class="reference-title-banner"> <h4 class="title">Albright 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0025"> <div class="citation-journal">Albright ES, Desmond R, Bell DS. <span class="citation-title">Efficacy of conversion from bedtime NPH insulin injection to once‐ or twice‐daily injections of insulin glargine in type 1 diabetic patients using basal/bolus therapy</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2004</span>;<span class="volume">27</span>(2):632‐3. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.27.2.632" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14747268" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Efficacy+of+conversion+from+bedtime+NPH+insulin+injection+to+once%E2%80%90+or+twice%E2%80%90daily+injections+of+insulin+glargine+in+type+1+diabetic+patients+using+basal/bolus+therapy+&author=ES+Albright&author=R+Desmond&author=DS+Bell&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000188739900066&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 27</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006297-bbs2-0025"> <div class="reference-title-banner"> <h4 class="title">Alemzadeh 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0026"> <div class="citation-journal">Alemzadeh R, et al. <span class="citation-title">Beneficial effects of flexible insulin therapy in children and adolescents with type 1 diabetes mellitus</span>. <span class="citation"> Acta Diabetologica </span> 40;<span class="volume">3</span>:137‐42. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006297-bbs2-0026"> <div class="reference-title-banner"> <h4 class="title">Alemzadeh 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0027"> <div class="citation-journal">Alemzadeh R, Berhe T, Wyatt DT. <span class="citation-title">Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycemia among preschool‐aged children with type 1 diabetes mellitus</span>. <span class="citation"> Pediatrics </span><span class="pubYear">2005</span>;<span class="volume">115</span>(5):1320‐4. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1542%2Fpeds.2004-1439" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15867042" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Flexible+insulin+therapy+with+glargine+insulin+improved+glycemic+control+and+reduced+severe+hypoglycemia+among+preschool%E2%80%90aged+children+with+type+1+diabetes+mellitus+&author=R+Alemzadeh&author=T+Berhe&author=DT+Wyatt&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000228833500033&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 25</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006297-bbs2-0027"> <div class="reference-title-banner"> <h4 class="title">Heise 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0028"> <div class="citation-journal">Heise T, et al. <span class="citation-title">Lower Within‐Subject Variability of Insulin Detemir in Comparison to NPH Insulin and Insulin Glargine in People With Type 1 Diabetes</span>. <span class="citation"> Diaetes </span><span class="pubYear">2003</span>;<span class="volume">53</span>:1614‐20. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiabetes.53.6.1614" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Lower+Within%E2%80%90Subject+Variability+of+Insulin+Detemir+in+Comparison+to+NPH+Insulin+and+Insulin+Glargine+in+People+With+Type+1+Diabetes+&author=T+Heise&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000221690200030&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 181</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006297-bbs2-0028"> <div class="reference-title-banner"> <h4 class="title">Hershon 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0029"> <div class="citation-journal">Hershon KS, et al. <span class="citation-title">Once‐daily insulin glargine compared with twice‐daily NPH insulin in patients with type 1 diabetes</span>. <span class="citation"> Endocrine Practice </span><span class="pubYear">2004</span>;<span class="volume">10</span>(1):10‐7. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.4158%2FEP.10.1.10" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15251616" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Once%E2%80%90daily+insulin+glargine+compared+with+twice%E2%80%90daily+NPH+insulin+in+patients+with+type+1+diabetes+&author=KS+Hershon&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006297-bbs2-0029"> <div class="reference-title-banner"> <h4 class="title">Herwig 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0030"> <div class="citation-journal">Herwig J, Scholl‐Schilling G, Bohles H. <span class="citation-title">Glycaemic control and hypoglycaemia in children, adolescents and young adults with unstable type 1 diabetes mellitus treated with insulin glargine or intermediate‐acting insulin</span>. <span class="citation"> Jounal of pediatric endocrinology and metabolism </span><span class="pubYear">2007</span>;<span class="volume">20</span>(4):517‐25. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1515%2FJPEM.2007.20.4.517" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Glycaemic+control+and+hypoglycaemia+in+children,+adolescents+and+young+adults+with+unstable+type+1+diabetes+mellitus+treated+with+insulin+glargine+or+intermediate%E2%80%90acting+insulin+&author=J+Herwig&author=G+Scholl%E2%80%90Schilling&author=H+Bohles&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2sXmsVGrsrw%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000246599200010&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 2</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006297-bbs2-0030"> <div class="reference-title-banner"> <h4 class="title">Kiess 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0031"> <div class="citation-journal">Kiess W, et al. <span class="citation-title">Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2004</span>;<span class="volume">27</span>(10):2567‐8. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.27.10.2567-a" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15451944" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+detemir+offers+improved+glycemic+control+compared+with+NPH+insulin+in+people+with+type+1+diabetes+&author=W+Kiess&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000224115700056&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 5</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006297-bbs2-0031"> <div class="reference-title-banner"> <h4 class="title">Lepore 2000 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0032"> <div class="citation-journal">Lepore M, Pampanelli S, Fanelli C, Porcellati F, Bartocci L, Di VA, et al. <span class="citation-title">Pharmacokinetics and pharmacodynamics of subcutaneous injection of long‐acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro</span>. <span class="citation"> Diabetes </span><span class="pubYear">2000</span>;<span class="volume">49</span>(12):2142‐8. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiabetes.49.12.2142" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11118018" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Pharmacokinetics+and+pharmacodynamics+of+subcutaneous+injection+of+long%E2%80%90acting+human+insulin+analog+glargine,+NPH+insulin,+and+ultralente+human+insulin+and+continuous+subcutaneous+infusion+of+insulin+lispro+&author=M+Lepore&author=S+Pampanelli&author=C+Fanelli&author=F+Porcellati&author=L+Bartocci&author=VA+Di&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3cXos1ejsLo%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000165573500023&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 338</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006297-bbs2-0032"> <div class="reference-title-banner"> <h4 class="title">Lepore 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0033"> <div class="citation-journal">Lepore G, et al. <span class="citation-title">Both continuous subcutaneous insulin infusion and a multiple daily insulin injection regimen with glargine as basal insulin are equally better than traditional multiple daily insulin injection treatment</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2003</span>;<span class="volume">26</span>(4):1321‐2. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.26.4.1321" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12663625" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Both+continuous+subcutaneous+insulin+infusion+and+a+multiple+daily+insulin+injection+regimen+with+glargine+as+basal+insulin+are+equally+better+than+traditional+multiple+daily+insulin+injection+treatment+&author=G+Lepore&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000185505300067&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 31</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006297-bbs2-0033"> <div class="reference-title-banner"> <h4 class="title">Manini 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0034"> <div class="citation-journal">Manini R, Forlani G, Moscatiello S, Zannoni C, Marzocchi R, Marchesini G. <span class="citation-title">Insulin glargine improves glycemic control and health‐related quality of life in type 1 diabetes</span>. <span class="citation"> Nutrition, Metabolism &amp; Cardiovascular Diseases </span><span class="pubYear">2007</span>;<span class="volume">17</span>:493‐8. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2Fj.numecd.2006.07.001" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+glargine+improves+glycemic+control+and+health%E2%80%90related+quality+of+life+in+type+1+diabetes+&author=R+Manini&author=G+Forlani&author=S+Moscatiello&author=C+Zannoni&author=R+Marzocchi&author=G+Marchesini&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD1cXkslSmsQ%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000250026800003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 5</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006297-bbs2-0034"> <div class="reference-title-banner"> <h4 class="title">Mimouni 1979 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0035"> <div class="citation-journal">Mimouni M, et al. <span class="citation-title">Comparison of one daily injection of NPH and crystalline PZI insulins on urinary glucose in diabetic children</span>. <span class="citation"> Acta Diabetologica Latina </span><span class="pubYear">1979</span>;<span class="volume">16</span>(1):63‐6. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1007%2FBF02590764" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/377878" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Comparison+of+one+daily+injection+of+NPH+and+crystalline+PZI+insulins+on+urinary+glucose+in+diabetic+children+&author=M+Mimouni&publication_year=1979&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaE1M3gsFOrsg%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1979GU19800008&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006297-bbs2-0035"> <div class="reference-title-banner"> <h4 class="title">Moretti 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0036"> <div class="citation-journal">Moretti V, et al. <span class="citation-title">Treatment with glargine in adolescents with type 1 diabetes mellitus: Clinical and metabolic control after 9 months</span>. <span class="citation"> Rivista Italiana di Medicina Dell'Adolescenza </span><span class="pubYear">2005</span>;<span class="volume">3</span>(1):36‐41. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Treatment+with+glargine+in+adolescents+with+type+1+diabetes+mellitus:+Clinical+and+metabolic+control+after+9+months+&author=V+Moretti&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006297-bbs2-0036"> <div class="reference-title-banner"> <h4 class="title">Palmer 2004 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0037"> <div class="citation-journal">Palmer AJ, et al. <span class="citation-title">Cost‐effectiveness of detemir‐based basal/bolus therapy versus NPH‐based basal/bolus therapy for type 1 diabetes in a UK setting: an economic analysis based on meta‐analysis results of four clinical trials</span>. <span class="citation"> Current Medical Research &amp; Opinion </span><span class="pubYear">2004</span>;<span class="volume">20</span>(11):1729‐46. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1185%2F030079904X5661" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Cost%E2%80%90effectiveness+of+detemir%E2%80%90based+basal/bolus+therapy+versus+NPH%E2%80%90based+basal/bolus+therapy+for+type+1+diabetes+in+a+UK+setting:+an+economic+analysis+based+on+meta%E2%80%90analysis+results+of+four+clinical+trials+&author=AJ+Palmer&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000225488600004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 13</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006297-bbs2-0037"> <div class="reference-title-banner"> <h4 class="title">Ratner 2003 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0038"> <div class="citation-journal">Ratner R. <span class="citation-title">Insulin glargine versus NPH insulin in patients with type 1 diabetes</span>. <span class="citation"> Drugs of Today </span><span class="pubYear">2003</span>;<span class="volume">39</span>(11):867‐76. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1358%2Fdot.2003.39.11.799464" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/14702132" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+glargine+versus+NPH+insulin+in+patients+with+type+1+diabetes&author=R+Ratner&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2cXisFKhurw%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000189275500004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 2</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006297-bbs2-0038"> <div class="reference-title-banner"> <h4 class="title">Saisho 2005 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0039"> <div class="citation-journal">Saisho Y, et al. <span class="citation-title">Effect of switching from NPH insulin to insulin glargine on glycemic control in Japanese type 1 diabetic patients</span>. <span class="citation"> Journal of the Japan Diabetes Society </span><span class="pubYear">2005</span>;<span class="volume">48</span>(9):685‐91. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Effect+of+switching+from+NPH+insulin+to+insulin+glargine+on+glycemic+control+in+Japanese+type+1+diabetic+patients+&author=Y+Saisho&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXht1Gmsr%2FO" target="_blank"><span>CAS</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006297-bbs2-0039"> <div class="reference-title-banner"> <h4 class="title">Urakami 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0040"> <div class="citation-journal">Urakami T, et al. <span class="citation-title">Usefulness of long acting insulin analogue glargine in basal‐bolus therapy for Japanese children and adolscents with type 1 diabetes mellitus</span>. <span class="citation"> Journal of Pediatric endocrinology and metabolism </span><span class="pubYear">2007</span>;<span class="volume">20</span>:807‐15. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1515%2FJPEM.2007.20.7.807" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17849743" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Usefulness+of+long+acting+insulin+analogue+glargine+in+basal%E2%80%90bolus+therapy+for+Japanese+children+and+adolscents+with+type+1+diabetes+mellitus+&author=T+Urakami&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2sXhtVentr3J" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000248735000009&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 2</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_excludedStudies" id="CD006297-bbs2-0040"> <div class="reference-title-banner"> <h4 class="title">Wutte 2007 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0041"> <div class="citation-journal">Wutte A, et al. <span class="citation-title">Proportional dose‐response relationship and lower within‐patient variability of insulin detemir and NPH insulin in subjects with type 1 diabetes mellitus</span>. <span class="citation"> Exp Clin Endocrinol Diabetes </span><span class="pubYear">2007</span>;<span class="volume">115</span>(7):461‐7. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1055%2Fs-2007-976512" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17647145" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Proportional+dose%E2%80%90response+relationship+and+lower+within%E2%80%90patient+variability+of+insulin+detemir+and+NPH+insulin+in+subjects+with+type+1+diabetes+mellitus+&author=A+Wutte&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2sXps1aktL0%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000248681200010&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 5</span></a></li> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD006297-bbs1-0003"> <h3 class="title">References to ongoing studies</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD006297-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD006297-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD006297-bbs1-0004">additional references</a></li> </ul> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD006297-bbs2-0041"> <div class="reference-title-banner"> <h4 class="title">Alcolado 2001 {unpublished data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0042"> <div class="citation-other"><span class="citation-title">Efficacy and safety of basal insulin analogue detemir and NPH insulin in patients with Type 1 diabetes on basal‐bolus regimen</span>. Ongoing study<span class="pubYear">1.2.01</span>. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_ongoingStudies" id="CD006297-bbs2-0042"> <div class="reference-title-banner"> <h4 class="title">Page 2001 {published data only} </h4> </div> <div class="bibliography-section" id="CD006297-bib-0043"> <div class="citation-other">Page M. <span class="citation-title">16 week multi‐center, open, randomised 3 group parallel study comparing insuln determir with NPH</span>. The National Research Register (NRR) Archive. <ul class="citation-link-group"> </ul> </div> </div> </div> </section> <section> <div class="section-header" id="CD006297-bbs1-0004"> <h3 class="title">Additional references</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a class="jump-to" href="#CD006297-bbs1-0001">included studies</a></li> <li><a class="jump-to" href="#CD006297-bbs1-0002">excluded studies</a></li> <li><a class="jump-to" href="#CD006297-bbs1-0003">ongoing studies</a></li> </ul> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006297-bbs2-0043"> <div class="reference-title-banner"> <h4 class="title">ADA 1997</h4> </div> <div class="bibliography-section" id="CD006297-bib-0044"> <div class="citation-journal">American Diabetes Association. <span class="citation-title">Report on the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1997</span>;<span class="volume">20 Suppl 1</span>:S5‐20. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1997WA46700002&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006297-bbs2-0044"> <div class="reference-title-banner"> <h4 class="title">ADA 1999</h4> </div> <div class="bibliography-section" id="CD006297-bib-0045"> <div class="citation-journal">The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. <span class="citation-title">Report of the Expert Committee on the diagnosis and classification of diabetes mellitus</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1999</span>;<span class="volume">22 Suppl 1</span>:S5‐19. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006297-bbs2-0045"> <div class="reference-title-banner"> <h4 class="title">Bolli 1999</h4> </div> <div class="bibliography-section" id="CD006297-bib-0046"> <div class="citation-journal">Bolli GB, Marchi RD, Park GD, Pramming S, Koivisto VA. <span class="citation-title">Insulin analogues and their potential in the management of diabetes mellitus</span>. <span class="citation"> Diabetologia </span><span class="pubYear">1999</span>;<span class="volume">42</span>:1151‐67. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1007%2Fs001250051286" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10525654" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Insulin+analogues+and+their+potential+in+the+management+of+diabetes+mellitus&author=GB+Bolli&author=RD+Marchi&author=GD+Park&author=S+Pramming&author=VA+Koivisto&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DyaK1MXmt1ymtr0%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000082935500001&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 187</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006297-bbs2-0046"> <div class="reference-title-banner"> <h4 class="title">Cohen 1960</h4> </div> <div class="bibliography-section" id="CD006297-bib-0047"> <div class="citation-journal">Cohen J. <span class="citation-title">A coefficient of agreement for nominal scales</span>. <span class="citation"> Educational and Psychological Measurement </span><span class="pubYear">1960</span>;<span class="volume">20</span>:37‐46. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1177%2F001316446002000104" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=A+coefficient+of+agreement+for+nominal+scales&author=J+Cohen&publication_year=1960&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1960CCC3600004&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 8015</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006297-bbs2-0047"> <div class="reference-title-banner"> <h4 class="title">Havelund 2004</h4> </div> <div class="bibliography-section" id="CD006297-bib-0048"> <div class="citation-journal">Havelund S, Plum A, Ribel U, Jonassen I, Volund A, Markussen J, et al. <span class="citation-title">The mechanism of protraction of insulin detemir, a long‐acting, acylated analog of human insulin</span>. <span class="citation"> Pharmaceutical research </span><span class="pubYear">2004</span>;<span class="volume">21</span>(8):1498‐504. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1023%2FB%3APHAM.0000036926.54824.37" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15359587" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=The+mechanism+of+protraction+of+insulin+detemir,+a+long%E2%80%90acting,+acylated+analog+of+human+insulin+&author=S+Havelund&author=A+Plum&author=U+Ribel&author=I+Jonassen&author=A+Volund&author=J+Markussen&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2cXmtlGntbg%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000223119800022&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 73</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006297-bbs2-0048"> <div class="reference-title-banner"> <h4 class="title">Heinemann 2000</h4> </div> <div class="bibliography-section" id="CD006297-bib-0049"> <div class="citation-journal">Heinemann L, Linkeschova R, Rave K, Hompesch B, Sedlak M, Heise T. <span class="citation-title">Time‐action profile of the long‐acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2000</span>;<span class="volume">23</span>(5):644‐9. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.23.5.644" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10834424" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Time%E2%80%90action+profile+of+the+long%E2%80%90acting+insulin+analog+insulin+glargine+(HOE901)+in+comparison+with+those+of+NPH+insulin+and+placebo+&author=L+Heinemann&author=R+Linkeschova&author=K+Rave&author=B+Hompesch&author=M+Sedlak&author=T+Heise&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3cXnvVymsb8%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000087022800017&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 184</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006297-bbs2-0049"> <div class="reference-title-banner"> <h4 class="title">Heise 2004</h4> </div> <div class="bibliography-section" id="CD006297-bib-0050"> <div class="citation-journal">Heise T, Nosek L, Ronn BB, Endahl L, Heinemann L, Kapitza C, et al. <span class="citation-title">Lower within‐subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes</span>. <span class="citation"> Diabetes </span><span class="pubYear">2004</span>;<span class="volume">53</span>(6):1614‐20. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiabetes.53.6.1614" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15161770" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Lower+within%E2%80%90subject+variability+of+insulin+detemir+in+comparison+to+NPH+insulin+and+insulin+glargine+in+people+with+type+1+diabetes+&author=T+Heise&author=L+Nosek&author=BB+Ronn&author=L+Endahl&author=L+Heinemann&author=C+Kapitza&publication_year=2004&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2cXkslCgsLc%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000221690200030&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 181</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006297-bbs2-0050"> <div class="reference-title-banner"> <h4 class="title">Higgins 2002</h4> </div> <div class="bibliography-section" id="CD006297-bib-0051"> <div class="citation-journal">Higgins JPT, Thompson SG. <span class="citation-title">Quantifying heterogeneity in a meta‐analysis</span>. <span class="citation"> Statistics in Medicine </span><span class="pubYear">2002</span>;<span class="volume">21</span>:1539‐58. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2Fsim.1186" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12111919" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Quantifying+heterogeneity+in+a+meta%E2%80%90analysis&author=JPT+Higgins&author=SG+Thompson&publication_year=2002&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000176016900005&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 7174</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006297-bbs2-0051"> <div class="reference-title-banner"> <h4 class="title">Higgins 2003</h4> </div> <div class="bibliography-section" id="CD006297-bib-0052"> <div class="citation-journal">Higgins JPT, Thompson SG, Deeks JJ, Altman DG. <span class="citation-title">Measuring inconsistency in meta‐analyses</span>. <span class="citation"> BMJ </span><span class="pubYear">2003</span>;<span class="volume">327</span>:557‐60. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1136%2Fbmj.327.7414.557" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/12958120" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Measuring+inconsistency+in+meta%E2%80%90analyses&author=JPT+Higgins&author=SG+Thompson&author=JJ+Deeks&author=DG+Altman&publication_year=2003&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000185283700028&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 15264</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006297-bbs2-0052"> <div class="reference-title-banner"> <h4 class="title">Higgins 2005</h4> </div> <div class="bibliography-section" id="CD006297-bib-0053"> <div class="citation-other">Higgins JPT, Green S, editors. <span class="citation-title">Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]</span>. In: The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley &amp; Sons, Ltd. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006297-bbs2-0053"> <div class="reference-title-banner"> <h4 class="title">Hirsch 1998</h4> </div> <div class="bibliography-section" id="CD006297-bib-0054"> <div class="citation-journal">Hirsch IB. <span class="citation-title">Intensive treatment of type 1 diabetes</span>. <span class="citation"> The Medical clinics of North America </span><span class="pubYear">1998</span>;<span class="volume">82</span>:689‐719. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2FS0025-7125%2805%2970020-1" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9706117" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Intensive+treatment+of+type+1+diabetes&author=IB+Hirsch&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DyaK1cXlt1Skur8%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000075085000003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 30</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006297-bbs2-0054"> <div class="reference-title-banner"> <h4 class="title">Horvath 2007</h4> </div> <div class="bibliography-section" id="CD006297-bib-0055"> <div class="citation-journal">Horvath K, Jeitler K, Berghold A, Ebrahim SH, Gratzer TW, Plank J, Kaiser T, Pieber TR, Siebenhofer A. <span class="citation-title">Long‐acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus</span>. <span class="citation"> Cochrane Database of Systematic Reviews </span><span class="pubYear">2007</span>, Issue 2. [DOI: <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002/14651858.CD005613.pub3" target="_blank"><span>10.1002/14651858.CD005613.pub3</span></a>] <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2F14651858.CD005613.pub3" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/17443605" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Long%E2%80%90acting+insulin+analogues+versus+NPH+insulin+(human+isophane+insulin)+for+type+2+diabetes+mellitus+&author=K+Horvath&author=K+Jeitler&author=A+Berghold&author=SH+Ebrahim&author=TW+Gratzer&author=J+Plank&author=T+Kaiser&author=TR+Pieber&author=A+Siebenhofer&publication_year=2007&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006297-bbs2-0055"> <div class="reference-title-banner"> <h4 class="title">Jadad 1996</h4> </div> <div class="bibliography-section" id="CD006297-bib-0056"> <div class="citation-journal">Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. <span class="citation-title">Assessing the quality of reports of randomized clinical trials: Is blinding necessary?</span>. <span class="citation"> Controlled Clinical Trials </span><span class="pubYear">1996</span>;<span class="volume">17</span>:1‐12. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2F0197-2456%2895%2900134-4" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/8721797" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Assessing+the+quality+of+reports+of+randomized+clinical+trials:+Is+blinding+necessary?&author=AR+Jadad&author=RA+Moore&author=D+Carroll&author=C+Jenkinson&author=DJ+Reynolds&author=DJ+Gavaghan&publication_year=1996&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK28zgvVCmug%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1996UA39800001&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 5192</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006297-bbs2-0056"> <div class="reference-title-banner"> <h4 class="title">Kurtzhals 2000</h4> </div> <div class="bibliography-section" id="CD006297-bib-0057"> <div class="citation-journal">Kurtzhals P, Schaffer L, Sorensen A, Kristensen C, Jonassen I, Schmid C, et al. <span class="citation-title">Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use.</span>. <span class="citation"> Diabetes </span><span class="pubYear">2000</span>;<span class="volume">49</span>(6):999‐1005. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiabetes.49.6.999" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10866053" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Correlations+of+receptor+binding+and+metabolic+and+mitogenic+potencies+of+insulin+analogs+designed+for+clinical+use.+&author=P+Kurtzhals&author=L+Schaffer&author=A+Sorensen&author=C+Kristensen&author=I+Jonassen&author=C+Schmid&publication_year=2000&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3cXjvFylu7w%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000087314100016&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 244</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006297-bbs2-0057"> <div class="reference-title-banner"> <h4 class="title">Moher 1999</h4> </div> <div class="bibliography-section" id="CD006297-bib-0058"> <div class="citation-journal">Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. <span class="citation-title">Improving the quality of reports of meta‐analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta‐analyses</span>. <span class="citation"> Lancet </span><span class="pubYear">1999</span>;<span class="volume">354</span>(9193):1896‐900. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1016%2FS0140-6736%2899%2904149-5" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10584742" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Improving+the+quality+of+reports+of+meta%E2%80%90analyses+of+randomised+controlled+trials:+the+QUOROM+statement.+Quality+of+Reporting+of+Meta%E2%80%90analyses+&author=D+Moher&author=DJ+Cook&author=S+Eastwood&author=I+Olkin&author=D+Rennie&author=DF+Stroup&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DC%2BD3c%2FkvFCgtQ%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000083909100044&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 1883</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006297-bbs2-0058"> <div class="reference-title-banner"> <h4 class="title">Rizza 1986</h4> </div> <div class="bibliography-section" id="CD006297-bib-0059"> <div class="citation-journal">Rizza R, O'Brien P, Service F. <span class="citation-title">Use of beef ultralente for basal insulin delivery: plasma insulin concentrations after chronic ultralente administration in patients with IDDM</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1986</span>;<span class="volume">9</span>:120‐3. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.9.2.120" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/3698778" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Use+of+beef+ultralente+for+basal+insulin+delivery:+plasma+insulin+concentrations+after+chronic+ultralente+administration+in+patients+with+IDDM+&author=R+Rizza&author=P+O'Brien&author=F+Service&publication_year=1986&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaL287ptFOksA%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1986A718300003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 16</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006297-bbs2-0059"> <div class="reference-title-banner"> <h4 class="title">Rosenstock 2005</h4> </div> <div class="bibliography-section" id="CD006297-bib-0060"> <div class="citation-journal">Rosenstock J, Dailey G, Massi‐Benedetti M, Fritsche A, Lin Z, Salzman A. <span class="citation-title">Reduced hypoglycemia risk with Insulin Glargine: A meta‐analysis comparing insulin glargine with human NPH insulin in type 2 diabetes</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">2005</span>;<span class="volume">28</span>:950‐5. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.2337%2Fdiacare.28.4.950" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/15793205" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Reduced+hypoglycemia+risk+with+Insulin+Glargine:+A+meta%E2%80%90analysis+comparing+insulin+glargine+with+human+NPH+insulin+in+type+2+diabetes+&author=J+Rosenstock&author=G+Dailey&author=M+Massi%E2%80%90Benedetti&author=A+Fritsche&author=Z+Lin&author=A+Salzman&publication_year=2005&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD2MXjtlKru7k%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000234548000035&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 107</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006297-bbs2-0060"> <div class="reference-title-banner"> <h4 class="title">Rosskamp 1999</h4> </div> <div class="bibliography-section" id="CD006297-bib-0061"> <div class="citation-journal">Rosskamp R, Park G. <span class="citation-title">Long acting insulin analogues</span>. <span class="citation"> Diabetes Care </span><span class="pubYear">1999</span>;<span class="volume">22 (Suppl 2)</span>:B109‐13. <ul class="citation-link-group"> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/10097910" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Long+acting+insulin+analogues&author=R+Rosskamp&author=G+Park&publication_year=1999&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000078860200020&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 45</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006297-bbs2-0061"> <div class="reference-title-banner"> <h4 class="title">Schulz 1995</h4> </div> <div class="bibliography-section" id="CD006297-bib-0062"> <div class="citation-journal">Schulz KF, Chalmers I, Hayes RJ, Altman DG. <span class="citation-title">Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials</span>. <span class="citation"> JAMA </span><span class="pubYear">1995</span>;<span class="volume">237</span>:408‐12. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1001%2Fjama.273.5.408" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Empirical+evidence+of+bias:+dimensions+of+methodological+quality+associated+with+estimates+of+treatment+effects+in+controlled+trials+&author=KF+Schulz&author=I+Chalmers&author=RJ+Hayes&author=DG+Altman&publication_year=1995&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3AA1995QD20300026&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 2796</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006297-bbs2-0062"> <div class="reference-title-banner"> <h4 class="title">WHO 1980</h4> </div> <div class="bibliography-section" id="CD006297-bib-0063"> <div class="citation-other">WHO Expert Committee on Diabetes Mellitus. <span class="citation-title">Second report. Technical Report Series 646</span>. Geneva. WHO, 1980. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006297-bbs2-0063"> <div class="reference-title-banner"> <h4 class="title">WHO 1985</h4> </div> <div class="bibliography-section" id="CD006297-bib-0064"> <div class="citation-other"><span class="citation-title">WHO Expert Committee on Diabetes Mellitus</span>. World Health Organization, 1985. Technical Report Series 727. <ul class="citation-link-group"> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006297-bbs2-0064"> <div class="reference-title-banner"> <h4 class="title">WHO 1998</h4> </div> <div class="bibliography-section" id="CD006297-bib-0065"> <div class="citation-journal">Alberti KM, Zimmet PZ. <span class="citation-title">Definition, diagnosis and classification of diabetes mellitus and its compliactions. Part I: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">1998</span>;<span class="volume">15</span>:539‐53. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1002%2F%28SICI%291096-9136%28199807%2915%3A7%3C539%3A%3AAID-DIA668%3E3.0.CO%3B2-S" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/9686693" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Definition,+diagnosis+and+classification+of+diabetes+mellitus+and+its+compliactions.+Part+I:+diagnosis+and+classification+of+diabetes+mellitus.+Provisional+report+of+a+WHO+consultation+&author=KM+Alberti&author=PZ+Zimmet&publication_year=1998&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:STN:280:DyaK1czkvFCrsA%3D%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000074777700003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 5837</span></a></li> </ul> </div> </div> </div> <div class="bibliographies references_additionalReferences" id="CD006297-bbs2-0065"> <div class="reference-title-banner"> <h4 class="title">Witthaus 2001</h4> </div> <div class="bibliography-section" id="CD006297-bib-0066"> <div class="citation-journal">Witthaus E, Stewart J, Bradley C. <span class="citation-title">Treatment satisfaction and psychological well‐being with insulin glargine compared with NPH in patients with Type 1 diabetes</span>. <span class="citation"> Diabetic Medicine </span><span class="pubYear">2001</span>;<span class="volume">18</span>:619‐25. <ul class="citation-link-group"> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MS6C63DQNEYG86UH/10.1046%2Fj.1464-5491.2001.00529.x" target="_blank"><span>Link to article</span></a></li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUPMNSGTLUPNSXT65UJNAYGP55X/pubmed/11553198" target="_blank"> <span>PubMed</span> </a> </li> <li> <a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/PNSXR55MMF3C635QN7UXZ3JPMNYXN/scholar_lookup?title=Treatment+satisfaction+and+psychological+well%E2%80%90being+with+insulin+glargine+compared+with+NPH+in+patients+with+Type+1+diabetes+&author=E+Witthaus&author=J+Stewart&author=C+Bradley&publication_year=2001&hl=en" target="_blank"> <span>Google Scholar</span> </a> </li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/resolve/reference/CAS?id=1:CAS:528:DC%2BD3MXntFGmsLw%3D" target="_blank"><span>CAS</span></a></li> <li><a class="citation-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MFZHA63PP7TXE55GNNYG875MMWTGP3JPMNYXN/InboundService.do?product=WOS&amp;SID=Z1FSlHDk1z1GrOHrYUW&amp;UT=WOS%3A000171186300003&amp;SrcApp=Wiley_Online_Library&amp;DestFail=http%3A%2F%2Fwww.webofknowledge.com&amp;action=retrieve&amp;Init=Yes&amp;SrcAuth=LinksAMR&amp;Func=Frame&amp;customersID=LinksAMR&amp;IsProductCode=Yes&amp;mode=FullRecord" target="_blank"><span>Web of Science® Times Cited: 54</span></a></li> </ul> </div> </div> </div> </section> </section> <section class="characteristicStudies" id="characteristicStudies"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title"> Characteristics of studies <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="characteristicIncludedStudiesContent" lang=""> <div class="section-header" id="CD006297-sec2-0015"> <h3 class="title">Characteristics of included studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD006297-sec2-0016" class="jump-to">excluded studies</a></li> <li><a href="#CD006297-sec2-0017" class="jump-to">ongoing studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Ashwell 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 16 weeks. <br> DURATION OF FOLLOW‐UP: <br> N/A <br> RUN‐IN PERIOD: <br> 4 weeks. <br> LANGUAGE OF PUBLICATION: <br> English. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Type 1 diabetic adult patients. <br> INCLUSION CRITERIA: <br> The people recruited were men and women aged 18‐65 years with Type 1 diabetes and no previous experience of insulin glargine, who had been using a multiple insulin injection regimen for at least 1 year and who had a random C‐peptide ? 0.10 nmol/L and HbA1c 7.0‐9.5%. Women of childbearing potential were required to be using adequate contraception. <br> EXCLUSION CRITERIA: <br> People with proliferative retinopathy, recurrent severe hypoglycaemia, impaired hepatic or renal function, or who worked night shifts were excluded from the trial <br> DIAGNOSTIC CRITERIA: <br> Not defined </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 5 <br> SETTING: <br> Out‐patient+inpatient <br> INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> Glargine (QD) + Lispro <br> CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> NPH (QD/BID)+HI <br> TREATMENT BEFORE STUDY: <br> ? <br> TITRATION PERIOD: <br> 4 weeks </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S): <br> Glycosylated haemoglobin <br> SECONDARY OUTCOMES: <br> insulin doses, pre‐breakfast SMBG concentration, 24‐h eightpoint SMBG levels, 24‐h inpatient plasma glucose levels, and monthly rate of hypoglycaemia </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>STATED AIM OF STUDY: <br> The aim of the present study was to compare blood glucose control in people with Type 1 diabetes managed with a multiple insulin injection regimen and strict glycaemic targets using insulin glargine plus insulin lispro in combination, and NPH insulin plus unmodified human insulin. </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A ‐ Adequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Chatterjee 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 36 weeks. <br> DURATION OF FOLLOW‐UP: <br> N/A <br> RUN‐IN PERIOD: <br> 4 weeks. <br> LANGUAGE OF PUBLICATION: <br> English. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Type 1 diabetic adult patients. <br> INCLUSION CRITERIA: <br> Age between 18 and 75 years, type 1 diabetes on insulin for at least 6 months, body mass index less than 45, baseline HbA1c 6‐11%, and ability and willingness to perform self‐blood glucose monitoring. <br> EXCLUSION CRITERIA: <br> ? <br> DIAGNOSTIC CRITERIA: <br> Not defined </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 1 <br> SETTING: <br> Out‐patient. <br> INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> Determir (QD) + Aspart <br> CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> NPH (BID) + Aspart <br> TREATMENT BEFORE STUDY: <br> Twice‐daily or multiple dose insulin injections. <br> TITRATION PERIOD: <br> ? </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S): <br> Glycosylated haemoglobin <br> SECONDARY OUTCOMES: <br> Frequency of reported severe hypoglycaemic episodes and overall frequency of both severe and non‐severe <br> hypoglycaemic events during the last 12 weeks of each treatment period. Other secondary endpoints were FPG, <br> weight, fasting lipids and questionnaire‐based patient satisfaction. Safety endpoints were adverse event recording and vital signs namely pulse and blood pressure. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>STATED AIM OF STUDY: <br> Combining insulin glargine and aspart in a basal bolus regimen </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">De Leeuw 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 12 months. <br> DURATION OF FOLLOW‐UP: <br> N/A <br> RUN‐IN PERIOD: <br> ? weeks. <br> LANGUAGE OF PUBLICATION: <br> English. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Type 1 diabetic adult patients. <br> INCLUSION CRITERIA: <br> Patients initiated had a history of type 1 diabetes for over 1 year and had used basal‐bolus therapy for at least 2 months prior to enrolment. <br> EXCLUSION CRITERIA: <br> Proliferative retinopathy, impaired hepatic or renal function, severe cardiac problems, uncontrolled hypertension, recurrent major hypoglycaemia or allergy to insulin. Pregnant or breast‐feeding women were also excluded <br> DIAGNOSTIC CRITERIA: <br> Not defined </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 42 <br> SETTING: <br> Out‐patient. <br> INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> Detemir (BID) + Aspart <br> CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> NPH (BID) + Aspart <br> TREATMENT BEFORE STUDY: <br> ? <br> TITRATION PERIOD: <br> ? </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S): <br> ? <br> SECONDARY OUTCOMES: <br> Glycosylated haemoglobin, FPG and 9‐point BG profiles, weight gain, hypoglycaemia. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>STATED AIM OF STUDY: <br> To assess the relative safety and efficacy over a 1‐year period of insulin detemir in comparison to NPH insulin, with IAsp as mealtime insulin. </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Francis 1986 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 4 months. <br> DURATION OF FOLLOW‐UP: <br> N/A <br> RUN‐IN PERIOD: <br> 3 months. <br> LANGUAGE OF PUBLICATION: <br> English. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Type 1 diabetic adult patients. <br> INCLUSION CRITERIA: <br> Insulin dependent patients with persistent elevation of fasting blood glucose which could not be corrected. <br> EXCLUSION CRITERIA: <br> ? <br> DIAGNOSTIC CRITERIA: <br> Not defined </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 1 <br> SETTING: <br> Out‐patient+inpatient. <br> INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> Human ultralente (BID)+PI <br> CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> Porcine lente (BID) + PI <br> TREATMENT BEFORE STUDY: <br> Twice day mixture of short and intermediate acting insulins. <br> TITRATION PERIOD: <br> ? </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S): <br> ? <br> SECONDARY OUTCOMES: <br> Blood glucose, glycosylated haemoglobin, lactate, pyruvate, alanine, glycerol, NEFA, 3‐hydroxybutyrate, free insulin, GH, cortisol, adrenaline, noradrenaline, hypoglycaemia </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>STATED AIM OF STUDY: <br> Compare human ultralente and porcine lente. </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Fulcher 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 30 weeks. <br> DURATION OF FOLLOW‐UP: <br> N/A <br> RUN‐IN PERIOD: <br> 2 weeks. <br> LANGUAGE OF PUBLICATION: <br> English. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Type 1 diabetic adult patients. <br> INCLUSION CRITERIA: <br> Patients with type 1 diabetes, aged 18‐80 years, who were treated with insulin for at least 1 year and who had inadequate glycaemic control (HbA1c ?8%) <br> EXCLUSION CRITERIA: <br> Nightshift workers, patients with known sensitivity <br> to the study drug or related drugs, and patients <br> with impaired hepatic function or any other clinically <br> relevant physiological or psychological medical conditions <br> were excluded. <br> DIAGNOSTIC CRITERIA: <br> Not defined </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 9 <br> SETTING: <br> Out‐patient. <br> INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> Glargine (QD) + lispro. <br> CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> NPH (QD)+lispro <br> TREATMENT BEFORE STUDY: <br> ? <br> TITRATION PERIOD: <br> 6 weeks. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S): <br> Glycosylated haemoglobin. <br> SECONDARY OUTCOMES: <br> Mean and variability of FBG, response rates for FBG and HbA1c, the incidence and rate of hypoglycaemia, weight change and lipid profiles. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>STATED AIM OF STUDY: <br> To compare the effects of glargine and NPH, when administered once daily at bedtime in a <br> 'treat‐to‐target', basal‐bolus regimen with lispro (administered three‐times daily before meals), on metabolic control in patients with suboptimally controlled type 1 diabetes (HbA1c ?8%). </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Hermansen 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 6 weeks. <br> DURATION OF FOLLOW‐UP: <br> N/A <br> RUN‐IN PERIOD: <br> 2 weeks. <br> LANGUAGE OF PUBLICATION: <br> English. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Type 1 diabetic adult patients. <br> INCLUSION CRITERIA: <br> Had received once‐daily (evening) NPH in combination with meal‐related human soluble insulin <br> (HSI) for at least 6 months and had documented type 1 diabetes for &gt; 2 years. <br> EXCLUSION CRITERIA: <br> Patients with proliferative retinopathy; impaired hepatic function (aspartate aminotransferase and/or alkaline phosphatase at least twice the upper normal level); impaired renal function (creatinine &gt; 150 µmol/L); decompensated heart failure; unstable angina pectoris; myocardial infarction within the last year; hypertension (systolic and/or diastolic blood pressure &gt; 180 and 100 mmHg, respectively); hypoglycemic unawareness; recurrent major hypoglycemia; or allergy to insulin or any compositional component, as well as those who abused alcohol or narcotics; used systemic corticosteroids, _‐blockers, or hormones within the past month; or were pregnant, breast‐feeding, or using inadequate contraceptive measures. Patients treated with other investigational products within the last 3 months or previously treated with insulin detemir were also excluded. <br> DIAGNOSTIC CRITERIA: <br> Not defined </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 7 <br> SETTING: <br> Out‐patient+inpatient. <br> INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> Detemir (QD)+ HI <br> CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> NPH (QD) + HI <br> TREATMENT BEFORE STUDY: <br> NPH + HI <br> TITRATION PERIOD: <br> ? </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S): <br> Area under the serum glucose curve <br> in the time interval from 23:00 to 08:00. <br> SECONDARY OUTCOMES: <br> mean serum glucose profiles, eight‐point blood glucose profiles, mean levels of home‐monitored fasting blood glucose, mean fructosamine level, insulin doses, hypoglycaemic episodes. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>STATED AIM OF STUDY: <br> Compare the blood glucose‐lowering effect of insulin detemir with that of NPH in terms of metabolic <br> control, intrasubject variation in fasting blood glucose, dose requirement, and safety in type 1 diabetic patients treated with basal‐bolus therapy. </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Hermansen 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 18 weeks. <br> DURATION OF FOLLOW‐UP: <br> N/A <br> RUN‐IN PERIOD: <br> ?. <br> LANGUAGE OF PUBLICATION: <br> English. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Type 1 diabetic adult patients. <br> INCLUSION CRITERIA: <br> Age &lt; 18 years, duration of diabetes &gt; 12 months, BMI &lt; 35 kg/m2, HbA1c &lt; 12%, total daily insulin dose &lt;1.4 U/kg, and current treatment with any basal‐bolus insulin regimen or biphasic insulin treatment for at least 6 months. <br> EXCLUSION CRITERIA: <br> Proliferative retinopathy requiring acute treatment, impaired renal or hepatic function, severe cardiac problems, uncontrolled hypertension, recurrent major hypoglycaemia, allergy to insulin, history of drug or alcohol dependence, pregnancy, and breast‐feeding. <br> DIAGNOSTIC CRITERIA: <br> Not defined </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 64. <br> SETTING: <br> Out‐patient. <br> INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> Detemir (BID) + aspart. <br> CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> NPH (BID) + HI <br> TREATMENT BEFORE STUDY: <br> ? <br> TITRATION PERIOD: <br> 6 weeks. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S): <br> Glycosylated haemoglobin. <br> SECONDARY OUTCOMES: <br> Within‐person day‐today variation in plasma glucose, the 8‐point plasma glucose profiles, hypoglycaemia, body weight. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>STATED AIM OF STUDY: <br> To bring together these respective components to compare a combination of the two analogues with conventional human insulin in basal‐bolus therapy for patients with Type 1 diabetes mellitus. </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Home 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 16 weeks. <br> DURATION OF FOLLOW‐UP: <br> N/A <br> RUN‐IN PERIOD: <br> 2 weeks. <br> LANGUAGE OF PUBLICATION: <br> English. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Type 1 diabetic adult patients. <br> INCLUSION CRITERIA: <br> Men and women &gt; 18 years old with type 1 diabetes for &gt; 1 year who were already using a mealtime basal regimen for &gt; 2 months, with basal insulin dose &lt; 100 units/day, HbA1c &lt; 12.0%, and BMI &lt; 35.5 kg/m2. <br> EXCLUSION CRITERIA: <br> Proliferative retinopathy, recurrent major hypoglycemia, impaired hepatic or renal function, or uncontrolled cardiovascular problems, use of medication known to interfere with glucose metabolism, pregnant or breast‐feeding women. <br> DIAGNOSTIC CRITERIA: <br> Not defined </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 52 <br> SETTING: <br> Out‐patient. <br> INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> Detemir (BID) + Aspart. <br> CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> NPH (BID) + Aspart. <br> TREATMENT BEFORE STUDY: <br> ? <br> TITRATION PERIOD: <br> ? </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S): <br> ? <br> SECONDARY OUTCOMES: <br> HbA1c, FPG, and prebreakfast self monitored plasma glucose, ten‐point self‐monitored plasma glucose profiles, total and nocturnal (2300 ‐0600) excursions in the CGMS profiles, hypoglycemia </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>STATED AIM OF STUDY: <br> Investigate whether insulin detemir provides improved glycemic control compared with NPH insulin, regardless of administration time, when used in a mealtime‐basal treatment regimen. </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Home 2005 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 28 weeks. <br> DURATION OF FOLLOW‐UP: <br> N/A <br> RUN‐IN PERIOD: <br> ? weeks. <br> LANGUAGE OF PUBLICATION: <br> English. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Type 1 diabetic adult patients. <br> INCLUSION CRITERIA: <br> Type 1 diabetics with low post‐prandial C‐peptide levels. <br> EXCLUSION CRITERIA: <br> ? <br> DIAGNOSTIC CRITERIA: <br> Not defined </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 63. <br> SETTING: <br> Out‐patient. <br> INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> Glargine (QD) + HI <br> CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> NPH (QD/BID) + HI <br> TREATMENT BEFORE STUDY: <br> NPH, Ultralente <br> TITRATION PERIOD: <br> ? </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S): <br> Glycosylated haemoglobin. <br> SECONDARY OUTCOMES: <br> Fasting plasma glucose, fasting blood glucose, nocturnal bloog glucose, hypoglycaemia. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>STATED AIM OF THE HOME 2005 PUBLICATION: <br> To compare the effect of insulin glargine and NPH on overall blood glucose control and safety. <br> STATED AIM OF THE WITTHAUS 2001 PUBLICATION: <br> To evaluate the impact of <br> using insulin glargine on satisfaction with treatment and <br> psychological well‐being. </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Kolendorf 2006 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 16 weeks. <br> DURATION OF FOLLOW‐UP: <br> N/A <br> RUN‐IN PERIOD: <br> 2 weeks. <br> LANGUAGE OF PUBLICATION: <br> English. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Type 1 diabetic adult patients. <br> INCLUSION CRITERIA: <br> Age &lt; 18 years with a history of Type 1 diabetes for at least 1 year, treated with a basal‐bolus insulin regimen for <br> 4 months with basal insulin (once, twice or three times daily) in combination with mealtime IAsp or insulin lispro three to four times daily, able and willing to perform self‐measured plasma glucose (SMPG). Only C‐peptide‐negative persons with glycosylated haemoglobin &lt; 9%, body mass index 35 kg/m2, total daily insulin dose 1.4 IU/kg per day and a basal insulin requirement 30% of the total daily insulin dose were included. <br> EXCLUSION CRITERIA: <br> Individuals with significant medical disorders were excluded, as were those with hypoglycaemic unawareness, recurrent major hypoglycaemia, allergy to insulin and pregnant or breast‐feeding women. <br> DIAGNOSTIC CRITERIA: <br> Not defined </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 11. <br> SETTING: <br> Out‐patient. <br> INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> Detemir (BID) + Aspart <br> CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> NPH (BID) + Aspart <br> TREATMENT BEFORE STUDY: <br> ? <br> TITRATION PERIOD: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S): <br> Incidence of total self‐recorded hypoglycaemic episodes with <br> detemir relative to NPH during the last 10 weeks of each <br> treatment period. <br> SECONDARY OUTCOMES: <br> Glycosylated haemoglobin, day‐to‐day within‐person variation in SMPG, weight. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>STATED AIM OF STUDY: <br> To establish whether basal‐bolus treatment with detemir in combination with IAsp was associated with lower risks of hypoglycaemia compared with treatment with NPH plus IAsp in individuals with Type 1 diabetes </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Murphy 2003 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 16 weeks. <br> DURATION OF FOLLOW‐UP: <br> N/A <br> RUN‐IN PERIOD: <br> 4 weeks. <br> LANGUAGE OF PUBLICATION: <br> English. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Type 1 diabetic children. <br> INCLUSION CRITERIA: <br> Age between 12 and 20 years, currently in puberty (Tanner stage B2/G2 or higher), duration of diabetes longer than 1 year or C‐peptide negative, and already using a basal‐bolus insulin regimen. <br> EXCLUSION CRITERIA: <br> Renal or hepatic impairment, evidence of diabetic complications, or unstable metabolic control (defined as HbA1c &gt;12%). <br> DIAGNOSTIC CRITERIA: <br> Not defined </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 1 <br> SETTING: <br> Out‐patient + inpatient. <br> INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> Glargine (QD) + lispro. <br> CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> NPH (QD) + HI <br> TREATMENT BEFORE STUDY: <br> ? <br> TITRATION PERIOD: <br> 4 weeks. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S): <br> Nocturnal <br> hypoglycaemia. <br> SECONDARY OUTCOMES: <br> HbA1c and blood glucose, overnight profile </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>STATED AIM OF STUDY: <br> Comparing the combination of insulin analogs insulin glargine plus lispro with human NPH plus regular human insulin by home blood glucose monitoring and overnight metabolic pro‐files in adolescents with type 1 diabetes who were already on MIR. </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Pieber 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 4 weeks. <br> DURATION OF FOLLOW‐UP: <br> N/A <br> RUN‐IN PERIOD: <br> N/A. <br> LANGUAGE OF PUBLICATION: <br> English. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Type 1 diabetic adult patients. <br> INCLUSION CRITERIA: <br> Clinically diagnosed type 1 diabetes who had been receiving insulin therapy for 1 year with a basal‐bolus regimen of NPH insulin once daily at bedtime or twice daily in the morning and at bedtime plus regular human insulin before meals was used for at least 2 months. <br> EXCLUSION CRITERIA: <br> The presence of known proliferative diabetic retinopathy, impaired hepatic or renal function, and a history of hypoglycemia unawareness <br> DIAGNOSTIC CRITERIA: <br> Not defined </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 42 <br> SETTING: <br> Out‐patient. <br> INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> Glargine 30 or glargine 80 (QD) + HI. <br> CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> NPH (QD) + RI <br> TREATMENT BEFORE STUDY: <br> A basal‐bolus regimen of NPH insulin once daily at bedtime (n = 177) or twice daily in the morning and at bedtime (n = 156) plus regular human insulin before meals was used for at least 2 months. <br> TITRATION PERIOD: <br> 3 weeks. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S): <br> ? <br> SECONDARY OUTCOMES: <br> Fasting plasma glucose, HbA1C , fructosamine, FBG, mean of a seven‐point blood glucose profile, and nocturnal blood glucose at 0300, hypoglycemia, antibodies to insulin. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>STATED AIM OF STUDY: <br> To compare the 4‐week efficacy and safety of two formulations of HOE 901 with NPH insulin </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Porcellati 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 1 year. <br> DURATION OF FOLLOW‐UP: <br> N/A <br> RUN‐IN PERIOD: <br> 1 month. <br> LANGUAGE OF PUBLICATION: <br> English. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Type 1 diabetic adult patients. <br> INCLUSION CRITERIA: <br> T1 DM (Table 1) and fasting plasma C‐peptide 0.15 nmol/L, on intensified treatment with multiple daily combinations of lispro and NPH insulin at each meal, and NPH at bedtime for at least 2 years. <br> EXCLUSION CRITERIA: <br> Free of any detectable microangiopathic complication and were negative at the screening for autonomic neuropathy, as judged on the basis of standard battery of cardiovascular tests. <br> DIAGNOSTIC CRITERIA: <br> Not defined </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 1 <br> SETTING: <br> Out‐patient + inpatient. <br> INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> Glargine (QD) + lispro <br> CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> NPH (QID) + lispro <br> TREATMENT BEFORE STUDY: <br> NPH + lispro <br> TITRATION PERIOD: <br> ? </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S): <br> Glycosylated haemoglobin. <br> SECONDARY OUTCOMES: <br> Home blood glucose monitoring, percantage of at target blood glucose measurements, blood glucose variability, hypoglycaemia, weight </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>STATED AIM OF STUDY: <br> First, to compare the long‐term glycaemic control in T1 DM with two regimens of optimized replacement of basal insulin, i.e. NPH combined with lispro insulin at each meal (and a fourth NPH injection at bedtime), and insulin glargine once daily. Second, to test the hypothesis that the less frequent hypoglycaemia expected to occur with insulin glargine as compared with NPH, resulted in better responses of counter‐regulatory hormones, symptoms and onset of cognitive dysfunction to hypoglycaemia. </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A ‐ Adequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Raskin 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 16 weeks. <br> DURATION OF FOLLOW‐UP: <br> N/A <br> RUN‐IN PERIOD: <br> 1 to 4 weeks. <br> LANGUAGE OF PUBLICATION: <br> English. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Type 1 diabetic adult patients. <br> INCLUSION CRITERIA: <br> Eligible patients had type 1 diabetes, were 18‐80 years of age, and had been receiving treatment with NPH insulin for at least 1 year and insulin lispro for at least 3 months. Patients had to have a serum C‐peptide level &lt; 9 mg/dl (0.5 mmol/L) in the presence of a blood glucose level _99.0 mg/dl (5.5 mmol/L) and a GHb value &lt; 12.0%. <br> EXCLUSION CRITERIA: <br> Patients with hepatic or renal impairment, those who were pregnant or breast feeding, and those who had received treatment with any glucose‐lowering drug other than insulin within 4 weeks of the study. <br> DIAGNOSTIC CRITERIA: <br> Not defined </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 60. <br> SETTING: <br> Out‐patient. <br> INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> Glargine (QD) + lispro <br> CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> NPH (QD/BID) + lispro <br> TREATMENT BEFORE STUDY: <br> NPH + lispro <br> TITRATION PERIOD: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S): <br> ? <br> SECONDARY OUTCOMES: <br> Glycosylated haemoglobin, FBG, FPG, hypoglycaemia. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>STATED AIM OF STUDY: <br> We compared the effects of insulin glargine once a day at bedtime and NPH insulin once or twice a day as basal insulin treatment for 16 weeks in patients with type 1 diabetes who were currently receiving NPH insulin for basal treatment and preprandial insulin lispro for postprandial glycemic control. </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Ratner 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 28 weeks. <br> DURATION OF FOLLOW‐UP: <br> N/A <br> RUN‐IN PERIOD: <br> 1 to 4 weeks. <br> LANGUAGE OF PUBLICATION: <br> English. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Type 1 diabetic adult patients. <br> INCLUSION CRITERIA: <br> Men and women 18‐80 years of age with type 1 diabetes (postprandial C‐peptide levels of _0.5 nmol/L) for at least 1 year and GHb levels of &lt;12.0% were eligible. <br> EXCLUSION CRITERIA: <br> Treatment with antidiabetic drugs other than insulin within 1 month of study entry, pregnancy, impaired hepatic function, and impaired renal function. Patients could not work a night shift. <br> DIAGNOSTIC CRITERIA: <br> Not defined </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 49. <br> SETTING: <br> Out‐patient. <br> INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> Glargine (QD) + RI <br> CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> NPH (QD/BID)+RI <br> TREATMENT BEFORE STUDY: <br> ? <br> TITRATION PERIOD: <br> ? </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S): <br> ? <br> SECONDARY OUTCOMES: <br> Mean changes from baseline of GHb and capillary FBG levels, median change from baseline of FPG levels, incidence of hypoglycemia, and incidence of hypoglycemia with a blood glucose level of &lt; 2.0 mmol/L. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>STATED AIM OF STUDY: <br> Safety and efficacy of once‐daily insulin glargine versus once‐ or twice‐daily NPH insulin as part of basal‐bolus insulin regimens for patients with type 1 diabetes. </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Robertson 2007 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 26 weeks. <br> DURATION OF FOLLOW‐UP: <br> N/A <br> RUN‐IN PERIOD: <br> ? weeks. <br> LANGUAGE OF PUBLICATION: <br> English. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Type 1 diabetic children. <br> INCLUSION CRITERIA: <br> Children with Type 1 diabetes aged between 6 and 17 years, treated with insulin for at least 12 months (total daily dose 2.0 U/kg), and with HbA1c 12.0% <br> EXCLUSION CRITERIA: <br> ? <br> DIAGNOSTIC CRITERIA: <br> Not defined </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 44. <br> SETTING: <br> Out‐patient. <br> INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> Detemir (QD/BID) + aspart. <br> CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> NPH (QD/BID) + Aspart. <br> TREATMENT BEFORE STUDY: <br> ? <br> TITRATION PERIOD: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S): <br> Glycosylated haemoglobin. <br> SECONDARY OUTCOMES: <br> Eight‐point plasma glucose profiles, self‐measured FPG, hypoglycaemia. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>STATED AIM OF STUDY: <br> To investigate the efficacy and safety of insulin detemir compared with NPH insulin in children with <br> Type 1 diabetes </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Rosenstock 2000 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 4 weeks. <br> DURATION OF FOLLOW‐UP: <br> N/A <br> RUN‐IN PERIOD: <br> ? weeks. <br> LANGUAGE OF PUBLICATION: <br> English. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Type 1 diabetic adult patients. <br> INCLUSION CRITERIA: <br> Age between 18 and 70 years, BMI of 18‐28 kg/m2, HbA1c of &lt; 10%, and postprandial serum C‐peptide of &lt;0.2 pmol/ml. All study patients had been on a basal‐bolus multiple daily insulin regimen for at least 2 months. <br> EXCLUSION CRITERIA: <br> ? <br> DIAGNOSTIC CRITERIA: <br> Not defined </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> Multicenter. <br> SETTING: <br> Out‐patient + inpatient. <br> INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> Glargine 30 or glargine 80 (QD) + HI <br> CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> NPH (QD/BID) + HI <br> TREATMENT BEFORE STUDY: <br> ? <br> TITRATION PERIOD: <br> ? </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S): <br> Fasting plasma glucose. <br> SECONDARY OUTCOMES: <br> Serial overnight plasma glucose, mean FBG, blood glucose profile, nocturnal blood glucose, stability of fasting glucose, fasting serum insulin, HbA1c, hypoglycaemia. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>STATED AIM OF STUDY: <br> The primary objective was to compare NPH insulin with the insulin glargine formulations with respect to fasting plasma glucose (FPG) in these patients. </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Rossetti 2003 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 3 months. <br> DURATION OF FOLLOW‐UP: <br> N/A <br> RUN‐IN PERIOD: <br> 2 weeks. <br> LANGUAGE OF PUBLICATION: <br> English. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Type 1 diabetic adult patients. <br> INCLUSION CRITERIA: <br> Patients already in long‐term near‐normoglycemia (HbA1c 6.0‐7.5%) during intensive therapy were studied. Treated with intensive insulin therapy and attending the Diabetes Clinic at least quarterly every year. C‐peptide negative (plasma C‐peptide &lt;0.10 nmol/L after 1 mg i.v. glucagon). <br> EXCLUSION CRITERIA: <br> Free of any detectable microangiopathic complication and negative at the screening for autonomic neuropathy, as judged on the basis of a standard battery of cardiovascular tests <br> DIAGNOSTIC CRITERIA: <br> Not defined </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 1. <br> SETTING: <br> Out‐patient + inpatient. <br> INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> Glargine dinner/et‐time (QD) + Lispro <br> CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> NPH (QID) + Lispro <br> TREATMENT BEFORE STUDY: <br> NPH QID basal therapy + Lispro <br> TITRATION PERIOD: <br> ?. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S): <br> GLycated haemoglobin <br> SECONDARY OUTCOMES: <br> blood glucose profile from home monitoring, percentage of measurements at target, blood glucose variability, hypoglycaemia,plasma insulin and glucose profiles. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>STATED AIM OF STUDY: <br> To establish glycaemic control between optimised NPH administration and glargine, and to compare dinnertime glargine with bedtime glargine. </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Russell‐Jones 2004 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 6 months. <br> DURATION OF FOLLOW‐UP: <br> N/A <br> RUN‐IN PERIOD: <br> 3 weeks. <br> LANGUAGE OF PUBLICATION: <br> English. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Type 1 diabetic adult patients. <br> INCLUSION CRITERIA: <br> Men and women &gt; 18 years with type 1 DM for &gt; 1 year using basal or premixed insulin QD and HI before meals for &gt; 2 months. <br> EXCLUSION CRITERIA: <br> Poorly controlled diabetes on QD regimen, pregnant or breastfeading, proliferative retinopathy, hepatic or renal impairment, reccurent major hypoglycaemia, or severe cardiac problems, or concomitent use of medication interfering with glucose metabolism. <br> DIAGNOSTIC CRITERIA: <br> Not defined </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 92. <br> SETTING: <br> Out‐patient + inpatient. <br> INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> Detemir (QD) + HI <br> CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> NPH (QD) + HI <br> TREATMENT BEFORE STUDY: <br> QD basal therapy + HI <br> TITRATION PERIOD: <br> 1 month. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S): <br> ? <br> SECONDARY OUTCOMES: <br> Glycosylated haemoglobin, FPG, SMBG, 24 hours glucose profiles, hypoglycaemia, weight </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>STATED AIM OF STUDY: <br> To compare the effect of QD basal insulin replacement using insulin detemir versus NPH at bedtime in combination with HI in patients with type 1 DM. </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Schober 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 6 months. <br> DURATION OF FOLLOW‐UP: <br> N/A <br> RUN‐IN PERIOD: <br> ? weeks. <br> LANGUAGE OF PUBLICATION: <br> English. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Type 1 diabetic children. <br> INCLUSION CRITERIA: <br> Patients with type 1 diabetes, aged 5‐16 years, who were using at least three daily preprandial injections of normal insulin and who had an HbA1c value of &lt;12%. <br> EXCLUSION CRITERIA: <br> ? <br> DIAGNOSTIC CRITERIA: <br> Not defined </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> Multy‐center. <br> SETTING: <br> Out‐patient. <br> INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> Glargine (QD) + HI <br> CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> NPH (QD/BID) + HI. <br> TREATMENT BEFORE STUDY: <br> ? <br> TITRATION PERIOD: </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S): <br> Mean change from baseline in GHb levels. <br> SECONDARY OUTCOMES: <br> Mean change in FBG levels from baseline and incidence of hypoglycemia. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>STATED AIM OF STUDY: <br> To compare the metabolic effect and safety of insulin glargine with NPH insulin in children and adolescents with type 1 diabetes. </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Tunbridge 1989 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 3 months. <br> DURATION OF FOLLOW‐UP: <br> N/A <br> RUN‐IN PERIOD: <br> 1 year (in another study). <br> LANGUAGE OF PUBLICATION: <br> English. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Type 1 diabetic adult patients. <br> INCLUSION CRITERIA: <br> Insulin dependent with C‐peptide &lt; 0.18, age &gt; 18. <br> EXCLUSION CRITERIA: <br> Proliferatice retinopathy, nephropathy, autonomic neuropathy, on medication likely to interfere with metabolic control, or pregnant. <br> DIAGNOSTIC CRITERIA: <br> Not defined </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 4. <br> SETTING: <br> Out‐patient. <br> INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> Ultralente (BID) + HI (premixed) <br> CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> Lente (BID) + HI (premixed). <br> TREATMENT BEFORE STUDY: <br> Lente and NPH <br> TITRATION PERIOD: <br> ? </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S): <br> ? <br> SECONDARY OUTCOMES: <br> Mean blood glucose, FBG, 0300 BG, HGA1C, fructosamine/albumin, triglycerides, weight, hypoglycaemia. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>STATED AIM OF STUDY: <br> Assess the efficacy of human ultralente given twice daily, with special interest on hypoglycaemic rate </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Vague 2003 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 26 weeks. <br> DURATION OF FOLLOW‐UP: <br> N/A <br> RUN‐IN PERIOD: <br> 3 weeks. <br> LANGUAGE OF PUBLICATION: <br> English. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Type 1 diabetic adult patients. <br> INCLUSION CRITERIA: <br> Patients with a history of type 1 diabetes for at least 1 year who had received basal (once or multiple times daily) bolus insulin treatment for at least 2 months were included in the trial. Only patients with an HbA1c level &lt;=12%, a BMI &lt;=35 kg/m2, and a total basal insulin dosage of &lt;=100 IU/day were included. <br> EXCLUSION CRITERIA: <br> patients with proliferative retinopathy, impaired hepatic or renal function, severe cardiac problems, uncontrolled hypertension, recurrent major hypoglycemia, or allergy to insulin. Pregnant or breast‐feeding women were also excluded. DIAGNOSTIC CRITERIA: <br> Not defined </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> 46. <br> SETTING: <br> Out‐patient + inpatient. <br> INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> Detemir (BID) + Aspart. <br> CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> NPH (BID) + Aspart. <br> TREATMENT BEFORE STUDY: <br> ? <br> TITRATION PERIOD: <br> 1 month. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S): <br> Glycosylated haemoglobin. <br> SECONDARY OUTCOMES: <br> Within subject SMBG flactuations, nightly glucose profile, weight, hypoglycaemia. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>STATED AIM OF STUDY: <br> To evaluate the metabolic control, risk of hypoglycemia, and other potential effects of treatment with insulin detemir in patients with type 1 diabetes on such a basal‐bolus regimen. </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Low risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>A ‐ Adequate</p> </td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Zinman 1999 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>DURATION OF INTERVENTION: <br> 1 year. <br> DURATION OF FOLLOW‐UP: <br> N/A <br> RUN‐IN PERIOD: <br> 2 weeks. <br> LANGUAGE OF PUBLICATION: <br> English. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>WHO PARTCIPATED: <br> Type 1 diabetic adult patients. <br> INCLUSION CRITERIA: <br> Patients with a clinical diagnosis of type 1 diabetes. <br> EXCLUSION CRITERIA: <br> Patients with severe retinopathy or neuropathy and patients who had experienced more than two severe hypoglycemic episodes in the past year <br> DIAGNOSTIC CRITERIA: <br> Not defined </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>NUMBER OF STUDY CENTRES: <br> ? <br> SETTING: <br> Out‐patient + inpatient. <br> INTERVENTION (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> Ultralente (QD) + lispro. <br> CONTROL (ROUTE, TOTAL DOSE/DAY, FREQUENCY): <br> NPH (QD) + lispro. <br> TREATMENT BEFORE STUDY: <br> ? <br> TITRATION PERIOD: <br> ? </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>PRIMARY OUTCOME(S): <br> ? <br> SECONDARY OUTCOMES: <br> Eight point blood glucose profile, glycosylated haemoglobin, hypoglycemia, weight, 24‐h free plasma insulin. </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="2" rowspan="1" bgcolor="#ffffff"> <p>STATED AIM OF STUDY: <br> To compare human ultralente (UL) insulin with human NPH insulin as basal insulin replacement in patients who use insulin lispro before meals. </p> </td> </tr> <tr> <td align="" valign="" colspan="3" rowspan="1" bgcolor="#ffffff"> <p><b><i>Risk of bias</i> </b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Authors' judgement</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Support for judgement</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Allocation concealment?</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unclear risk</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B ‐ Unclear</p> </td> </tr> </tbody> </table> </div> </p> </section> <section class="characteristicsOfExcludedStudies" lang=""> <div class="section-header" id="CD006297-sec2-0016"> <h3 class="title">Characteristics of excluded studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD006297-sec2-0015" class="jump-to">included studies</a></li> <li><a href="#CD006297-sec2-0017" class="jump-to">ongoing studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Reason for exclusion</p> </td> </tr> </thead> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006297-bbs2-0024">Albright 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No RCT.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006297-bbs2-0025">Alemzadeh 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Flexible multiple daily insulin versus conventional treatment, no RCT.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006297-bbs2-0026">Alemzadeh 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Inetrvention, no RCT.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006297-bbs2-0027">Heise 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RCT. Pharmakodynamic and pharmakokinetic profiles.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006297-bbs2-0028">Hershon 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subgroup analysis of Ratner et al.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006297-bbs2-0029">Herwig 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No RCT. Extensio of one arm from Schober 2001.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006297-bbs2-0030">Kiess 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Comment to Home et al.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006297-bbs2-0031">Lepore 2000</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RCT. Pharmakodynamic and pharmakokinetic profiles.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006297-bbs2-0032">Lepore 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Most probably not an RCT with insulin pump as control.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006297-bbs2-0033">Manini 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No RCT.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006297-bbs2-0034">Mimouni 1979</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No RCT.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006297-bbs2-0035">Moretti 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006297-bbs2-0036">Palmer 2004</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Economic analysis based on meta‐analysis.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006297-bbs2-0037">Ratner 2003</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Review.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006297-bbs2-0038">Saisho 2005</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No RCT.</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006297-bbs2-0039">Urakami 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Not RCT</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><a href="references#CD006297-bbs2-0040">Wutte 2007</a> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>RCT, assessing dose response relationship of determir and NPH over 24 hours, without regarding efficacy or adverse outcomes. </p> </td> </tr> </tbody> </table> </div> </p> </section> <section class="characteristicsOfOngoingStudies" lang=""> <div class="section-header" id="CD006297-sec2-0017"> <h3 class="title">Characteristics of ongoing studies [ordered by study ID]</h3> <div class="jump-to"> <p>Jump to: </p> <ul class="jump-to-links"> <li><a href="#CD006297-sec2-0015" class="jump-to">included studies</a></li> <li><a href="#CD006297-sec2-0016" class="jump-to">excluded studies</a></li> </ul> </div> </div> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Alcolado 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Efficacy and safety of basal insulin analogue detemir and NPH insulin in patients with Type 1 diabetes on basal‐bolus regimen </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Patients with type 1 diabetes attending diabetes ceter</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Detemir vs. NPH</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>?</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2.01</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Dr. John Alcolado</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> <div class="table" id=""> <table> <div class="table-heading"><span class="table-label"></span><span class="table-title">Page 2001 </span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Trial name or title</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16 week multi‐center, open, randomised 3 group parallel study comparing insulin detemir with NPH </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Methods</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Participants</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Patients with type 1 diabetes</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Interventions</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Detemir vs. NPH</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcomes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>?</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Starting date</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2.01</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Contact information</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Dr. M.D. Page</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Notes</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> </div> </p> </section> </section> <section class="dataAndAnalyses" id="dataAndAnalyses"> <section class="dataAndAnalyses" lang="en"> <div class="section-header section-collapse-header" id="CD006297-sec1-0010"> <h2 class="title section-collapse-title">Data and analyses<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <div class="table" id="CD006297-tbl-0001"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">Efficacy</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Glycated haemoglobin <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00101"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-001-01.png?filename=nCD006297-CMP-001-01.ppt&amp;title=1.1&amp;caption=Comparison%201%20Efficacy%2C%20Outcome%201%20Glycated%20haemoglobin.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.1</div> </div> <hr class="top"><img data-id="CD006297-fig-00101" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-001-01.png" alt="Comparison 1 Efficacy, Outcome 1 Glycated haemoglobin."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Efficacy, Outcome 1 Glycated haemoglobin.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Short term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1259</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.17, 0.00]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2724</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.17 [‐0.23, ‐0.10]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.3 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3302</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.01 [‐0.06, 0.08]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Fasting blood glucose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00102"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-001-02.png?filename=nCD006297-CMP-001-02.ppt&amp;title=1.2&amp;caption=Comparison%201%20Efficacy%2C%20Outcome%202%20Fasting%20blood%20glucose.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.2</div> </div> <hr class="top"><img data-id="CD006297-fig-00102" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-001-02.png" alt="Comparison 1 Efficacy, Outcome 2 Fasting blood glucose."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Efficacy, Outcome 2 Fasting blood glucose.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Short term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1326</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.94 [‐1.22, ‐0.66]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2015</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.06 [‐1.29, ‐0.82]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.3 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2687</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.70 [‐0.89, ‐0.52]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Fasting plasma glucose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00103"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-001-03.png?filename=nCD006297-CMP-001-03.ppt&amp;title=1.3&amp;caption=Comparison%201%20Efficacy%2C%20Outcome%203%20Fasting%20plasma%20glucose.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.3</div> </div> <hr class="top"><img data-id="CD006297-fig-00103" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-001-03.png" alt="Comparison 1 Efficacy, Outcome 3 Fasting plasma glucose."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Efficacy, Outcome 3 Fasting plasma glucose.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.1 Short term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1208</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.42 [‐1.94, ‐0.91]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.2 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2211</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.06 [‐1.41, ‐0.70]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.3 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2182</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.81 [‐1.29, ‐0.32]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 Mean daily self measured blood glucose (SMBG) average (7‐8 points) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>790</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.47 [‐0.58, ‐0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00104"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-001-04.png?filename=nCD006297-CMP-001-04.ppt&amp;title=1.4&amp;caption=Comparison%201%20Efficacy%2C%20Outcome%204%20Mean%20daily%20self%20measured%20blood%20glucose%20%28SMBG%29%20average%20%287%E2%80%908%20points%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.4</div> </div> <hr class="top"><img data-id="CD006297-fig-00104" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-001-04.png" alt="Comparison 1 Efficacy, Outcome 4 Mean daily self measured blood glucose (SMBG) average (7‐8 points)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Efficacy, Outcome 4 Mean daily self measured blood glucose (SMBG) average (7‐8 points). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.1 Short term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>425</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.47 [‐0.58, ‐0.35]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.2 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>244</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.43 [‐1.09, 0.24]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.3 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>121</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.5 [‐0.98, ‐0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Glycated haemoglobin‐ total <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6666</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.12, ‐0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00105"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-001-05.png?filename=nCD006297-CMP-001-05.ppt&amp;title=1.5&amp;caption=Comparison%201%20Efficacy%2C%20Outcome%205%20Glycated%20haemoglobin%E2%80%90%20total.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.5</div> </div> <hr class="top"><img data-id="CD006297-fig-00105" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-001-05.png" alt="Comparison 1 Efficacy, Outcome 5 Glycated haemoglobin‐ total."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Efficacy, Outcome 5 Glycated haemoglobin‐ total.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Fasting blood glucose‐total <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5409</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.86 [1.00, ‐0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00106"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-001-06.png?filename=nCD006297-CMP-001-06.ppt&amp;title=1.6&amp;caption=Comparison%201%20Efficacy%2C%20Outcome%206%20Fasting%20blood%20glucose%E2%80%90total.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.6</div> </div> <hr class="top"><img data-id="CD006297-fig-00106" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-001-06.png" alt="Comparison 1 Efficacy, Outcome 6 Fasting blood glucose‐total."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Efficacy, Outcome 6 Fasting blood glucose‐total.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">7 Fasting plasma glucose‐ total <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4868</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.63 [‐0.86, ‐0.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00107"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-001-07.png?filename=nCD006297-CMP-001-07.ppt&amp;title=1.7&amp;caption=Comparison%201%20Efficacy%2C%20Outcome%207%20Fasting%20plasma%20glucose%E2%80%90%20total.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 1.7</div> </div> <hr class="top"><img data-id="CD006297-fig-00107" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-001-07.png" alt="Comparison 1 Efficacy, Outcome 7 Fasting plasma glucose‐ total."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 1 Efficacy, Outcome 7 Fasting plasma glucose‐ total.</p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD006297-tbl-0002"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">Hypoglycemia</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Percent of participating experiencing hypoglycemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00201"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-002-01.png?filename=nCD006297-CMP-002-01.ppt&amp;title=2.1&amp;caption=Comparison%202%20Hypoglycemia%2C%20Outcome%201%20Percent%20of%20participating%20experiencing%20hypoglycemia.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.1</div> </div> <hr class="top"><img data-id="CD006297-fig-00201" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-002-01.png" alt="Comparison 2 Hypoglycemia, Outcome 1 Percent of participating experiencing hypoglycemia."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 Hypoglycemia, Outcome 1 Percent of participating experiencing hypoglycemia.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6131</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.93 [0.80, 1.08]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5827</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.73 [0.61, 0.87]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.3 Nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5406</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.70 [0.63, 0.79]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Hypoglycemic events per 100 patient's days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00202"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-002-02.png?filename=nCD006297-CMP-002-02.ppt&amp;title=2.2&amp;caption=Comparison%202%20Hypoglycemia%2C%20Outcome%202%20Hypoglycemic%20events%20per%20100%20patient%27s%20days.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 2.2</div> </div> <hr class="top"><img data-id="CD006297-fig-00202" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-002-02.png" alt="Comparison 2 Hypoglycemia, Outcome 2 Hypoglycemic events per 100 patient's days."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 2 Hypoglycemia, Outcome 2 Hypoglycemic events per 100 patient's days.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4704</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.77 [‐0.89, ‐0.65]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4564</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.00 [‐0.02, 0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.3 Nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4971</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.40 [‐0.45, ‐0.34]</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD006297-tbl-0003"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 3.</span>&nbsp;<span class="table-title">Adverse Events</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Number of serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4878</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.89 [0.66, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00301"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-003-01.png?filename=nCD006297-CMP-003-01.ppt&amp;title=3.1&amp;caption=Comparison%203%20Adverse%20Events%2C%20Outcome%201%20Number%20of%20serious%20adverse%20events.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.1</div> </div> <hr class="top"><img data-id="CD006297-fig-00301" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-003-01.png" alt="Comparison 3 Adverse Events, Outcome 1 Number of serious adverse events."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 Adverse Events, Outcome 1 Number of serious adverse events.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Type of serious adverse events and reasons for death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other data</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00302"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/?filename=&amp;title=3.2&amp;caption=Comparison%203%20Adverse%20Events%2C%20Outcome%202%20Type%20of%20serious%20adverse%20events%20and%20reasons%20for%20death.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.2</div> </div> <hr class="top"> <hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 Adverse Events, Outcome 2 Type of serious adverse events and reasons for death. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>23</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6787</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.33 [0.03, 3.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00303"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-003-03.png?filename=nCD006297-CMP-003-03.ppt&amp;title=3.3&amp;caption=Comparison%203%20Adverse%20Events%2C%20Outcome%203%20Death.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 3.3</div> </div> <hr class="top"><img data-id="CD006297-fig-00303" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-003-03.png" alt="Comparison 3 Adverse Events, Outcome 3 Death."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 3 Adverse Events, Outcome 3 Death.</p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD006297-tbl-0004"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 4.</span>&nbsp;<span class="table-title">Weight gain</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Weight gain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2862</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.67 [‐0.88, ‐0.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00401"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-004-01.png?filename=nCD006297-CMP-004-01.ppt&amp;title=4.1&amp;caption=Comparison%204%20Weight%20gain%2C%20Outcome%201%20Weight%20gain.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 4.1</div> </div> <hr class="top"><img data-id="CD006297-fig-00401" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-004-01.png" alt="Comparison 4 Weight gain, Outcome 1 Weight gain."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 4 Weight gain, Outcome 1 Weight gain.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1674</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.83 [‐1.10, ‐0.56]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1188</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.38 [‐0.74, ‐0.02]</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD006297-tbl-0005"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 5.</span>&nbsp;<span class="table-title">Insulin dose</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Basal Insulin dose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>18</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5713</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.02 [‐0.03, ‐0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00501"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-005-01.png?filename=nCD006297-CMP-005-01.ppt&amp;title=5.1&amp;caption=Comparison%205%20Insulin%20dose%2C%20Outcome%201%20Basal%20Insulin%20dose.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 5.1</div> </div> <hr class="top"><img data-id="CD006297-fig-00501" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-005-01.png" alt="Comparison 5 Insulin dose, Outcome 1 Basal Insulin dose."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 5 Insulin dose, Outcome 1 Basal Insulin dose.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Bolus insulin dose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4509</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.00 [‐0.01, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00502"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-005-02.png?filename=nCD006297-CMP-005-02.ppt&amp;title=5.2&amp;caption=Comparison%205%20Insulin%20dose%2C%20Outcome%202%20Bolus%20insulin%20dose.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 5.2</div> </div> <hr class="top"><img data-id="CD006297-fig-00502" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-005-02.png" alt="Comparison 5 Insulin dose, Outcome 2 Bolus insulin dose."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 5 Insulin dose, Outcome 2 Bolus insulin dose.</p> </div> </div> </div> </td> </tr> </tbody> </table> </div> <div class="table" id="CD006297-tbl-0006"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 6.</span>&nbsp;<span class="table-title">Children‐ efficacy</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Glycated haemoglobin <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00601"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-006-01.png?filename=nCD006297-CMP-006-01.ppt&amp;title=6.1&amp;caption=Comparison%206%20Children%E2%80%90%20efficacy%2C%20Outcome%201%20Glycated%20haemoglobin.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 6.1</div> </div> <hr class="top"><img data-id="CD006297-fig-00601" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-006-01.png" alt="Comparison 6 Children‐ efficacy, Outcome 1 Glycated haemoglobin."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 6 Children‐ efficacy, Outcome 1 Glycated haemoglobin.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Children</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>399</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.07 [‐0.29, 0.15]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Fasting blood glucose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00602"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-006-02.png?filename=nCD006297-CMP-006-02.ppt&amp;title=6.2&amp;caption=Comparison%206%20Children%E2%80%90%20efficacy%2C%20Outcome%202%20Fasting%20blood%20glucose.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 6.2</div> </div> <hr class="top"><img data-id="CD006297-fig-00602" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-006-02.png" alt="Comparison 6 Children‐ efficacy, Outcome 2 Fasting blood glucose."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 6 Children‐ efficacy, Outcome 2 Fasting blood glucose.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Children</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>399</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.88 [‐1.26, ‐0.51]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Fasting plasma glucose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00603"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-006-03.png?filename=nCD006297-CMP-006-03.ppt&amp;title=6.3&amp;caption=Comparison%206%20Children%E2%80%90%20efficacy%2C%20Outcome%203%20Fasting%20plasma%20glucose.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 6.3</div> </div> <hr class="top"><img data-id="CD006297-fig-00603" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-006-03.png" alt="Comparison 6 Children‐ efficacy, Outcome 3 Fasting plasma glucose."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 6 Children‐ efficacy, Outcome 3 Fasting plasma glucose.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.1 Children</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>50</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.40 [‐0.00, 0.80]</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD006297-tbl-0007"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 7.</span>&nbsp;<span class="table-title">Heterogeneity analyses</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Glycated haemoglobin‐ random effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00701"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-01.png?filename=nCD006297-CMP-007-01.ppt&amp;title=7.1&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%201%20Glycated%20haemoglobin%E2%80%90%20random%20effect%20model.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.1</div> </div> <hr class="top"><img data-id="CD006297-fig-00701" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-01.png" alt="Comparison 7 Heterogeneity analyses, Outcome 1 Glycated haemoglobin‐ random effect model."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 1 Glycated haemoglobin‐ random effect model. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Short term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1259</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.13 [‐0.33, 0.07]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2724</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.17 [‐0.26, ‐0.08]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.3 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3302</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.01 [‐0.11, 0.10]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Fasting blood glucose‐ random effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00702"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-02.png?filename=nCD006297-CMP-007-02.ppt&amp;title=7.2&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%202%20Fasting%20blood%20glucose%E2%80%90%20random%20effect%20model.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.2</div> </div> <hr class="top"><img data-id="CD006297-fig-00702" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-02.png" alt="Comparison 7 Heterogeneity analyses, Outcome 2 Fasting blood glucose‐ random effect model."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 2 Fasting blood glucose‐ random effect model. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Short term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1326</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.94 [‐1.32, ‐0.55]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2015</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.10 [‐1.42, ‐0.78]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.3 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2687</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.88 [‐1.47, ‐0.30]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Fasting plasma glucose‐ random effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00703"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-03.png?filename=nCD006297-CMP-007-03.ppt&amp;title=7.3&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%203%20Fasting%20plasma%20glucose%E2%80%90%20random%20effect%20model.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.3</div> </div> <hr class="top"><img data-id="CD006297-fig-00703" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-03.png" alt="Comparison 7 Heterogeneity analyses, Outcome 3 Fasting plasma glucose‐ random effect model."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 3 Fasting plasma glucose‐ random effect model. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.1 Short term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1208</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.51 [‐2.20, ‐0.81]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.2 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2211</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.06 [‐1.99, ‐0.13]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.3 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2182</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.81 [‐1.60, ‐0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ random effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>790</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.33 [‐0.73, 0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00704"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-04.png?filename=nCD006297-CMP-007-04.ppt&amp;title=7.4&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%204%20Mean%20daily%20self%20measured%20blood%20glucose%20%28SMBG%29%20average%20%287%E2%80%908%20points%29%E2%80%90%20random%20effect%20model.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.4</div> </div> <hr class="top"><img data-id="CD006297-fig-00704" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-04.png" alt="Comparison 7 Heterogeneity analyses, Outcome 4 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ random effect model."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 4 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ random effect model. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.1 Short term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>425</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.20 [‐0.68, 0.28]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.2 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>244</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.72 [‐2.97, 1.53]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.3 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>121</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.5 [‐0.98, ‐0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Fasting blood glucose‐total‐ random effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5409</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.01 [‐1.31, ‐0.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00705"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-05.png?filename=nCD006297-CMP-007-05.ppt&amp;title=7.5&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%205%20Fasting%20blood%20glucose%E2%80%90total%E2%80%90%20random%20effect%20model.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.5</div> </div> <hr class="top"><img data-id="CD006297-fig-00705" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-05.png" alt="Comparison 7 Heterogeneity analyses, Outcome 5 Fasting blood glucose‐total‐ random effect model."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 5 Fasting blood glucose‐total‐ random effect model. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Fasting plasma glucose‐ total‐ random effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4868</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.03 [‐1.66, ‐0.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00706"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-06.png?filename=nCD006297-CMP-007-06.ppt&amp;title=7.6&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%206%20Fasting%20plasma%20glucose%E2%80%90%20total%E2%80%90%20random%20effect%20model.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.6</div> </div> <hr class="top"><img data-id="CD006297-fig-00706" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-06.png" alt="Comparison 7 Heterogeneity analyses, Outcome 6 Fasting plasma glucose‐ total‐ random effect model."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 6 Fasting plasma glucose‐ total‐ random effect model. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">7 Percent of participating experiencing hypoglycemia‐ random effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00707"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-07.png?filename=nCD006297-CMP-007-07.ppt&amp;title=7.7&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%207%20Percent%20of%20participating%20experiencing%20hypoglycemia%E2%80%90%20random%20effect%20model.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.7</div> </div> <hr class="top"><img data-id="CD006297-fig-00707" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-07.png" alt="Comparison 7 Heterogeneity analyses, Outcome 7 Percent of participating experiencing hypoglycemia‐ random effect model."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 7 Percent of participating experiencing hypoglycemia‐ random effect model. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7.1 Total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6131</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.97 [0.79, 1.19]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7.2 Severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5827</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.73 [0.61, 0.87]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7.3 Nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5406</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.67 [0.53, 0.84]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">8 Hypoglycemic events per 100 patient's days‐ random effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00708"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-08.png?filename=nCD006297-CMP-007-08.ppt&amp;title=7.8&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%208%20Hypoglycemic%20events%20per%20100%20patient%27s%20days%E2%80%90%20random%20effect%20model.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.8</div> </div> <hr class="top"><img data-id="CD006297-fig-00708" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-08.png" alt="Comparison 7 Heterogeneity analyses, Outcome 8 Hypoglycemic events per 100 patient's days‐ random effect model."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 8 Hypoglycemic events per 100 patient's days‐ random effect model. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.1 Total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4704</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.42 [‐3.53, ‐1.30]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.2 Severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4564</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.01 [‐0.04, 0.05]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.3 Nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4971</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.25 [‐1.63, ‐0.87]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">9 Number of serious adverse events‐ random effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4878</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.89 [0.65, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00709"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-09.png?filename=nCD006297-CMP-007-09.ppt&amp;title=7.9&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%209%20Number%20of%20serious%20adverse%20events%E2%80%90%20random%20effect%20model.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.9</div> </div> <hr class="top"><img data-id="CD006297-fig-00709" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-09.png" alt="Comparison 7 Heterogeneity analyses, Outcome 9 Number of serious adverse events‐ random effect model."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 9 Number of serious adverse events‐ random effect model. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">10 Glycated haemoglobin‐ final values versus change from baseline <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00710"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-10.png?filename=nCD006297-CMP-007-10.ppt&amp;title=7.10&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2010%20Glycated%20haemoglobin%E2%80%90%20final%20values%20versus%20change%20from%20baseline.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.10</div> </div> <hr class="top"><img data-id="CD006297-fig-00710" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-10.png" alt="Comparison 7 Heterogeneity analyses, Outcome 10 Glycated haemoglobin‐ final values versus change from baseline."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 10 Glycated haemoglobin‐ final values versus change from baseline. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10.1 Short term‐ final value</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1003</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.16 [‐0.28, ‐0.04]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10.2 Short term‐ change from baseline</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>256</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [‐0.12, 0.12]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10.3 Intermediate term‐ final value</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2724</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.17 [‐0.23, ‐0.10]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10.4 Long term‐ final value</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1834</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.20, 0.03]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10.5 Long term‐ change from baseline</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1468</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.07 [‐0.02, 0.16]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">11 Fasting blood glucose‐total‐ final values versus change from baseline <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5409</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.86 [1.00, ‐0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00711"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-11.png?filename=nCD006297-CMP-007-11.ppt&amp;title=7.11&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2011%20Fasting%20blood%20glucose%E2%80%90total%E2%80%90%20final%20values%20versus%20change%20from%20baseline.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.11</div> </div> <hr class="top"><img data-id="CD006297-fig-00711" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-11.png" alt="Comparison 7 Heterogeneity analyses, Outcome 11 Fasting blood glucose‐total‐ final values versus change from baseline."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 11 Fasting blood glucose‐total‐ final values versus change from baseline. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11.1 Fasting blood glucose‐total‐ final values</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3816</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.01 [‐1.19, ‐0.84]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11.2 Fasting blood glucose‐total‐ change from baseline</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1593</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.60 [‐0.82, ‐0.37]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">12 Fasting plasma glucose‐ total‐ final values versus change from baseline <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4868</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.63 [‐0.86, ‐0.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00712"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-12.png?filename=nCD006297-CMP-007-12.ppt&amp;title=7.12&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2012%20Fasting%20plasma%20glucose%E2%80%90%20total%E2%80%90%20final%20values%20versus%20change%20from%20baseline.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.12</div> </div> <hr class="top"><img data-id="CD006297-fig-00712" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-12.png" alt="Comparison 7 Heterogeneity analyses, Outcome 12 Fasting plasma glucose‐ total‐ final values versus change from baseline."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 12 Fasting plasma glucose‐ total‐ final values versus change from baseline. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12.1 Fasting plasma glucose‐ total‐ final values</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3749</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.64 [‐0.89, ‐0.40]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12.2 Fasting plasma glucose‐ total‐ change from baseline</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1119</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.53 [‐1.20, 0.13]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">13 Glycated haemoglobin‐ long acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6666</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.12, ‐0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00713"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-13.png?filename=nCD006297-CMP-007-13.ppt&amp;title=7.13&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2013%20Glycated%20haemoglobin%E2%80%90%20long%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.13</div> </div> <hr class="top"><img data-id="CD006297-fig-00713" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-13.png" alt="Comparison 7 Heterogeneity analyses, Outcome 13 Glycated haemoglobin‐ long acting type."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 13 Glycated haemoglobin‐ long acting type. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13.1 Glargine</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3249</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.07 [‐0.13, ‐0.01]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13.2 Detemir</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3095</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.11 [‐0.19, ‐0.04]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13.3 Ultralente</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>322</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.08 [‐0.17, 0.32]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">14 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ long acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>790</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.47 [‐0.58, ‐0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00714"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-14.png?filename=nCD006297-CMP-007-14.ppt&amp;title=7.14&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2014%20Mean%20daily%20self%20measured%20blood%20glucose%20%28SMBG%29%20average%20%287%E2%80%908%20points%29%E2%80%90%20long%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.14</div> </div> <hr class="top"><img data-id="CD006297-fig-00714" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-14.png" alt="Comparison 7 Heterogeneity analyses, Outcome 14 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ long acting type."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 14 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ long acting type. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14.1 Glargine</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>540</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.49 [‐0.61, ‐0.38]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14.2 Detemir</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>118</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.10 [‐0.73, 0.53]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14.3 Ultralente</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>132</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.40 [‐0.43, 1.23]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">15 Fasting blood glucose‐total‐ long acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5409</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.86 [1.00, ‐0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00715"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-15.png?filename=nCD006297-CMP-007-15.ppt&amp;title=7.15&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2015%20Fasting%20blood%20glucose%E2%80%90total%E2%80%90%20long%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.15</div> </div> <hr class="top"><img data-id="CD006297-fig-00715" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-15.png" alt="Comparison 7 Heterogeneity analyses, Outcome 15 Fasting blood glucose‐total‐ long acting type."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 15 Fasting blood glucose‐total‐ long acting type. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15.1 Glargine</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2963</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.82 [‐0.99, ‐0.65]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15.2 Detemir</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2302</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.90 [‐1.15, ‐0.64]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15.3 Ultralente</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>144</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.17 [‐3.42, ‐0.91]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">16 Fasting plasma glucose‐ total‐ long acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4868</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.63 [‐0.86, ‐0.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00716"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-16.png?filename=nCD006297-CMP-007-16.ppt&amp;title=7.16&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2016%20Fasting%20plasma%20glucose%E2%80%90%20total%E2%80%90%20long%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.16</div> </div> <hr class="top"><img data-id="CD006297-fig-00716" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-16.png" alt="Comparison 7 Heterogeneity analyses, Outcome 16 Fasting plasma glucose‐ total‐ long acting type."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 16 Fasting plasma glucose‐ total‐ long acting type. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16.1 Glargine</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2377</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.45 [‐0.73, ‐0.16]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16.2 Detemir</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2491</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.94 [‐1.31, ‐0.57]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">17 Percent of participating experiencing hypoglycemia‐ long acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00717"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-17.png?filename=nCD006297-CMP-007-17.ppt&amp;title=7.17&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2017%20Percent%20of%20participating%20experiencing%20hypoglycemia%E2%80%90%20long%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.17</div> </div> <hr class="top"><img data-id="CD006297-fig-00717" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-17.png" alt="Comparison 7 Heterogeneity analyses, Outcome 17 Percent of participating experiencing hypoglycemia‐ long acting type."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 17 Percent of participating experiencing hypoglycemia‐ long acting type. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17.1 Glargine‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2918</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.96 [0.79, 1.17]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17.2 Glargine‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2871</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.76 [0.58, 0.98]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17.3 Glargine‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2311</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.84 [0.70, 1.00]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17.4 Detemir‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3213</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.87 [0.69, 1.11]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17.5 Detemir‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2956</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.70 [0.54, 0.90]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17.6 Detemir‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3095</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.61 [0.52, 0.72]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">18 Number of serious adverse events‐ long acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4878</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.89 [0.66, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00718"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-18.png?filename=nCD006297-CMP-007-18.ppt&amp;title=7.18&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2018%20Number%20of%20serious%20adverse%20events%E2%80%90%20long%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.18</div> </div> <hr class="top"><img data-id="CD006297-fig-00718" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-18.png" alt="Comparison 7 Heterogeneity analyses, Outcome 18 Number of serious adverse events‐ long acting type."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 18 Number of serious adverse events‐ long acting type. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>18.1 Glargine</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2347</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.69 [0.46, 1.04]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>18.2 Detemir</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2531</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.27 [0.78, 2.05]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">19 Hypoglycemic events per 100 patient's days‐ long acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00719"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-19.png?filename=nCD006297-CMP-007-19.ppt&amp;title=7.19&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2019%20Hypoglycemic%20events%20per%20100%20patient%27s%20days%E2%80%90%20long%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.19</div> </div> <hr class="top"><img data-id="CD006297-fig-00719" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-19.png" alt="Comparison 7 Heterogeneity analyses, Outcome 19 Hypoglycemic events per 100 patient's days‐ long acting type."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 19 Hypoglycemic events per 100 patient's days‐ long acting type. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19.1 Glargine‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1675</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.41 [‐0.54, ‐0.27]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19.2 Glargine‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1614</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.00 [‐0.02, 0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19.3 Glargine‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1746</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.14 [‐0.21, ‐0.07]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19.4 Detemir‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2897</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.24 [‐2.51, ‐1.97]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19.5 Detemir‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2640</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.01 [‐0.04, 0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19.6 Detemir‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3213</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.89 [‐0.99, ‐0.79]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19.7 Ultralente‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>132</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.49 [‐0.36, 1.34]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19.8 Ultralente‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>310</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.20 [0.08, 0.32]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19.9 Ultralente‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.97 [‐4.49, ‐1.45]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">20 Glycated haemoglobin‐ intermediate acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6666</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.12, ‐0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00720"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-20.png?filename=nCD006297-CMP-007-20.ppt&amp;title=7.20&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2020%20Glycated%20haemoglobin%E2%80%90%20intermediate%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.20</div> </div> <hr class="top"><img data-id="CD006297-fig-00720" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-20.png" alt="Comparison 7 Heterogeneity analyses, Outcome 20 Glycated haemoglobin‐ intermediate acting type."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 20 Glycated haemoglobin‐ intermediate acting type. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20.1 NPH</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6522</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.13, ‐0.04]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20.2 Lente</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>144</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.01 [‐0.53, 0.51]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">21 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ intermediate acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>790</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.47 [‐0.58, ‐0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00721"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-21.png?filename=nCD006297-CMP-007-21.ppt&amp;title=7.21&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2021%20Mean%20daily%20self%20measured%20blood%20glucose%20%28SMBG%29%20average%20%287%E2%80%908%20points%29%E2%80%90%20intermediate%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.21</div> </div> <hr class="top"><img data-id="CD006297-fig-00721" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-21.png" alt="Comparison 7 Heterogeneity analyses, Outcome 21 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ intermediate acting type."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 21 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ intermediate acting type. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>21.1 NPH</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>658</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.48 [‐0.59, ‐0.37]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>21.2 Lente</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>132</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.40 [‐0.43, 1.23]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">22 Fasting blood glucose‐total‐ intermediate acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5409</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.86 [1.00, ‐0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00722"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-22.png?filename=nCD006297-CMP-007-22.ppt&amp;title=7.22&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2022%20Fasting%20blood%20glucose%E2%80%90total%E2%80%90%20intermediate%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.22</div> </div> <hr class="top"><img data-id="CD006297-fig-00722" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-22.png" alt="Comparison 7 Heterogeneity analyses, Outcome 22 Fasting blood glucose‐total‐ intermediate acting type."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 22 Fasting blood glucose‐total‐ intermediate acting type. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22.1 NPH</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5265</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.84 [‐0.98, ‐0.70]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22.2 Lente</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>144</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.17 [‐3.42, ‐0.91]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">23 Hypoglycemic events per 100 patient's days‐ intermediate acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00723"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-23.png?filename=nCD006297-CMP-007-23.ppt&amp;title=7.23&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2023%20Hypoglycemic%20events%20per%20100%20patient%27s%20days%E2%80%90%20intermediate%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.23</div> </div> <hr class="top"><img data-id="CD006297-fig-00723" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-23.png" alt="Comparison 7 Heterogeneity analyses, Outcome 23 Hypoglycemic events per 100 patient's days‐ intermediate acting type."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 23 Hypoglycemic events per 100 patient's days‐ intermediate acting type. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>23.1 NPH‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4572</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.80 [‐0.92, ‐0.68]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>23.2 NPH‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4432</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.00 [‐0.02, 0.01]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>23.3 NPH‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4959</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.39 [‐0.45, ‐0.33]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>23.4 Lente‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>132</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.49 [‐0.36, 1.34]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>23.5 Lente‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>132</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.98 [0.66, 1.30]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>23.6 Lente‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.97 [‐4.49, ‐1.45]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">24 Glycated haemoglobin‐ short acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6666</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.12, ‐0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00724"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-24.png?filename=nCD006297-CMP-007-24.ppt&amp;title=7.24&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2024%20Glycated%20haemoglobin%E2%80%90%20short%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.24</div> </div> <hr class="top"><img data-id="CD006297-fig-00724" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-24.png" alt="Comparison 7 Heterogeneity analyses, Outcome 24 Glycated haemoglobin‐ short acting type."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 24 Glycated haemoglobin‐ short acting type. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>24.1 Porcine insulin</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.10 [‐1.75, 1.55]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>24.2 Human insulin versus insulin analogues</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>757</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.29 [‐0.41, ‐0.17]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>24.3 Human insulin</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2936</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.03 [‐0.04, 0.09]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>24.4 Insulin analogues</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2961</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.13 [‐0.20, ‐0.06]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">25 Fasting blood glucose‐total‐ short acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5409</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.86 [1.00, ‐0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00725"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-25.png?filename=nCD006297-CMP-007-25.ppt&amp;title=7.25&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2025%20Fasting%20blood%20glucose%E2%80%90total%E2%80%90%20short%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.25</div> </div> <hr class="top"><img data-id="CD006297-fig-00725" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-25.png" alt="Comparison 7 Heterogeneity analyses, Outcome 25 Fasting blood glucose‐total‐ short acting type."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 25 Fasting blood glucose‐total‐ short acting type. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>25.1 Human insulin</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3054</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.75 [‐0.92, ‐0.58]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>25.2 Insulin analogues</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2181</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.96 [‐1.22, ‐0.70]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>25.3 Porcine insulin</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐4.8 [‐7.78, ‐1.82]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>25.4 Human insulin versus insulin analogues</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>162</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.26 [‐1.75, ‐0.77]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">26 Fasting plasma glucose‐ total‐ short acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4868</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.63 [‐0.86, ‐0.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00726"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-26.png?filename=nCD006297-CMP-007-26.ppt&amp;title=7.26&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2026%20Fasting%20plasma%20glucose%E2%80%90%20total%E2%80%90%20short%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.26</div> </div> <hr class="top"><img data-id="CD006297-fig-00726" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-26.png" alt="Comparison 7 Heterogeneity analyses, Outcome 26 Fasting plasma glucose‐ total‐ short acting type."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 26 Fasting plasma glucose‐ total‐ short acting type. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>26.1 Human insulin</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2455</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.13 [‐1.54, ‐0.72]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>26.2 Insulin analogues</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1768</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.62 [‐2.14, ‐1.11]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>26.3 Human insulin versus insulin analogues</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>645</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.07 [‐0.26, 0.39]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">27 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ short acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>790</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.47 [‐0.58, ‐0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00727"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-27.png?filename=nCD006297-CMP-007-27.ppt&amp;title=7.27&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2027%20Mean%20daily%20self%20measured%20blood%20glucose%20%28SMBG%29%20average%20%287%E2%80%908%20points%29%E2%80%90%20short%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.27</div> </div> <hr class="top"><img data-id="CD006297-fig-00727" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-27.png" alt="Comparison 7 Heterogeneity analyses, Outcome 27 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ short acting type."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 27 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ short acting type. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>27.1 Human insulin</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>506</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.15 [‐0.26, 0.56]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>27.2 Insulin analogues</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>172</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.5 [‐0.61, ‐0.39]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>27.3 Human insulin versus insulin analogues</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>112</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.90 [‐3.01, ‐0.79]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">28 Percent of participating experiencing hypoglycemia‐ short acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00728"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-28.png?filename=nCD006297-CMP-007-28.ppt&amp;title=7.28&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2028%20Percent%20of%20participating%20experiencing%20hypoglycemia%E2%80%90%20short%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.28</div> </div> <hr class="top"><img data-id="CD006297-fig-00728" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-28.png" alt="Comparison 7 Heterogeneity analyses, Outcome 28 Percent of participating experiencing hypoglycemia‐ short acting type."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 28 Percent of participating experiencing hypoglycemia‐ short acting type. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>28.1 Human insulin versus insulin analogues‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>757</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.96 [0.57, 1.62]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>28.2 Human insulin versus insulin analogues‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>707</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.46 [0.34, 0.63]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>28.3 Human insulin‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2925</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.98 [0.80, 1.19]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>28.4 Human insulin‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2669</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.68 [0.52, 0.89]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>28.5 Human insulin‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2821</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.87 [0.74, 1.03]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>28.6 Insulin analogues‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3953</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.91 [0.74, 1.14]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>28.7 Insulin analogues‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2401</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.72 [0.54, 0.96]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>28.8 Insulin analogues‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2497</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.75 [0.63, 0.90]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">29 Number of serious adverse events‐ short acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4878</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.89 [0.66, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00729"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-29.png?filename=nCD006297-CMP-007-29.ppt&amp;title=7.29&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2029%20Number%20of%20serious%20adverse%20events%E2%80%90%20short%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.29</div> </div> <hr class="top"><img data-id="CD006297-fig-00729" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-29.png" alt="Comparison 7 Heterogeneity analyses, Outcome 29 Number of serious adverse events‐ short acting type."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 29 Number of serious adverse events‐ short acting type. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>29.1 Human insulin</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2925</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.73 [0.49, 1.09]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>29.2 Insulin analogues</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1196</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.18 [0.64, 2.17]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>29.3 Human insulin versus insulin analogues</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>757</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.16 [0.54, 2.51]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">30 Hypoglycemic events per 100 patient's days‐ short acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>18</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00730"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-30.png?filename=nCD006297-CMP-007-30.ppt&amp;title=7.30&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2030%20Hypoglycemic%20events%20per%20100%20patient%27s%20days%E2%80%90%20short%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.30</div> </div> <hr class="top"><img data-id="CD006297-fig-00730" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-30.png" alt="Comparison 7 Heterogeneity analyses, Outcome 30 Hypoglycemic events per 100 patient's days‐ short acting type."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 30 Hypoglycemic events per 100 patient's days‐ short acting type. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30.1 Human insulin‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1531</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.42 [‐0.56, ‐0.28]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30.2 Human insulin‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1531</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.01 [‐0.03, 0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30.3 Human insulin‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1399</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.17 [‐0.25, ‐0.10]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30.4 Insulin analogues‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2416</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.07 [‐2.38, ‐1.75]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30.5 Insulin analogues‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2388</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.01 [‐0.01, 0.04]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30.6 Insulin analogues‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2803</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.63 [‐0.74, ‐0.52]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30.7 Human insulin versus insulin analogues‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>757</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.61 [‐2.02, ‐1.19]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30.8 Human insulin versus insulin analogues‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>645</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.02 [‐0.07, 0.03]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30.9 Human insulin versus insulin analogues‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>757</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.94 [‐1.10, ‐0.77]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">31 Glycated haemoglobin‐ number of basal doses (long acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6666</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.12, ‐0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00731"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-31.png?filename=nCD006297-CMP-007-31.ppt&amp;title=7.31&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2031%20Glycated%20haemoglobin%E2%80%90%20number%20of%20basal%20doses%20%28long%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.31</div> </div> <hr class="top"><img data-id="CD006297-fig-00731" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-31.png" alt="Comparison 7 Heterogeneity analyses, Outcome 31 Glycated haemoglobin‐ number of basal doses (long acting)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 31 Glycated haemoglobin‐ number of basal doses (long acting). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>31.1 Once daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3996</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.07 [‐0.13, ‐0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>31.2 Twice or more daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2145</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.13 [‐0.21, ‐0.05]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>31.3 According to glucose control</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>525</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.10 [‐0.10, 0.30]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">32 Fasting blood glucose‐total‐ number of basal doses (long acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5409</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.86 [1.00, ‐0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00732"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-32.png?filename=nCD006297-CMP-007-32.ppt&amp;title=7.32&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2032%20Fasting%20blood%20glucose%E2%80%90total%E2%80%90%20number%20of%20basal%20doses%20%28long%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.32</div> </div> <hr class="top"><img data-id="CD006297-fig-00732" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-32.png" alt="Comparison 7 Heterogeneity analyses, Outcome 32 Fasting blood glucose‐total‐ number of basal doses (long acting)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 32 Fasting blood glucose‐total‐ number of basal doses (long acting). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>32.1 Once daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3828</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.83 [‐0.98, ‐0.68]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>32.2 Twice or more daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1234</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.99 [‐1.38, ‐0.60]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>32.3 According to glucose control</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>347</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.20 [‐2.18, ‐0.22]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">33 Fasting plasma glucose‐ total‐ number of basal doses (long acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4868</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.63 [‐0.86, ‐0.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00733"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-33.png?filename=nCD006297-CMP-007-33.ppt&amp;title=7.33&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2033%20Fasting%20plasma%20glucose%E2%80%90%20total%E2%80%90%20number%20of%20basal%20doses%20%28long%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.33</div> </div> <hr class="top"><img data-id="CD006297-fig-00733" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-33.png" alt="Comparison 7 Heterogeneity analyses, Outcome 33 Fasting plasma glucose‐ total‐ number of basal doses (long acting)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 33 Fasting plasma glucose‐ total‐ number of basal doses (long acting). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>33.1 Once daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3124</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.54 [‐0.81, ‐0.27]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>33.2 Twice or more daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1744</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.87 [‐1.31, ‐0.43]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">34 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ number of basal doses (long acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>790</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.47 [‐0.58, ‐0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00734"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-34.png?filename=nCD006297-CMP-007-34.ppt&amp;title=7.34&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2034%20Mean%20daily%20self%20measured%20blood%20glucose%20%28SMBG%29%20average%20%287%E2%80%908%20points%29%E2%80%90%20number%20of%20basal%20doses%20%28long%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.34</div> </div> <hr class="top"><img data-id="CD006297-fig-00734" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-34.png" alt="Comparison 7 Heterogeneity analyses, Outcome 34 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ number of basal doses (long acting)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 34 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ number of basal doses (long acting). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>34.1 Once daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>607</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.35 [‐0.67, ‐0.03]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>34.2 Twice or more daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>183</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.48 [‐0.60, ‐0.37]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">35 Percent of participating experiencing hypoglycemia‐ number of basal doses (long acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00735"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-35.png?filename=nCD006297-CMP-007-35.ppt&amp;title=7.35&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2035%20Percent%20of%20participating%20experiencing%20hypoglycemia%E2%80%90%20number%20of%20basal%20doses%20%28long%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.35</div> </div> <hr class="top"><img data-id="CD006297-fig-00735" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-35.png" alt="Comparison 7 Heterogeneity analyses, Outcome 35 Percent of participating experiencing hypoglycemia‐ number of basal doses (long acting)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 35 Percent of participating experiencing hypoglycemia‐ number of basal doses (long acting). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>35.1 Once daily‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3783</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.01 [0.84, 1.21]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>35.2 Once daily‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3736</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.74 [0.59, 0.94]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>35.3 Once daily‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3058</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.86 [0.73, 1.00]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>35.4 Twice or more daily‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2001</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.78 [0.58, 1.04]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>35.5 Twice or more daily‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2491</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.69 [0.52, 0.93]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>35.6 Twice or more daily‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1576</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.53 [0.42, 0.65]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>35.7 According to glucose control‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>347</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.44 [0.09, 2.06]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>35.8 According to glucose control‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>347</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.76 [0.43, 1.35]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>35.9 According to glucose control‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>347</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.42 [0.22, 0.78]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">36 Number of serious adverse events‐ number of basal doses (long acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5303</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.81 [0.63, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00736"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-36.png?filename=nCD006297-CMP-007-36.ppt&amp;title=7.36&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2036%20Number%20of%20serious%20adverse%20events%E2%80%90%20number%20of%20basal%20doses%20%28long%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.36</div> </div> <hr class="top"><img data-id="CD006297-fig-00736" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-36.png" alt="Comparison 7 Heterogeneity analyses, Outcome 36 Number of serious adverse events‐ number of basal doses (long acting)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 36 Number of serious adverse events‐ number of basal doses (long acting). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>36.1 Once daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3212</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.75 [0.52, 1.09]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>36.2 Twice or more daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1744</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.86 [0.60, 1.23]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>36.3 ACcording to glucose control</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>347</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.99 [0.18, 5.49]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">37 Hypoglycemic events per 100 patient's days‐ number of basal doses (long acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00737"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-37.png?filename=nCD006297-CMP-007-37.ppt&amp;title=7.37&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2037%20Hypoglycemic%20events%20per%20100%20patient%27s%20days%E2%80%90%20number%20of%20basal%20doses%20%28long%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.37</div> </div> <hr class="top"><img data-id="CD006297-fig-00737" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-37.png" alt="Comparison 7 Heterogeneity analyses, Outcome 37 Hypoglycemic events per 100 patient's days‐ number of basal doses (long acting)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 37 Hypoglycemic events per 100 patient's days‐ number of basal doses (long acting). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>37.1 Once daily‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2540</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.45 [‐0.58, ‐0.31]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>37.2 Once daily‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2479</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.00 [‐0.02, 0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>37.3 Once daily‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2611</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.20 [‐0.26, ‐0.13]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>37.4 Twice or more daily‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1817</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.22 [‐2.51, ‐1.92]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>37.5 Twice or more daily‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1560</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.00 [‐0.04, 0.04]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>37.6 Twice or more daily‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2013</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.97 [‐1.09, ‐0.85]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>37.7 According to glucose control‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>347</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐3.30 [‐4.53, ‐2.07]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>37.8 According to glucose control‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>525</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.02 [‐0.07, 0.12]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>37.9 According to glucose control‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>347</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.11 [‐1.58, ‐0.64]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">38 Glycated haemoglobin‐ number of basal doses (intermediate acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6666</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.12, ‐0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00738"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-38.png?filename=nCD006297-CMP-007-38.ppt&amp;title=7.38&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2038%20Glycated%20haemoglobin%E2%80%90%20number%20of%20basal%20doses%20%28intermediate%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.38</div> </div> <hr class="top"><img data-id="CD006297-fig-00738" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-38.png" alt="Comparison 7 Heterogeneity analyses, Outcome 38 Glycated haemoglobin‐ number of basal doses (intermediate acting)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 38 Glycated haemoglobin‐ number of basal doses (intermediate acting). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>38.1 Once daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>922</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.15 [‐0.32, 0.03]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>38.2 Twice or more daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2431</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.19 [‐0.25, ‐0.12]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>38.3 According to glucose control</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3313</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.01 [‐0.05, 0.07]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">39 Fasting blood glucose‐total‐ number of basal doses (intermediate acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5409</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.86 [1.00, ‐0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00739"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-39.png?filename=nCD006297-CMP-007-39.ppt&amp;title=7.39&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2039%20Fasting%20blood%20glucose%E2%80%90total%E2%80%90%20number%20of%20basal%20doses%20%28intermediate%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.39</div> </div> <hr class="top"><img data-id="CD006297-fig-00739" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-39.png" alt="Comparison 7 Heterogeneity analyses, Outcome 39 Fasting blood glucose‐total‐ number of basal doses (intermediate acting)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 39 Fasting blood glucose‐total‐ number of basal doses (intermediate acting). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>39.1 Once daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1040</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.97 [‐1.26, ‐0.68]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>39.2 Twice or more daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1234</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.99 [‐1.38, ‐0.60]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>39.3 According to glucose control</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3135</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.79 [‐0.96, ‐0.62]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">40 Fasting plasma glucose‐ total‐ number of basal doses (intermediate acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4868</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.63 [‐0.86, ‐0.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00740"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-40.png?filename=nCD006297-CMP-007-40.ppt&amp;title=7.40&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2040%20Fasting%20plasma%20glucose%E2%80%90%20total%E2%80%90%20number%20of%20basal%20doses%20%28intermediate%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.40</div> </div> <hr class="top"><img data-id="CD006297-fig-00740" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-40.png" alt="Comparison 7 Heterogeneity analyses, Outcome 40 Fasting plasma glucose‐ total‐ number of basal doses (intermediate acting)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 40 Fasting plasma glucose‐ total‐ number of basal doses (intermediate acting). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>40.1 Once daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>797</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.03 [‐0.32, 0.38]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>40.2 Twice or more daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1744</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.87 [‐1.31, ‐0.43]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>40.3 According to glucose control</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2327</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.32 [‐1.73, ‐0.91]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">41 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ number of basal doses (intermediate acting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>790</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.47 [‐0.58, ‐0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00741"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-41.png?filename=nCD006297-CMP-007-41.ppt&amp;title=7.41&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2041%20Mean%20daily%20self%20measured%20blood%20glucose%20%28SMBG%29%20average%20%287%E2%80%908%20points%29%E2%80%90%20number%20of%20basal%20doses%20%28intermediate%20acting.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.41</div> </div> <hr class="top"><img data-id="CD006297-fig-00741" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-41.png" alt="Comparison 7 Heterogeneity analyses, Outcome 41 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ number of basal doses (intermediate acting."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 41 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ number of basal doses (intermediate acting. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>41.1 Once daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>118</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.10 [‐0.73, 0.53]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>41.2 Twice or more daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>304</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.48 [‐0.60, ‐0.37]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>41.3 According to blood glucose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>368</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.35 [‐0.95, 0.25]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">42 Percent of participating experiencing hypoglycemia‐ number of basal doses (intermediate acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00742"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-42.png?filename=nCD006297-CMP-007-42.ppt&amp;title=7.42&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2042%20Percent%20of%20participating%20experiencing%20hypoglycemia%E2%80%90%20number%20of%20basal%20doses%20%28intermediate%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.42</div> </div> <hr class="top"><img data-id="CD006297-fig-00742" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-42.png" alt="Comparison 7 Heterogeneity analyses, Outcome 42 Percent of participating experiencing hypoglycemia‐ number of basal doses (intermediate acting)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 42 Percent of participating experiencing hypoglycemia‐ number of basal doses (intermediate acting). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>42.1 Once daily‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>990</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.42 [0.90, 2.22]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>42.2 Once daily‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>915</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.68 [0.41, 1.15]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>42.3 Once daily‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>872</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.91 [0.67, 1.24]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>42.4 Twice or more daily‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2115</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.81 [0.61, 1.07]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>42.5 Twice or more daily‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2030</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.69 [0.50, 0.96]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>42.6 Twice or more daily‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1744</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.55 [0.45, 0.69]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>42.7 According to blood glucose‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3026</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.92 [0.75, 1.12]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>42.8 According to blood glucose‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2882</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.76 [0.59, 0.96]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>42.9 According to blood glucose‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2790</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.76 [0.64, 0.89]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">43 Number of serious adverse events‐ number of basal doses (intermediate acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4878</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.89 [0.66, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00743"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-43.png?filename=nCD006297-CMP-007-43.ppt&amp;title=7.43&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2043%20Number%20of%20serious%20adverse%20events%E2%80%90%20number%20of%20basal%20doses%20%28intermediate%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.43</div> </div> <hr class="top"><img data-id="CD006297-fig-00743" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-43.png" alt="Comparison 7 Heterogeneity analyses, Outcome 43 Number of serious adverse events‐ number of basal doses (intermediate acting)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 43 Number of serious adverse events‐ number of basal doses (intermediate acting). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>43.1 Once daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1040</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.24 [0.56, 2.74]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>43.2 Twice or more daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1319</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.31 [0.74, 2.33]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>43.3 According to glucose control</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2519</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.67 [0.44, 1.00]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">44 Hypoglycemic events per 100 patient's days‐ number of basal doses (intermediate acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00744"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-44.png?filename=nCD006297-CMP-007-44.ppt&amp;title=7.44&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2044%20Hypoglycemic%20events%20per%20100%20patient%27s%20days%E2%80%90%20number%20of%20basal%20doses%20%28intermediate%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.44</div> </div> <hr class="top"><img data-id="CD006297-fig-00744" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-44.png" alt="Comparison 7 Heterogeneity analyses, Outcome 44 Hypoglycemic events per 100 patient's days‐ number of basal doses (intermediate acting)."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 44 Hypoglycemic events per 100 patient's days‐ number of basal doses (intermediate acting). </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>44.1 Once daily‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1040</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.49 [‐0.97, ‐0.01]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>44.2 Once daily‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1040</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.00 [‐0.05, 0.04]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>44.3 Once daily‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1040</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.60 [‐0.79, ‐0.41]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>44.4 Twice or more daily‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2052</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.30 [‐2.58, ‐2.03]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>44.5 Twice or more daily‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1846</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.00 [‐0.03, 0.03]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>44.6 Twice or more daily‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2319</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.86 [‐0.97, ‐0.76]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>44.7 According to glucose control‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1612</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.40 [‐0.54, ‐0.26]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>44.8 According to glucose control‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1678</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.00 [‐0.02, 0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>44.9 According to glucose control‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1612</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.12 [‐0.19, ‐0.04]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">45 Glycated haemoglobin‐ diabetes status <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>21</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6633</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.13, ‐0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00745"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-45.png?filename=nCD006297-CMP-007-45.ppt&amp;title=7.45&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2045%20Glycated%20haemoglobin%E2%80%90%20diabetes%20status.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.45</div> </div> <hr class="top"><img data-id="CD006297-fig-00745" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-45.png" alt="Comparison 7 Heterogeneity analyses, Outcome 45 Glycated haemoglobin‐ diabetes status."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 45 Glycated haemoglobin‐ diabetes status.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>45.1 Fare</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2167</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.04 [‐0.11, 0.03]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>45.2 Intermediate</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4138</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.11 [‐0.17, ‐0.05]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>45.3 Poor</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>328</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.06 [‐0.38, 0.25]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">46 Fasting blood glucose‐total‐ diabetes status <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5060</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.77 [‐0.91, ‐0.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00746"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-46.png?filename=nCD006297-CMP-007-46.ppt&amp;title=7.46&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2046%20Fasting%20blood%20glucose%E2%80%90total%E2%80%90%20diabetes%20status.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.46</div> </div> <hr class="top"><img data-id="CD006297-fig-00746" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-46.png" alt="Comparison 7 Heterogeneity analyses, Outcome 46 Fasting blood glucose‐total‐ diabetes status."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 46 Fasting blood glucose‐total‐ diabetes status. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>46.1 Fare</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1856</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.48 [‐0.69, ‐0.28]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>46.2 Intermediate</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3192</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.01 [‐1.21, ‐0.81]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>46.3 Poor</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐4.8 [‐7.78, ‐1.82]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">47 Fasting plasma glucose‐ total‐ diabetes status <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4868</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.63 [‐0.86, ‐0.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00747"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-47.png?filename=nCD006297-CMP-007-47.ppt&amp;title=7.47&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2047%20Fasting%20plasma%20glucose%E2%80%90%20total%E2%80%90%20diabetes%20status.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.47</div> </div> <hr class="top"><img data-id="CD006297-fig-00747" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-47.png" alt="Comparison 7 Heterogeneity analyses, Outcome 47 Fasting plasma glucose‐ total‐ diabetes status."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 47 Fasting plasma glucose‐ total‐ diabetes status. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>47.1 Fare</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1738</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.07 [‐1.56, ‐0.58]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>47.2 Intermediate</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2814</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.51 [‐0.76, ‐0.25]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>47.3 Poor</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>316</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">48 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ diabetes status <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>790</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.47 [‐0.58, ‐0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00748"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-48.png?filename=nCD006297-CMP-007-48.ppt&amp;title=7.48&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2048%20Mean%20daily%20self%20measured%20blood%20glucose%20%28SMBG%29%20average%20%287%E2%80%908%20points%29%E2%80%90%20diabetes%20status.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.48</div> </div> <hr class="top"><img data-id="CD006297-fig-00748" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-48.png" alt="Comparison 7 Heterogeneity analyses, Outcome 48 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ diabetes status."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 48 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ diabetes status. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>48.1 Fare</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>290</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.49 [‐0.60, ‐0.38]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>48.2 Intermediate</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>500</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.09 [‐0.58, 0.40]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">49 Percent of participating experiencing hypoglycemia‐ diabetes status <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00749"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-49.png?filename=nCD006297-CMP-007-49.ppt&amp;title=7.49&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2049%20Percent%20of%20participating%20experiencing%20hypoglycemia%E2%80%90%20diabetes%20status.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.49</div> </div> <hr class="top"><img data-id="CD006297-fig-00749" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-49.png" alt="Comparison 7 Heterogeneity analyses, Outcome 49 Percent of participating experiencing hypoglycemia‐ diabetes status."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 49 Percent of participating experiencing hypoglycemia‐ diabetes status. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>49.1 Fare‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2113</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.94 [0.75, 1.19]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>49.2 Fare‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2028</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.69 [0.49, 0.98]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>49.3 Fare‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1995</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.88 [0.73, 1.07]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>49.4 Intermediate‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3353</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.90 [0.72, 1.13]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>49.5 Intermediate‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3134</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.77 [0.59, 0.99]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>49.6 Intermediate‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3095</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.60 [0.51, 0.70]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>49.7 Poor‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>316</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.97 [0.29, 3.24]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>49.8 Poor‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>316</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.60 [0.32, 1.10]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>49.9 Poor‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>316</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.67 [0.33, 1.35]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">50 Number of serious adverse events‐ diabetes status <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4529</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.06 [0.76, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00750"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-50.png?filename=nCD006297-CMP-007-50.ppt&amp;title=7.50&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2050%20Number%20of%20serious%20adverse%20events%E2%80%90%20diabetes%20status.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.50</div> </div> <hr class="top"><img data-id="CD006297-fig-00750" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-50.png" alt="Comparison 7 Heterogeneity analyses, Outcome 50 Number of serious adverse events‐ diabetes status."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 50 Number of serious adverse events‐ diabetes status. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>50.1 Fare</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1237</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.97 [0.57, 1.64]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>50.2 Intermediate</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2976</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.25 [0.76, 2.04]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>50.3 Poor</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>316</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.77 [0.29, 2.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">51 Hypoglycemic events per 100 patient's days‐ diabetes status <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00751"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-51.png?filename=nCD006297-CMP-007-51.ppt&amp;title=7.51&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2051%20Hypoglycemic%20events%20per%20100%20patient%27s%20days%E2%80%90%20diabetes%20status.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 7.51</div> </div> <hr class="top"><img data-id="CD006297-fig-00751" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-51.png" alt="Comparison 7 Heterogeneity analyses, Outcome 51 Hypoglycemic events per 100 patient's days‐ diabetes status."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 51 Hypoglycemic events per 100 patient's days‐ diabetes status. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>51.1 Fare‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1649</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.55 [‐0.69, ‐0.41]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>51.2 Fare‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1443</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.01 [‐0.03, 0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>51.3 Fare‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1720</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.19 [‐0.26, ‐0.12]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>51.4 Intermediate‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3055</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.46 [‐1.71, ‐1.22]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>51.5 Intermediate‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3121</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.00 [‐0.02, 0.03]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>51.6 Intermediate‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2923</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.69 [‐0.78, ‐0.59]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>51.7 Poor‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>328</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.80 [‐2.29, ‐1.32]</p> </td> </tr> </tbody> </table> </div> <div class="table" id="CD006297-tbl-0008"> <table class="comparison"><a href="#0" class="open-table-viewer open-in-figure-viewer">Open in table viewer</a><div class="table-heading"><span class="table-label">Comparison 8.</span>&nbsp;<span class="table-title">Sensitivity analysis</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Glycated haemoglobin‐ large trials ommited <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5300</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.12, ‐0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00801"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-01.png?filename=nCD006297-CMP-008-01.ppt&amp;title=8.1&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%201%20Glycated%20haemoglobin%E2%80%90%20large%20trials%20ommited.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 8.1</div> </div> <hr class="top"><img data-id="CD006297-fig-00801" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-01.png" alt="Comparison 8 Sensitivity analysis, Outcome 1 Glycated haemoglobin‐ large trials ommited."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 1 Glycated haemoglobin‐ large trials ommited.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Short term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>640</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.18, 0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2105</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.18 [‐0.25, ‐0.10]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.3 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2555</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.03 [‐0.05, 0.11]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Glycated haemoglobin‐ low quality ommited <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6267</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.05 [‐0.10, ‐0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00802"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-02.png?filename=nCD006297-CMP-008-02.ppt&amp;title=8.2&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%202%20Glycated%20haemoglobin%E2%80%90%20low%20quality%20ommited.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 8.2</div> </div> <hr class="top"><img data-id="CD006297-fig-00802" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-02.png" alt="Comparison 8 Sensitivity analysis, Outcome 2 Glycated haemoglobin‐ low quality ommited."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 2 Glycated haemoglobin‐ low quality ommited.</p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Short term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>875</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.04 [‐0.13, 0.06]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2560</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.16 [‐0.23, ‐0.08]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.3 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2832</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.04 [‐0.03, 0.12]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Fasting blood glucose‐total‐ low quality ommited <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4559</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.75 [‐0.91, ‐0.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00803"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-03.png?filename=nCD006297-CMP-008-03.ppt&amp;title=8.3&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%203%20Fasting%20blood%20glucose%E2%80%90total%E2%80%90%20low%20quality%20ommited.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 8.3</div> </div> <hr class="top"><img data-id="CD006297-fig-00803" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-03.png" alt="Comparison 8 Sensitivity analysis, Outcome 3 Fasting blood glucose‐total‐ low quality ommited."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 3 Fasting blood glucose‐total‐ low quality ommited. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 Fasting plasma glucose‐ total‐ low quality ommited <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4485</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.07 [‐1.36, ‐0.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00804"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-04.png?filename=nCD006297-CMP-008-04.ppt&amp;title=8.4&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%204%20Fasting%20plasma%20glucose%E2%80%90%20total%E2%80%90%20low%20quality%20ommited.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 8.4</div> </div> <hr class="top"><img data-id="CD006297-fig-00804" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-04.png" alt="Comparison 8 Sensitivity analysis, Outcome 4 Fasting plasma glucose‐ total‐ low quality ommited."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 4 Fasting plasma glucose‐ total‐ low quality ommited. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ low quality ommited <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>500</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.09 [‐0.58, 0.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00805"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-05.png?filename=nCD006297-CMP-008-05.ppt&amp;title=8.5&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%205%20Mean%20daily%20self%20measured%20blood%20glucose%20%28SMBG%29%20average%20%287%E2%80%908%20points%29%E2%80%90%20low%20quality%20ommited.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 8.5</div> </div> <hr class="top"><img data-id="CD006297-fig-00805" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-05.png" alt="Comparison 8 Sensitivity analysis, Outcome 5 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ low quality ommited."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 5 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ low quality ommited. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.1 Short term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>256</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.30 [‐0.42, 1.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.2 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>244</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.43 [‐1.09, 0.24]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.3 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Percent of participating experiencing hypoglycemia‐ low quality ommited <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00806"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-06.png?filename=nCD006297-CMP-008-06.ppt&amp;title=8.6&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%206%20Percent%20of%20participating%20experiencing%20hypoglycemia%E2%80%90%20low%20quality%20ommited.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 8.6</div> </div> <hr class="top"><img data-id="CD006297-fig-00806" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-06.png" alt="Comparison 8 Sensitivity analysis, Outcome 6 Percent of participating experiencing hypoglycemia‐ low quality ommited."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 6 Percent of participating experiencing hypoglycemia‐ low quality ommited. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6.1 Total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5214</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.92 [0.77, 1.09]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6.2 Severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4688</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.71 [0.58, 0.88]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6.3 Nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5070</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.73 [0.64, 0.82]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">7 Hypoglycemic events per 100 patient's days‐ low quality ommited <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00807"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-07.png?filename=nCD006297-CMP-008-07.ppt&amp;title=8.7&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%207%20Hypoglycemic%20events%20per%20100%20patient%27s%20days%E2%80%90%20low%20quality%20ommited.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 8.7</div> </div> <hr class="top"><img data-id="CD006297-fig-00807" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-07.png" alt="Comparison 8 Sensitivity analysis, Outcome 7 Hypoglycemic events per 100 patient's days‐ low quality ommited."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 7 Hypoglycemic events per 100 patient's days‐ low quality ommited. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7.1 Total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4301</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.70 [‐0.82, ‐0.58]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7.2 Severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4110</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.00 [‐0.02, 0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7.3 Nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4497</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.38 [‐0.44, ‐0.32]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">8 Glycated haemoglobin‐ selection bias analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4077</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.12 [‐0.18, ‐0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00808"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-08.png?filename=nCD006297-CMP-008-08.ppt&amp;title=8.8&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%208%20Glycated%20haemoglobin%E2%80%90%20selection%20bias%20analysis.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 8.8</div> </div> <hr class="top"><img data-id="CD006297-fig-00808" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-08.png" alt="Comparison 8 Sensitivity analysis, Outcome 8 Glycated haemoglobin‐ selection bias analysis."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 8 Glycated haemoglobin‐ selection bias analysis. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.1 Short term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>619</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.10 [‐0.27, 0.07]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.2 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2405</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.19 [‐0.27, ‐0.12]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.3 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1053</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.02 [‐0.09, 0.14]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">9 Fasting blood glucose‐total‐ selection bias analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2628</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.72 [‐0.93, ‐0.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00809"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-09.png?filename=nCD006297-CMP-008-09.ppt&amp;title=8.9&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%209%20Fasting%20blood%20glucose%E2%80%90total%E2%80%90%20selection%20bias%20analysis.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 8.9</div> </div> <hr class="top"><img data-id="CD006297-fig-00809" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-09.png" alt="Comparison 8 Sensitivity analysis, Outcome 9 Fasting blood glucose‐total‐ selection bias analysis."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 9 Fasting blood glucose‐total‐ selection bias analysis. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">10 Fasting plasma glucose‐ total‐ selection bias analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2632</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.92 [‐1.26, ‐0.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00810"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-10.png?filename=nCD006297-CMP-008-10.ppt&amp;title=8.10&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%2010%20Fasting%20plasma%20glucose%E2%80%90%20total%E2%80%90%20selection%20bias%20analysis.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 8.10</div> </div> <hr class="top"><img data-id="CD006297-fig-00810" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-10.png" alt="Comparison 8 Sensitivity analysis, Outcome 10 Fasting plasma glucose‐ total‐ selection bias analysis."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 10 Fasting plasma glucose‐ total‐ selection bias analysis. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">11 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ selection bias analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>365</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.47 [‐0.86, ‐0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00811"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-11.png?filename=nCD006297-CMP-008-11.ppt&amp;title=8.11&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%2011%20Mean%20daily%20self%20measured%20blood%20glucose%20%28SMBG%29%20average%20%287%E2%80%908%20points%29%E2%80%90%20selection%20bias%20analysis.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 8.11</div> </div> <hr class="top"><img data-id="CD006297-fig-00811" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-11.png" alt="Comparison 8 Sensitivity analysis, Outcome 11 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ selection bias analysis."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 11 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ selection bias analysis. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11.1 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>244</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.43 [‐1.09, 0.24]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11.2 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>121</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.5 [‐0.98, ‐0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">12 Percent of participating experiencing hypoglycemia‐ selection bias analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00812"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-12.png?filename=nCD006297-CMP-008-12.ppt&amp;title=8.12&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%2012%20Percent%20of%20participating%20experiencing%20hypoglycemia%E2%80%90%20selection%20bias%20analysis.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 8.12</div> </div> <hr class="top"><img data-id="CD006297-fig-00812" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-12.png" alt="Comparison 8 Sensitivity analysis, Outcome 12 Percent of participating experiencing hypoglycemia‐ selection bias analysis."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 12 Percent of participating experiencing hypoglycemia‐ selection bias analysis. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12.1 Total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3093</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.92 [0.73, 1.15]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12.2 Severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3326</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.77 [0.61, 0.98]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12.3 Nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3091</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.74 [0.63, 0.86]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">13 Hypoglycemic events per 100 patient's days‐ selection bias analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00813"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-13.png?filename=nCD006297-CMP-008-13.ppt&amp;title=8.13&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%2013%20Hypoglycemic%20events%20per%20100%20patient%27s%20days%E2%80%90%20selection%20bias%20analysis.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 8.13</div> </div> <hr class="top"><img data-id="CD006297-fig-00813" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-13.png" alt="Comparison 8 Sensitivity analysis, Outcome 13 Hypoglycemic events per 100 patient's days‐ selection bias analysis."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 13 Hypoglycemic events per 100 patient's days‐ selection bias analysis. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13.1 Total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2873</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.82 [‐2.07, ‐1.56]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13.2 Severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2811</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.01 [‐0.01, 0.03]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13.3 Nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2741</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.64 [‐0.74, ‐0.54]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">14 Glycated haemoglobin‐ attrition bias analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3919</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.10 [‐0.17, ‐0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00814"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-14.png?filename=nCD006297-CMP-008-14.ppt&amp;title=8.14&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%2014%20Glycated%20haemoglobin%E2%80%90%20attrition%20bias%20analysis.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 8.14</div> </div> <hr class="top"><img data-id="CD006297-fig-00814" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-14.png" alt="Comparison 8 Sensitivity analysis, Outcome 14 Glycated haemoglobin‐ attrition bias analysis."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 14 Glycated haemoglobin‐ attrition bias analysis. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14.1 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1672</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.22 [‐0.31, ‐0.13]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14.2 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2247</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.01 [‐0.08, 0.11]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">15 Fasting blood glucose‐total‐ attrition bias analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2830</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.73 [‐0.94, ‐0.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00815"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-15.png?filename=nCD006297-CMP-008-15.ppt&amp;title=8.15&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%2015%20Fasting%20blood%20glucose%E2%80%90total%E2%80%90%20attrition%20bias%20analysis.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 8.15</div> </div> <hr class="top"><img data-id="CD006297-fig-00815" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-15.png" alt="Comparison 8 Sensitivity analysis, Outcome 15 Fasting blood glucose‐total‐ attrition bias analysis."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 15 Fasting blood glucose‐total‐ attrition bias analysis. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">16 Fasting plasma glucose‐ total‐ attrition bias analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3025</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.98 [‐1.34, ‐0.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00816"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-16.png?filename=nCD006297-CMP-008-16.ppt&amp;title=8.16&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%2016%20Fasting%20plasma%20glucose%E2%80%90%20total%E2%80%90%20attrition%20bias%20analysis.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 8.16</div> </div> <hr class="top"><img data-id="CD006297-fig-00816" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-16.png" alt="Comparison 8 Sensitivity analysis, Outcome 16 Fasting plasma glucose‐ total‐ attrition bias analysis."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 16 Fasting plasma glucose‐ total‐ attrition bias analysis. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">17 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ attrition bias analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>244</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.43 [‐1.09, 0.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00817"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-17.png?filename=nCD006297-CMP-008-17.ppt&amp;title=8.17&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%2017%20Mean%20daily%20self%20measured%20blood%20glucose%20%28SMBG%29%20average%20%287%E2%80%908%20points%29%E2%80%90%20attrition%20bias%20analysis.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 8.17</div> </div> <hr class="top"><img data-id="CD006297-fig-00817" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-17.png" alt="Comparison 8 Sensitivity analysis, Outcome 17 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ attrition bias analysis."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 17 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ attrition bias analysis. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17.1 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>244</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.43 [‐1.09, 0.24]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">18 Percent of participating experiencing hypoglycemia‐ attrition bias analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00818"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-18.png?filename=nCD006297-CMP-008-18.ppt&amp;title=8.18&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%2018%20Percent%20of%20participating%20experiencing%20hypoglycemia%E2%80%90%20attrition%20bias%20analysis.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 8.18</div> </div> <hr class="top"><img data-id="CD006297-fig-00818" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-18.png" alt="Comparison 8 Sensitivity analysis, Outcome 18 Percent of participating experiencing hypoglycemia‐ attrition bias analysis."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 18 Percent of participating experiencing hypoglycemia‐ attrition bias analysis. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>18.1 Total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3497</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.79 [0.65, 0.97]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>18.2 Severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3484</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.68 [0.54, 0.87]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>18.3 Nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3609</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.62 [0.53, 0.73]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">19 Hypoglycemic events per 100 patient's days‐ attrition bias analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"> <div class="figure" id="CD006297-fig-00819"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <li><a href="#0" class="open-in-figure-viewer">Open in figure viewer</a></li> <li><a class="btn btn-link" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-19.png?filename=nCD006297-CMP-008-19.ppt&amp;title=8.19&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%2019%20Hypoglycemic%20events%20per%20100%20patient%27s%20days%E2%80%90%20attrition%20bias%20analysis.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a></li> </nav> <div class="figure-label">Analysis 8.19</div> </div> <hr class="top"><img data-id="CD006297-fig-00819" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-19.png" alt="Comparison 8 Sensitivity analysis, Outcome 19 Hypoglycemic events per 100 patient's days‐ attrition bias analysis."><hr class="bottom"> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 19 Hypoglycemic events per 100 patient's days‐ attrition bias analysis. </p> </div> </div> </div> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19.1 Total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3425</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.70 [‐0.83, ‐0.58]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19.2 Severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3491</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.01 [‐0.03, 0.01]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19.3 Nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3609</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.38 [‐0.44, ‐0.32]</p> </td> </tr> </tbody> </table> </div> </section> </section> <div class="figures-list"> <div class="figure" id="CD006297-fig-0001"> <img data-id="CD006297-fig-0001" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-AFig-FIG01.png" alt="Figure 1: Trials identified"> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Figure 1: Trials identified</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/full#CD006297-fig-0001" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-AFig-FIG01.png?filename=nCD006297-AFig-FIG01.ppt&amp;title=1&amp;caption=Figure%201%3A%20Trials%20identified&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-AFig-FIG01.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-0002"><img data-id="CD006297-fig-0002" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-AFig-FIG02.png" alt="Intermediate acting versus long acting insulin"> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Intermediate acting versus long acting insulin</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/full#CD006297-fig-0002" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-AFig-FIG02.png?filename=nCD006297-AFig-FIG02.ppt&amp;title=2&amp;caption=Intermediate%20acting%20versus%20long%20acting%20insulin&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-AFig-FIG02.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00101"><img data-id="CD006297-fig-00101" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-001-01.png" alt="Comparison 1 Efficacy, Outcome 1 Glycated haemoglobin."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Efficacy, Outcome 1 Glycated haemoglobin.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00101" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-001-01.png?filename=nCD006297-CMP-001-01.ppt&amp;title=1.1&amp;caption=Comparison%201%20Efficacy%2C%20Outcome%201%20Glycated%20haemoglobin.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-001-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00102"><img data-id="CD006297-fig-00102" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-001-02.png" alt="Comparison 1 Efficacy, Outcome 2 Fasting blood glucose."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Efficacy, Outcome 2 Fasting blood glucose.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00102" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-001-02.png?filename=nCD006297-CMP-001-02.ppt&amp;title=1.2&amp;caption=Comparison%201%20Efficacy%2C%20Outcome%202%20Fasting%20blood%20glucose.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-001-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00103"><img data-id="CD006297-fig-00103" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-001-03.png" alt="Comparison 1 Efficacy, Outcome 3 Fasting plasma glucose."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Efficacy, Outcome 3 Fasting plasma glucose.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00103" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-001-03.png?filename=nCD006297-CMP-001-03.ppt&amp;title=1.3&amp;caption=Comparison%201%20Efficacy%2C%20Outcome%203%20Fasting%20plasma%20glucose.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-001-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00104"><img data-id="CD006297-fig-00104" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-001-04.png" alt="Comparison 1 Efficacy, Outcome 4 Mean daily self measured blood glucose (SMBG) average (7‐8 points)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Efficacy, Outcome 4 Mean daily self measured blood glucose (SMBG) average (7‐8 points). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00104" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-001-04.png?filename=nCD006297-CMP-001-04.ppt&amp;title=1.4&amp;caption=Comparison%201%20Efficacy%2C%20Outcome%204%20Mean%20daily%20self%20measured%20blood%20glucose%20%28SMBG%29%20average%20%287%E2%80%908%20points%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-001-04.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00105"><img data-id="CD006297-fig-00105" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-001-05.png" alt="Comparison 1 Efficacy, Outcome 5 Glycated haemoglobin‐ total."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Efficacy, Outcome 5 Glycated haemoglobin‐ total.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00105" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-001-05.png?filename=nCD006297-CMP-001-05.ppt&amp;title=1.5&amp;caption=Comparison%201%20Efficacy%2C%20Outcome%205%20Glycated%20haemoglobin%E2%80%90%20total.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-001-05.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00106"><img data-id="CD006297-fig-00106" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-001-06.png" alt="Comparison 1 Efficacy, Outcome 6 Fasting blood glucose‐total."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Efficacy, Outcome 6 Fasting blood glucose‐total.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00106" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-001-06.png?filename=nCD006297-CMP-001-06.ppt&amp;title=1.6&amp;caption=Comparison%201%20Efficacy%2C%20Outcome%206%20Fasting%20blood%20glucose%E2%80%90total.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-001-06.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00107"><img data-id="CD006297-fig-00107" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-001-07.png" alt="Comparison 1 Efficacy, Outcome 7 Fasting plasma glucose‐ total."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Efficacy, Outcome 7 Fasting plasma glucose‐ total.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00107" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-001-07.png?filename=nCD006297-CMP-001-07.ppt&amp;title=1.7&amp;caption=Comparison%201%20Efficacy%2C%20Outcome%207%20Fasting%20plasma%20glucose%E2%80%90%20total.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-001-07.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00201"><img data-id="CD006297-fig-00201" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-002-01.png" alt="Comparison 2 Hypoglycemia, Outcome 1 Percent of participating experiencing hypoglycemia."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Hypoglycemia, Outcome 1 Percent of participating experiencing hypoglycemia.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00201" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-002-01.png?filename=nCD006297-CMP-002-01.ppt&amp;title=2.1&amp;caption=Comparison%202%20Hypoglycemia%2C%20Outcome%201%20Percent%20of%20participating%20experiencing%20hypoglycemia.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-002-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00202"><img data-id="CD006297-fig-00202" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-002-02.png" alt="Comparison 2 Hypoglycemia, Outcome 2 Hypoglycemic events per 100 patient's days."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Hypoglycemia, Outcome 2 Hypoglycemic events per 100 patient's days.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00202" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-002-02.png?filename=nCD006297-CMP-002-02.ppt&amp;title=2.2&amp;caption=Comparison%202%20Hypoglycemia%2C%20Outcome%202%20Hypoglycemic%20events%20per%20100%20patient%27s%20days.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-002-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00301"><img data-id="CD006297-fig-00301" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-003-01.png" alt="Comparison 3 Adverse Events, Outcome 1 Number of serious adverse events."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Adverse Events, Outcome 1 Number of serious adverse events.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00301" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-003-01.png?filename=nCD006297-CMP-003-01.ppt&amp;title=3.1&amp;caption=Comparison%203%20Adverse%20Events%2C%20Outcome%201%20Number%20of%20serious%20adverse%20events.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-003-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00302"> <p> <div class="table" id=""> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" valign="" colspan="4" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Study</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Treatment</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Control</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Death</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ashwell 2006</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>insulin overdose</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>urinary tract infection</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Chatterjee 2007</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>not defined</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>not defined</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>N</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>De Leeuw 2005</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>retinal edema, macula lutea degeneration, hyperglycemia</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>hypoglycemia, retinal disorder</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Francis 1986</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>not defined</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>not defined</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Fulcher 2005</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>not defined</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>not defined</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Hermansen 2001</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>hypoglycemia</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Hermansen 2004</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>hyperglycemia, allergic reaction, inejction site reaction</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>not defined</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>lung tumor</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Home 2004</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>hypoglycemia</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>hypoglycemia</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Home 2005</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>not defined</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>not defined</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Kolendorf 2006</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>myocardial infarction</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Murphy 2003</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>gastroenteritis</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Pieber 2000</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Porcellati 2004</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Raskin 2000</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>hypoglycemia</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>hypoglycemia</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ratner 2000</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>hypoglycemia, fall</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>hypoglycemia, fall</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Robertson 2007</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ketoacidosis</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>ketoacidosis</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Rosenstock 2000</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Rossetti 2003</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>not defined</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>not definned</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Russell‐Jones 2004</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>hypoglycemia</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>hypoglycemia, hyperglycemia</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Schober 2001</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>not defined</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>not defined</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Tunbridge 1989</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Vague 2003</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>headache vomiting and malaise, uterine carcinoma, severe hypoglycaemia</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>severe hypoglycaemia</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Zinman 1999</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>NA</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Adverse Events, Outcome 2 Type of serious adverse events and reasons for death. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00302" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/?filename=&amp;title=3.2&amp;caption=Comparison%203%20Adverse%20Events%2C%20Outcome%202%20Type%20of%20serious%20adverse%20events%20and%20reasons%20for%20death.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00303"><img data-id="CD006297-fig-00303" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-003-03.png" alt="Comparison 3 Adverse Events, Outcome 3 Death."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Adverse Events, Outcome 3 Death.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00303" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-003-03.png?filename=nCD006297-CMP-003-03.ppt&amp;title=3.3&amp;caption=Comparison%203%20Adverse%20Events%2C%20Outcome%203%20Death.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-003-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00401"><img data-id="CD006297-fig-00401" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-004-01.png" alt="Comparison 4 Weight gain, Outcome 1 Weight gain."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Weight gain, Outcome 1 Weight gain.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00401" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-004-01.png?filename=nCD006297-CMP-004-01.ppt&amp;title=4.1&amp;caption=Comparison%204%20Weight%20gain%2C%20Outcome%201%20Weight%20gain.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-004-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00501"><img data-id="CD006297-fig-00501" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-005-01.png" alt="Comparison 5 Insulin dose, Outcome 1 Basal Insulin dose."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Insulin dose, Outcome 1 Basal Insulin dose.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00501" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-005-01.png?filename=nCD006297-CMP-005-01.ppt&amp;title=5.1&amp;caption=Comparison%205%20Insulin%20dose%2C%20Outcome%201%20Basal%20Insulin%20dose.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-005-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00502"><img data-id="CD006297-fig-00502" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-005-02.png" alt="Comparison 5 Insulin dose, Outcome 2 Bolus insulin dose."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Insulin dose, Outcome 2 Bolus insulin dose.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00502" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-005-02.png?filename=nCD006297-CMP-005-02.ppt&amp;title=5.2&amp;caption=Comparison%205%20Insulin%20dose%2C%20Outcome%202%20Bolus%20insulin%20dose.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-005-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00601"><img data-id="CD006297-fig-00601" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-006-01.png" alt="Comparison 6 Children‐ efficacy, Outcome 1 Glycated haemoglobin."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Children‐ efficacy, Outcome 1 Glycated haemoglobin.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00601" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-006-01.png?filename=nCD006297-CMP-006-01.ppt&amp;title=6.1&amp;caption=Comparison%206%20Children%E2%80%90%20efficacy%2C%20Outcome%201%20Glycated%20haemoglobin.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-006-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00602"><img data-id="CD006297-fig-00602" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-006-02.png" alt="Comparison 6 Children‐ efficacy, Outcome 2 Fasting blood glucose."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Children‐ efficacy, Outcome 2 Fasting blood glucose.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00602" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-006-02.png?filename=nCD006297-CMP-006-02.ppt&amp;title=6.2&amp;caption=Comparison%206%20Children%E2%80%90%20efficacy%2C%20Outcome%202%20Fasting%20blood%20glucose.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-006-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00603"><img data-id="CD006297-fig-00603" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-006-03.png" alt="Comparison 6 Children‐ efficacy, Outcome 3 Fasting plasma glucose."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Children‐ efficacy, Outcome 3 Fasting plasma glucose.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00603" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-006-03.png?filename=nCD006297-CMP-006-03.ppt&amp;title=6.3&amp;caption=Comparison%206%20Children%E2%80%90%20efficacy%2C%20Outcome%203%20Fasting%20plasma%20glucose.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-006-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00701"><img data-id="CD006297-fig-00701" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-01.png" alt="Comparison 7 Heterogeneity analyses, Outcome 1 Glycated haemoglobin‐ random effect model."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 1 Glycated haemoglobin‐ random effect model. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00701" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-01.png?filename=nCD006297-CMP-007-01.ppt&amp;title=7.1&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%201%20Glycated%20haemoglobin%E2%80%90%20random%20effect%20model.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00702"><img data-id="CD006297-fig-00702" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-02.png" alt="Comparison 7 Heterogeneity analyses, Outcome 2 Fasting blood glucose‐ random effect model."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 2 Fasting blood glucose‐ random effect model. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00702" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-02.png?filename=nCD006297-CMP-007-02.ppt&amp;title=7.2&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%202%20Fasting%20blood%20glucose%E2%80%90%20random%20effect%20model.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00703"><img data-id="CD006297-fig-00703" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-03.png" alt="Comparison 7 Heterogeneity analyses, Outcome 3 Fasting plasma glucose‐ random effect model."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 3 Fasting plasma glucose‐ random effect model. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00703" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-03.png?filename=nCD006297-CMP-007-03.ppt&amp;title=7.3&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%203%20Fasting%20plasma%20glucose%E2%80%90%20random%20effect%20model.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00704"><img data-id="CD006297-fig-00704" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-04.png" alt="Comparison 7 Heterogeneity analyses, Outcome 4 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ random effect model."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 4 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ random effect model. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00704" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-04.png?filename=nCD006297-CMP-007-04.ppt&amp;title=7.4&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%204%20Mean%20daily%20self%20measured%20blood%20glucose%20%28SMBG%29%20average%20%287%E2%80%908%20points%29%E2%80%90%20random%20effect%20model.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-04.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00705"><img data-id="CD006297-fig-00705" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-05.png" alt="Comparison 7 Heterogeneity analyses, Outcome 5 Fasting blood glucose‐total‐ random effect model."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.5</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 5 Fasting blood glucose‐total‐ random effect model. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00705" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-05.png?filename=nCD006297-CMP-007-05.ppt&amp;title=7.5&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%205%20Fasting%20blood%20glucose%E2%80%90total%E2%80%90%20random%20effect%20model.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-05.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00706"><img data-id="CD006297-fig-00706" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-06.png" alt="Comparison 7 Heterogeneity analyses, Outcome 6 Fasting plasma glucose‐ total‐ random effect model."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.6</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 6 Fasting plasma glucose‐ total‐ random effect model. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00706" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-06.png?filename=nCD006297-CMP-007-06.ppt&amp;title=7.6&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%206%20Fasting%20plasma%20glucose%E2%80%90%20total%E2%80%90%20random%20effect%20model.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-06.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00707"><img data-id="CD006297-fig-00707" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-07.png" alt="Comparison 7 Heterogeneity analyses, Outcome 7 Percent of participating experiencing hypoglycemia‐ random effect model."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.7</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 7 Percent of participating experiencing hypoglycemia‐ random effect model. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00707" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-07.png?filename=nCD006297-CMP-007-07.ppt&amp;title=7.7&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%207%20Percent%20of%20participating%20experiencing%20hypoglycemia%E2%80%90%20random%20effect%20model.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-07.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00708"><img data-id="CD006297-fig-00708" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-08.png" alt="Comparison 7 Heterogeneity analyses, Outcome 8 Hypoglycemic events per 100 patient's days‐ random effect model."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.8</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 8 Hypoglycemic events per 100 patient's days‐ random effect model. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00708" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-08.png?filename=nCD006297-CMP-007-08.ppt&amp;title=7.8&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%208%20Hypoglycemic%20events%20per%20100%20patient%27s%20days%E2%80%90%20random%20effect%20model.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-08.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00709"><img data-id="CD006297-fig-00709" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-09.png" alt="Comparison 7 Heterogeneity analyses, Outcome 9 Number of serious adverse events‐ random effect model."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.9</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 9 Number of serious adverse events‐ random effect model. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00709" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-09.png?filename=nCD006297-CMP-007-09.ppt&amp;title=7.9&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%209%20Number%20of%20serious%20adverse%20events%E2%80%90%20random%20effect%20model.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-09.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00710"><img data-id="CD006297-fig-00710" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-10.png" alt="Comparison 7 Heterogeneity analyses, Outcome 10 Glycated haemoglobin‐ final values versus change from baseline."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.10</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 10 Glycated haemoglobin‐ final values versus change from baseline. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00710" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-10.png?filename=nCD006297-CMP-007-10.ppt&amp;title=7.10&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2010%20Glycated%20haemoglobin%E2%80%90%20final%20values%20versus%20change%20from%20baseline.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-10.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00711"><img data-id="CD006297-fig-00711" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-11.png" alt="Comparison 7 Heterogeneity analyses, Outcome 11 Fasting blood glucose‐total‐ final values versus change from baseline."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.11</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 11 Fasting blood glucose‐total‐ final values versus change from baseline. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00711" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-11.png?filename=nCD006297-CMP-007-11.ppt&amp;title=7.11&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2011%20Fasting%20blood%20glucose%E2%80%90total%E2%80%90%20final%20values%20versus%20change%20from%20baseline.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-11.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00712"><img data-id="CD006297-fig-00712" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-12.png" alt="Comparison 7 Heterogeneity analyses, Outcome 12 Fasting plasma glucose‐ total‐ final values versus change from baseline."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.12</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 12 Fasting plasma glucose‐ total‐ final values versus change from baseline. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00712" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-12.png?filename=nCD006297-CMP-007-12.ppt&amp;title=7.12&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2012%20Fasting%20plasma%20glucose%E2%80%90%20total%E2%80%90%20final%20values%20versus%20change%20from%20baseline.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-12.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00713"><img data-id="CD006297-fig-00713" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-13.png" alt="Comparison 7 Heterogeneity analyses, Outcome 13 Glycated haemoglobin‐ long acting type."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.13</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 13 Glycated haemoglobin‐ long acting type. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00713" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-13.png?filename=nCD006297-CMP-007-13.ppt&amp;title=7.13&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2013%20Glycated%20haemoglobin%E2%80%90%20long%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-13.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00714"><img data-id="CD006297-fig-00714" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-14.png" alt="Comparison 7 Heterogeneity analyses, Outcome 14 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ long acting type."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.14</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 14 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ long acting type. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00714" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-14.png?filename=nCD006297-CMP-007-14.ppt&amp;title=7.14&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2014%20Mean%20daily%20self%20measured%20blood%20glucose%20%28SMBG%29%20average%20%287%E2%80%908%20points%29%E2%80%90%20long%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-14.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00715"><img data-id="CD006297-fig-00715" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-15.png" alt="Comparison 7 Heterogeneity analyses, Outcome 15 Fasting blood glucose‐total‐ long acting type."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.15</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 15 Fasting blood glucose‐total‐ long acting type. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00715" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-15.png?filename=nCD006297-CMP-007-15.ppt&amp;title=7.15&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2015%20Fasting%20blood%20glucose%E2%80%90total%E2%80%90%20long%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-15.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00716"><img data-id="CD006297-fig-00716" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-16.png" alt="Comparison 7 Heterogeneity analyses, Outcome 16 Fasting plasma glucose‐ total‐ long acting type."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.16</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 16 Fasting plasma glucose‐ total‐ long acting type. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00716" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-16.png?filename=nCD006297-CMP-007-16.ppt&amp;title=7.16&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2016%20Fasting%20plasma%20glucose%E2%80%90%20total%E2%80%90%20long%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-16.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00717"><img data-id="CD006297-fig-00717" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-17.png" alt="Comparison 7 Heterogeneity analyses, Outcome 17 Percent of participating experiencing hypoglycemia‐ long acting type."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.17</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 17 Percent of participating experiencing hypoglycemia‐ long acting type. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00717" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-17.png?filename=nCD006297-CMP-007-17.ppt&amp;title=7.17&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2017%20Percent%20of%20participating%20experiencing%20hypoglycemia%E2%80%90%20long%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-17.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00718"><img data-id="CD006297-fig-00718" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-18.png" alt="Comparison 7 Heterogeneity analyses, Outcome 18 Number of serious adverse events‐ long acting type."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.18</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 18 Number of serious adverse events‐ long acting type. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00718" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-18.png?filename=nCD006297-CMP-007-18.ppt&amp;title=7.18&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2018%20Number%20of%20serious%20adverse%20events%E2%80%90%20long%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-18.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00719"><img data-id="CD006297-fig-00719" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-19.png" alt="Comparison 7 Heterogeneity analyses, Outcome 19 Hypoglycemic events per 100 patient's days‐ long acting type."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.19</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 19 Hypoglycemic events per 100 patient's days‐ long acting type. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00719" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-19.png?filename=nCD006297-CMP-007-19.ppt&amp;title=7.19&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2019%20Hypoglycemic%20events%20per%20100%20patient%27s%20days%E2%80%90%20long%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-19.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00720"><img data-id="CD006297-fig-00720" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-20.png" alt="Comparison 7 Heterogeneity analyses, Outcome 20 Glycated haemoglobin‐ intermediate acting type."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.20</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 20 Glycated haemoglobin‐ intermediate acting type. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00720" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-20.png?filename=nCD006297-CMP-007-20.ppt&amp;title=7.20&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2020%20Glycated%20haemoglobin%E2%80%90%20intermediate%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-20.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00721"><img data-id="CD006297-fig-00721" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-21.png" alt="Comparison 7 Heterogeneity analyses, Outcome 21 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ intermediate acting type."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.21</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 21 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ intermediate acting type. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00721" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-21.png?filename=nCD006297-CMP-007-21.ppt&amp;title=7.21&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2021%20Mean%20daily%20self%20measured%20blood%20glucose%20%28SMBG%29%20average%20%287%E2%80%908%20points%29%E2%80%90%20intermediate%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-21.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00722"><img data-id="CD006297-fig-00722" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-22.png" alt="Comparison 7 Heterogeneity analyses, Outcome 22 Fasting blood glucose‐total‐ intermediate acting type."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.22</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 22 Fasting blood glucose‐total‐ intermediate acting type. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00722" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-22.png?filename=nCD006297-CMP-007-22.ppt&amp;title=7.22&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2022%20Fasting%20blood%20glucose%E2%80%90total%E2%80%90%20intermediate%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-22.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00723"><img data-id="CD006297-fig-00723" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-23.png" alt="Comparison 7 Heterogeneity analyses, Outcome 23 Hypoglycemic events per 100 patient's days‐ intermediate acting type."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.23</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 23 Hypoglycemic events per 100 patient's days‐ intermediate acting type. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00723" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-23.png?filename=nCD006297-CMP-007-23.ppt&amp;title=7.23&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2023%20Hypoglycemic%20events%20per%20100%20patient%27s%20days%E2%80%90%20intermediate%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-23.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00724"><img data-id="CD006297-fig-00724" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-24.png" alt="Comparison 7 Heterogeneity analyses, Outcome 24 Glycated haemoglobin‐ short acting type."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.24</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 24 Glycated haemoglobin‐ short acting type. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00724" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-24.png?filename=nCD006297-CMP-007-24.ppt&amp;title=7.24&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2024%20Glycated%20haemoglobin%E2%80%90%20short%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-24.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00725"><img data-id="CD006297-fig-00725" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-25.png" alt="Comparison 7 Heterogeneity analyses, Outcome 25 Fasting blood glucose‐total‐ short acting type."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.25</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 25 Fasting blood glucose‐total‐ short acting type. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00725" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-25.png?filename=nCD006297-CMP-007-25.ppt&amp;title=7.25&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2025%20Fasting%20blood%20glucose%E2%80%90total%E2%80%90%20short%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-25.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00726"><img data-id="CD006297-fig-00726" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-26.png" alt="Comparison 7 Heterogeneity analyses, Outcome 26 Fasting plasma glucose‐ total‐ short acting type."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.26</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 26 Fasting plasma glucose‐ total‐ short acting type. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00726" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-26.png?filename=nCD006297-CMP-007-26.ppt&amp;title=7.26&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2026%20Fasting%20plasma%20glucose%E2%80%90%20total%E2%80%90%20short%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-26.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00727"><img data-id="CD006297-fig-00727" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-27.png" alt="Comparison 7 Heterogeneity analyses, Outcome 27 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ short acting type."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.27</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 27 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ short acting type. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00727" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-27.png?filename=nCD006297-CMP-007-27.ppt&amp;title=7.27&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2027%20Mean%20daily%20self%20measured%20blood%20glucose%20%28SMBG%29%20average%20%287%E2%80%908%20points%29%E2%80%90%20short%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-27.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00728"><img data-id="CD006297-fig-00728" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-28.png" alt="Comparison 7 Heterogeneity analyses, Outcome 28 Percent of participating experiencing hypoglycemia‐ short acting type."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.28</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 28 Percent of participating experiencing hypoglycemia‐ short acting type. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00728" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-28.png?filename=nCD006297-CMP-007-28.ppt&amp;title=7.28&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2028%20Percent%20of%20participating%20experiencing%20hypoglycemia%E2%80%90%20short%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-28.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00729"><img data-id="CD006297-fig-00729" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-29.png" alt="Comparison 7 Heterogeneity analyses, Outcome 29 Number of serious adverse events‐ short acting type."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.29</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 29 Number of serious adverse events‐ short acting type. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00729" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-29.png?filename=nCD006297-CMP-007-29.ppt&amp;title=7.29&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2029%20Number%20of%20serious%20adverse%20events%E2%80%90%20short%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-29.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00730"><img data-id="CD006297-fig-00730" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-30.png" alt="Comparison 7 Heterogeneity analyses, Outcome 30 Hypoglycemic events per 100 patient's days‐ short acting type."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.30</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 30 Hypoglycemic events per 100 patient's days‐ short acting type. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00730" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-30.png?filename=nCD006297-CMP-007-30.ppt&amp;title=7.30&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2030%20Hypoglycemic%20events%20per%20100%20patient%27s%20days%E2%80%90%20short%20acting%20type.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-30.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00731"><img data-id="CD006297-fig-00731" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-31.png" alt="Comparison 7 Heterogeneity analyses, Outcome 31 Glycated haemoglobin‐ number of basal doses (long acting)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.31</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 31 Glycated haemoglobin‐ number of basal doses (long acting). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00731" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-31.png?filename=nCD006297-CMP-007-31.ppt&amp;title=7.31&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2031%20Glycated%20haemoglobin%E2%80%90%20number%20of%20basal%20doses%20%28long%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-31.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00732"><img data-id="CD006297-fig-00732" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-32.png" alt="Comparison 7 Heterogeneity analyses, Outcome 32 Fasting blood glucose‐total‐ number of basal doses (long acting)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.32</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 32 Fasting blood glucose‐total‐ number of basal doses (long acting). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00732" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-32.png?filename=nCD006297-CMP-007-32.ppt&amp;title=7.32&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2032%20Fasting%20blood%20glucose%E2%80%90total%E2%80%90%20number%20of%20basal%20doses%20%28long%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-32.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00733"><img data-id="CD006297-fig-00733" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-33.png" alt="Comparison 7 Heterogeneity analyses, Outcome 33 Fasting plasma glucose‐ total‐ number of basal doses (long acting)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.33</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 33 Fasting plasma glucose‐ total‐ number of basal doses (long acting). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00733" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-33.png?filename=nCD006297-CMP-007-33.ppt&amp;title=7.33&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2033%20Fasting%20plasma%20glucose%E2%80%90%20total%E2%80%90%20number%20of%20basal%20doses%20%28long%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-33.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00734"><img data-id="CD006297-fig-00734" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-34.png" alt="Comparison 7 Heterogeneity analyses, Outcome 34 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ number of basal doses (long acting)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.34</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 34 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ number of basal doses (long acting). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00734" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-34.png?filename=nCD006297-CMP-007-34.ppt&amp;title=7.34&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2034%20Mean%20daily%20self%20measured%20blood%20glucose%20%28SMBG%29%20average%20%287%E2%80%908%20points%29%E2%80%90%20number%20of%20basal%20doses%20%28long%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-34.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00735"><img data-id="CD006297-fig-00735" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-35.png" alt="Comparison 7 Heterogeneity analyses, Outcome 35 Percent of participating experiencing hypoglycemia‐ number of basal doses (long acting)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.35</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 35 Percent of participating experiencing hypoglycemia‐ number of basal doses (long acting). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00735" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-35.png?filename=nCD006297-CMP-007-35.ppt&amp;title=7.35&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2035%20Percent%20of%20participating%20experiencing%20hypoglycemia%E2%80%90%20number%20of%20basal%20doses%20%28long%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-35.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00736"><img data-id="CD006297-fig-00736" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-36.png" alt="Comparison 7 Heterogeneity analyses, Outcome 36 Number of serious adverse events‐ number of basal doses (long acting)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.36</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 36 Number of serious adverse events‐ number of basal doses (long acting). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00736" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-36.png?filename=nCD006297-CMP-007-36.ppt&amp;title=7.36&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2036%20Number%20of%20serious%20adverse%20events%E2%80%90%20number%20of%20basal%20doses%20%28long%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-36.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00737"><img data-id="CD006297-fig-00737" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-37.png" alt="Comparison 7 Heterogeneity analyses, Outcome 37 Hypoglycemic events per 100 patient's days‐ number of basal doses (long acting)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.37</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 37 Hypoglycemic events per 100 patient's days‐ number of basal doses (long acting). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00737" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-37.png?filename=nCD006297-CMP-007-37.ppt&amp;title=7.37&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2037%20Hypoglycemic%20events%20per%20100%20patient%27s%20days%E2%80%90%20number%20of%20basal%20doses%20%28long%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-37.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00738"><img data-id="CD006297-fig-00738" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-38.png" alt="Comparison 7 Heterogeneity analyses, Outcome 38 Glycated haemoglobin‐ number of basal doses (intermediate acting)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.38</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 38 Glycated haemoglobin‐ number of basal doses (intermediate acting). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00738" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-38.png?filename=nCD006297-CMP-007-38.ppt&amp;title=7.38&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2038%20Glycated%20haemoglobin%E2%80%90%20number%20of%20basal%20doses%20%28intermediate%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-38.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00739"><img data-id="CD006297-fig-00739" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-39.png" alt="Comparison 7 Heterogeneity analyses, Outcome 39 Fasting blood glucose‐total‐ number of basal doses (intermediate acting)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.39</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 39 Fasting blood glucose‐total‐ number of basal doses (intermediate acting). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00739" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-39.png?filename=nCD006297-CMP-007-39.ppt&amp;title=7.39&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2039%20Fasting%20blood%20glucose%E2%80%90total%E2%80%90%20number%20of%20basal%20doses%20%28intermediate%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-39.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00740"><img data-id="CD006297-fig-00740" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-40.png" alt="Comparison 7 Heterogeneity analyses, Outcome 40 Fasting plasma glucose‐ total‐ number of basal doses (intermediate acting)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.40</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 40 Fasting plasma glucose‐ total‐ number of basal doses (intermediate acting). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00740" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-40.png?filename=nCD006297-CMP-007-40.ppt&amp;title=7.40&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2040%20Fasting%20plasma%20glucose%E2%80%90%20total%E2%80%90%20number%20of%20basal%20doses%20%28intermediate%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-40.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00741"><img data-id="CD006297-fig-00741" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-41.png" alt="Comparison 7 Heterogeneity analyses, Outcome 41 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ number of basal doses (intermediate acting."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.41</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 41 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ number of basal doses (intermediate acting. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00741" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-41.png?filename=nCD006297-CMP-007-41.ppt&amp;title=7.41&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2041%20Mean%20daily%20self%20measured%20blood%20glucose%20%28SMBG%29%20average%20%287%E2%80%908%20points%29%E2%80%90%20number%20of%20basal%20doses%20%28intermediate%20acting.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-41.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00742"><img data-id="CD006297-fig-00742" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-42.png" alt="Comparison 7 Heterogeneity analyses, Outcome 42 Percent of participating experiencing hypoglycemia‐ number of basal doses (intermediate acting)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.42</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 42 Percent of participating experiencing hypoglycemia‐ number of basal doses (intermediate acting). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00742" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-42.png?filename=nCD006297-CMP-007-42.ppt&amp;title=7.42&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2042%20Percent%20of%20participating%20experiencing%20hypoglycemia%E2%80%90%20number%20of%20basal%20doses%20%28intermediate%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-42.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00743"><img data-id="CD006297-fig-00743" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-43.png" alt="Comparison 7 Heterogeneity analyses, Outcome 43 Number of serious adverse events‐ number of basal doses (intermediate acting)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.43</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 43 Number of serious adverse events‐ number of basal doses (intermediate acting). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00743" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-43.png?filename=nCD006297-CMP-007-43.ppt&amp;title=7.43&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2043%20Number%20of%20serious%20adverse%20events%E2%80%90%20number%20of%20basal%20doses%20%28intermediate%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-43.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00744"><img data-id="CD006297-fig-00744" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-44.png" alt="Comparison 7 Heterogeneity analyses, Outcome 44 Hypoglycemic events per 100 patient's days‐ number of basal doses (intermediate acting)."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.44</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 44 Hypoglycemic events per 100 patient's days‐ number of basal doses (intermediate acting). </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00744" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-44.png?filename=nCD006297-CMP-007-44.ppt&amp;title=7.44&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2044%20Hypoglycemic%20events%20per%20100%20patient%27s%20days%E2%80%90%20number%20of%20basal%20doses%20%28intermediate%20acting%29.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-44.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00745"><img data-id="CD006297-fig-00745" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-45.png" alt="Comparison 7 Heterogeneity analyses, Outcome 45 Glycated haemoglobin‐ diabetes status."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.45</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 45 Glycated haemoglobin‐ diabetes status.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00745" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-45.png?filename=nCD006297-CMP-007-45.ppt&amp;title=7.45&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2045%20Glycated%20haemoglobin%E2%80%90%20diabetes%20status.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-45.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00746"><img data-id="CD006297-fig-00746" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-46.png" alt="Comparison 7 Heterogeneity analyses, Outcome 46 Fasting blood glucose‐total‐ diabetes status."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.46</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 46 Fasting blood glucose‐total‐ diabetes status. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00746" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-46.png?filename=nCD006297-CMP-007-46.ppt&amp;title=7.46&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2046%20Fasting%20blood%20glucose%E2%80%90total%E2%80%90%20diabetes%20status.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-46.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00747"><img data-id="CD006297-fig-00747" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-47.png" alt="Comparison 7 Heterogeneity analyses, Outcome 47 Fasting plasma glucose‐ total‐ diabetes status."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.47</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 47 Fasting plasma glucose‐ total‐ diabetes status. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00747" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-47.png?filename=nCD006297-CMP-007-47.ppt&amp;title=7.47&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2047%20Fasting%20plasma%20glucose%E2%80%90%20total%E2%80%90%20diabetes%20status.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-47.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00748"><img data-id="CD006297-fig-00748" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-48.png" alt="Comparison 7 Heterogeneity analyses, Outcome 48 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ diabetes status."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.48</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 48 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ diabetes status. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00748" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-48.png?filename=nCD006297-CMP-007-48.ppt&amp;title=7.48&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2048%20Mean%20daily%20self%20measured%20blood%20glucose%20%28SMBG%29%20average%20%287%E2%80%908%20points%29%E2%80%90%20diabetes%20status.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-48.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00749"><img data-id="CD006297-fig-00749" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-49.png" alt="Comparison 7 Heterogeneity analyses, Outcome 49 Percent of participating experiencing hypoglycemia‐ diabetes status."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.49</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 49 Percent of participating experiencing hypoglycemia‐ diabetes status. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00749" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-49.png?filename=nCD006297-CMP-007-49.ppt&amp;title=7.49&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2049%20Percent%20of%20participating%20experiencing%20hypoglycemia%E2%80%90%20diabetes%20status.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-49.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00750"><img data-id="CD006297-fig-00750" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-50.png" alt="Comparison 7 Heterogeneity analyses, Outcome 50 Number of serious adverse events‐ diabetes status."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.50</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 50 Number of serious adverse events‐ diabetes status. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00750" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-50.png?filename=nCD006297-CMP-007-50.ppt&amp;title=7.50&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2050%20Number%20of%20serious%20adverse%20events%E2%80%90%20diabetes%20status.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-50.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00751"><img data-id="CD006297-fig-00751" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-51.png" alt="Comparison 7 Heterogeneity analyses, Outcome 51 Hypoglycemic events per 100 patient's days‐ diabetes status."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.51</div> <div class="figure-caption"> <p>Comparison 7 Heterogeneity analyses, Outcome 51 Hypoglycemic events per 100 patient's days‐ diabetes status. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00751" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-007-51.png?filename=nCD006297-CMP-007-51.ppt&amp;title=7.51&amp;caption=Comparison%207%20Heterogeneity%20analyses%2C%20Outcome%2051%20Hypoglycemic%20events%20per%20100%20patient%27s%20days%E2%80%90%20diabetes%20status.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-007-51.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00801"><img data-id="CD006297-fig-00801" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-01.png" alt="Comparison 8 Sensitivity analysis, Outcome 1 Glycated haemoglobin‐ large trials ommited."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 1 Glycated haemoglobin‐ large trials ommited.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00801" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-01.png?filename=nCD006297-CMP-008-01.ppt&amp;title=8.1&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%201%20Glycated%20haemoglobin%E2%80%90%20large%20trials%20ommited.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-01.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00802"><img data-id="CD006297-fig-00802" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-02.png" alt="Comparison 8 Sensitivity analysis, Outcome 2 Glycated haemoglobin‐ low quality ommited."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 2 Glycated haemoglobin‐ low quality ommited.</p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00802" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-02.png?filename=nCD006297-CMP-008-02.ppt&amp;title=8.2&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%202%20Glycated%20haemoglobin%E2%80%90%20low%20quality%20ommited.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-02.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00803"><img data-id="CD006297-fig-00803" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-03.png" alt="Comparison 8 Sensitivity analysis, Outcome 3 Fasting blood glucose‐total‐ low quality ommited."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 3 Fasting blood glucose‐total‐ low quality ommited. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00803" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-03.png?filename=nCD006297-CMP-008-03.ppt&amp;title=8.3&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%203%20Fasting%20blood%20glucose%E2%80%90total%E2%80%90%20low%20quality%20ommited.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-03.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00804"><img data-id="CD006297-fig-00804" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-04.png" alt="Comparison 8 Sensitivity analysis, Outcome 4 Fasting plasma glucose‐ total‐ low quality ommited."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.4</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 4 Fasting plasma glucose‐ total‐ low quality ommited. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00804" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-04.png?filename=nCD006297-CMP-008-04.ppt&amp;title=8.4&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%204%20Fasting%20plasma%20glucose%E2%80%90%20total%E2%80%90%20low%20quality%20ommited.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-04.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00805"><img data-id="CD006297-fig-00805" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-05.png" alt="Comparison 8 Sensitivity analysis, Outcome 5 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ low quality ommited."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.5</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 5 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ low quality ommited. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00805" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-05.png?filename=nCD006297-CMP-008-05.ppt&amp;title=8.5&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%205%20Mean%20daily%20self%20measured%20blood%20glucose%20%28SMBG%29%20average%20%287%E2%80%908%20points%29%E2%80%90%20low%20quality%20ommited.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-05.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00806"><img data-id="CD006297-fig-00806" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-06.png" alt="Comparison 8 Sensitivity analysis, Outcome 6 Percent of participating experiencing hypoglycemia‐ low quality ommited."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.6</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 6 Percent of participating experiencing hypoglycemia‐ low quality ommited. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00806" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-06.png?filename=nCD006297-CMP-008-06.ppt&amp;title=8.6&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%206%20Percent%20of%20participating%20experiencing%20hypoglycemia%E2%80%90%20low%20quality%20ommited.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-06.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00807"><img data-id="CD006297-fig-00807" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-07.png" alt="Comparison 8 Sensitivity analysis, Outcome 7 Hypoglycemic events per 100 patient's days‐ low quality ommited."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.7</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 7 Hypoglycemic events per 100 patient's days‐ low quality ommited. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00807" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-07.png?filename=nCD006297-CMP-008-07.ppt&amp;title=8.7&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%207%20Hypoglycemic%20events%20per%20100%20patient%27s%20days%E2%80%90%20low%20quality%20ommited.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-07.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00808"><img data-id="CD006297-fig-00808" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-08.png" alt="Comparison 8 Sensitivity analysis, Outcome 8 Glycated haemoglobin‐ selection bias analysis."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.8</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 8 Glycated haemoglobin‐ selection bias analysis. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00808" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-08.png?filename=nCD006297-CMP-008-08.ppt&amp;title=8.8&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%208%20Glycated%20haemoglobin%E2%80%90%20selection%20bias%20analysis.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-08.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00809"><img data-id="CD006297-fig-00809" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-09.png" alt="Comparison 8 Sensitivity analysis, Outcome 9 Fasting blood glucose‐total‐ selection bias analysis."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.9</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 9 Fasting blood glucose‐total‐ selection bias analysis. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00809" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-09.png?filename=nCD006297-CMP-008-09.ppt&amp;title=8.9&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%209%20Fasting%20blood%20glucose%E2%80%90total%E2%80%90%20selection%20bias%20analysis.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-09.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00810"><img data-id="CD006297-fig-00810" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-10.png" alt="Comparison 8 Sensitivity analysis, Outcome 10 Fasting plasma glucose‐ total‐ selection bias analysis."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.10</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 10 Fasting plasma glucose‐ total‐ selection bias analysis. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00810" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-10.png?filename=nCD006297-CMP-008-10.ppt&amp;title=8.10&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%2010%20Fasting%20plasma%20glucose%E2%80%90%20total%E2%80%90%20selection%20bias%20analysis.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-10.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00811"><img data-id="CD006297-fig-00811" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-11.png" alt="Comparison 8 Sensitivity analysis, Outcome 11 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ selection bias analysis."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.11</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 11 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ selection bias analysis. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00811" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-11.png?filename=nCD006297-CMP-008-11.ppt&amp;title=8.11&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%2011%20Mean%20daily%20self%20measured%20blood%20glucose%20%28SMBG%29%20average%20%287%E2%80%908%20points%29%E2%80%90%20selection%20bias%20analysis.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-11.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00812"><img data-id="CD006297-fig-00812" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-12.png" alt="Comparison 8 Sensitivity analysis, Outcome 12 Percent of participating experiencing hypoglycemia‐ selection bias analysis."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.12</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 12 Percent of participating experiencing hypoglycemia‐ selection bias analysis. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00812" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-12.png?filename=nCD006297-CMP-008-12.ppt&amp;title=8.12&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%2012%20Percent%20of%20participating%20experiencing%20hypoglycemia%E2%80%90%20selection%20bias%20analysis.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-12.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00813"><img data-id="CD006297-fig-00813" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-13.png" alt="Comparison 8 Sensitivity analysis, Outcome 13 Hypoglycemic events per 100 patient's days‐ selection bias analysis."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.13</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 13 Hypoglycemic events per 100 patient's days‐ selection bias analysis. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00813" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-13.png?filename=nCD006297-CMP-008-13.ppt&amp;title=8.13&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%2013%20Hypoglycemic%20events%20per%20100%20patient%27s%20days%E2%80%90%20selection%20bias%20analysis.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-13.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00814"><img data-id="CD006297-fig-00814" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-14.png" alt="Comparison 8 Sensitivity analysis, Outcome 14 Glycated haemoglobin‐ attrition bias analysis."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.14</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 14 Glycated haemoglobin‐ attrition bias analysis. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00814" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-14.png?filename=nCD006297-CMP-008-14.ppt&amp;title=8.14&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%2014%20Glycated%20haemoglobin%E2%80%90%20attrition%20bias%20analysis.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-14.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00815"><img data-id="CD006297-fig-00815" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-15.png" alt="Comparison 8 Sensitivity analysis, Outcome 15 Fasting blood glucose‐total‐ attrition bias analysis."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.15</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 15 Fasting blood glucose‐total‐ attrition bias analysis. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00815" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-15.png?filename=nCD006297-CMP-008-15.ppt&amp;title=8.15&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%2015%20Fasting%20blood%20glucose%E2%80%90total%E2%80%90%20attrition%20bias%20analysis.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-15.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00816"><img data-id="CD006297-fig-00816" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-16.png" alt="Comparison 8 Sensitivity analysis, Outcome 16 Fasting plasma glucose‐ total‐ attrition bias analysis."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.16</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 16 Fasting plasma glucose‐ total‐ attrition bias analysis. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00816" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-16.png?filename=nCD006297-CMP-008-16.ppt&amp;title=8.16&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%2016%20Fasting%20plasma%20glucose%E2%80%90%20total%E2%80%90%20attrition%20bias%20analysis.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-16.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00817"><img data-id="CD006297-fig-00817" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-17.png" alt="Comparison 8 Sensitivity analysis, Outcome 17 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ attrition bias analysis."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.17</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 17 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ attrition bias analysis. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00817" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-17.png?filename=nCD006297-CMP-008-17.ppt&amp;title=8.17&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%2017%20Mean%20daily%20self%20measured%20blood%20glucose%20%28SMBG%29%20average%20%287%E2%80%908%20points%29%E2%80%90%20attrition%20bias%20analysis.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-17.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00818"><img data-id="CD006297-fig-00818" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-18.png" alt="Comparison 8 Sensitivity analysis, Outcome 18 Percent of participating experiencing hypoglycemia‐ attrition bias analysis."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.18</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 18 Percent of participating experiencing hypoglycemia‐ attrition bias analysis. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00818" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-18.png?filename=nCD006297-CMP-008-18.ppt&amp;title=8.18&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%2018%20Percent%20of%20participating%20experiencing%20hypoglycemia%E2%80%90%20attrition%20bias%20analysis.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-18.png">Open in new tab</a></div> </div> <div class="figure" id="CD006297-fig-00819"><img data-id="CD006297-fig-00819" src="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-19.png" alt="Comparison 8 Sensitivity analysis, Outcome 19 Hypoglycemic events per 100 patient's days‐ attrition bias analysis."> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.19</div> <div class="figure-caption"> <p>Comparison 8 Sensitivity analysis, Outcome 19 Hypoglycemic events per 100 patient's days‐ attrition bias analysis. </p> </div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-fig-00819" class="figureList">Navigate to figure in Review</a><button href="#" class="print-figure">Print figure</button><a class="" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/ppt/CDSR/CD006297/image_n/nCD006297-CMP-008-19.png?filename=nCD006297-CMP-008-19.ppt&amp;title=8.19&amp;caption=Comparison%208%20Sensitivity%20analysis%2C%20Outcome%2019%20Hypoglycemic%20events%20per%20100%20patient%27s%20days%E2%80%90%20attrition%20bias%20analysis.&amp;citation=Vardi M, Jacobson E, Nini A, Bitterman H. Intermediate acting versus long acting insulin for type 1 diabetes mellitus. Cochrane Database of Systematic Reviews 2008, 3. Art. No.: CD006297. DOI: http://dx.doi.org/10.1002/14651858.CD006297.pub2"> Download as PowerPoint </a><a class="figure-viewer-isolate" target="_blank" href="/cdsr/doi/10.1002/14651858.CD006297.pub2/media/CDSR/CD006297/image_n/nCD006297-CMP-008-19.png">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD006297-tbl-0009"> <div class="table-heading"><span class="table-label">Table 1.</span>&nbsp;<span class="table-title">Diabetes mellitus status at entry</span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Study</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Diabetes status</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ashwell 2006</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intermediate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Chatterjee 2007</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intermediate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>De Leeuw 2005</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Poor</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Francis 1986</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Poor</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Fulcher 2005</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intermediate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Hermansen 2001</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Fare</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Hermansen 2004</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intermediate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Home 2004</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intermediate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Home 2005</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Fare</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Kolendorf 2006</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Fare</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Murphy 2003</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intermediate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Pieber 2000</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intermediate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Porcellati 2004</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Fare</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Raskin 2000</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Fare</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ratner 2000</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Fare</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Robertson 2007</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intermediate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Rosenstock 2000</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intermediate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Rossetti 2003</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Fare</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Russell‐Jones 2004</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intermediate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Schober 2001</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Unknown</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Tunbridge 1989</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intermediate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Vague 2003</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intermediate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Zinman 1999</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Intemediate</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Fare = glycosylated haemoglobin &lt; 8%; Intermediate= glycosylated haemoglobin 8% to 10%, Poor = glycosylated haemoglobin &gt; 10% </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Diabetes status was determined according to baseline glycosylated haemoglobin mean/median as reported. </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span>&nbsp;<span class="table-title">Diabetes mellitus status at entry</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/full#CD006297-tbl-0009" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD006297-tbl-0010"> <div class="table-heading"><span class="table-label">Table 2.</span>&nbsp;<span class="table-title">Study quality (summary)</span></div> <tbody> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Study</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Selection bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Patients blinding</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Caregiver blinding</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Attrition bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Detection bias</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Overall incl. perfor</b> </p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p><b>Overall excl. perfor</b> </p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Aswell 2006</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>De Leeuw 2005</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Francis 1986</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Fulcher 2005</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Hermansen 2001</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐ (blocks of 4)</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Hermansen 2004</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Home 2004</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Home 2005</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Kolendorf 2006</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Murphy 2003</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Pieber 2000</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Porcellati 2004</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Raskin 2000</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Ratner 2000</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Rosenstock 2000</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Russel‐Jones 2004</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Schober 2001</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Tunbridge 1989</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Zinman 1999</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Chatterjee 2007</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Robertson 2007</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Rossetti 2003</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> </tr> <tr> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Vague 2003</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>+</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>unknown</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>C</p> </td> <td align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>B</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span>&nbsp;<span class="table-title">Study quality (summary)</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/full#CD006297-tbl-0010" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD006297-tbl-0001" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">Efficacy</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Glycated haemoglobin <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Short term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1259</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.17, 0.00]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2724</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.17 [‐0.23, ‐0.10]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.3 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3302</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.01 [‐0.06, 0.08]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Fasting blood glucose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Short term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1326</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.94 [‐1.22, ‐0.66]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2015</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.06 [‐1.29, ‐0.82]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.3 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2687</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.70 [‐0.89, ‐0.52]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Fasting plasma glucose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.1 Short term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1208</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.42 [‐1.94, ‐0.91]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.2 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2211</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.06 [‐1.41, ‐0.70]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.3 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2182</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.81 [‐1.29, ‐0.32]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 Mean daily self measured blood glucose (SMBG) average (7‐8 points) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>790</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.47 [‐0.58, ‐0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.1 Short term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>425</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.47 [‐0.58, ‐0.35]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.2 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>244</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.43 [‐1.09, 0.24]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.3 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>121</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.5 [‐0.98, ‐0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Glycated haemoglobin‐ total <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6666</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.12, ‐0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Fasting blood glucose‐total <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5409</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.86 [1.00, ‐0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">7 Fasting plasma glucose‐ total <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4868</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.63 [‐0.86, ‐0.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span>&nbsp;<span class="table-title">Efficacy</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-tbl-0001" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD006297-tbl-0002" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">Hypoglycemia</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Percent of participating experiencing hypoglycemia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6131</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.93 [0.80, 1.08]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5827</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.73 [0.61, 0.87]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.3 Nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5406</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.70 [0.63, 0.79]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Hypoglycemic events per 100 patient's days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4704</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.77 [‐0.89, ‐0.65]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4564</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.00 [‐0.02, 0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.3 Nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4971</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.40 [‐0.45, ‐0.34]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span>&nbsp;<span class="table-title">Hypoglycemia</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-tbl-0002" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD006297-tbl-0003" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 3.</span>&nbsp;<span class="table-title">Adverse Events</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Number of serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4878</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.89 [0.66, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Type of serious adverse events and reasons for death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Other data</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>23</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6787</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.33 [0.03, 3.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span>&nbsp;<span class="table-title">Adverse Events</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-tbl-0003" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD006297-tbl-0004" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 4.</span>&nbsp;<span class="table-title">Weight gain</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Weight gain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2862</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.67 [‐0.88, ‐0.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1674</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.83 [‐1.10, ‐0.56]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1188</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.38 [‐0.74, ‐0.02]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span>&nbsp;<span class="table-title">Weight gain</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-tbl-0004" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD006297-tbl-0005" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 5.</span>&nbsp;<span class="table-title">Insulin dose</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Basal Insulin dose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>18</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5713</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.02 [‐0.03, ‐0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Bolus insulin dose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4509</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.00 [‐0.01, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span>&nbsp;<span class="table-title">Insulin dose</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-tbl-0005" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD006297-tbl-0006" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 6.</span>&nbsp;<span class="table-title">Children‐ efficacy</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Glycated haemoglobin <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Children</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>399</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.07 [‐0.29, 0.15]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Fasting blood glucose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Children</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>399</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.88 [‐1.26, ‐0.51]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Fasting plasma glucose <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.1 Children</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>50</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.40 [‐0.00, 0.80]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span>&nbsp;<span class="table-title">Children‐ efficacy</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-tbl-0006" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD006297-tbl-0007" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 7.</span>&nbsp;<span class="table-title">Heterogeneity analyses</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Glycated haemoglobin‐ random effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Short term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1259</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.13 [‐0.33, 0.07]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2724</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.17 [‐0.26, ‐0.08]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.3 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3302</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.01 [‐0.11, 0.10]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Fasting blood glucose‐ random effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Short term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1326</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.94 [‐1.32, ‐0.55]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2015</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.10 [‐1.42, ‐0.78]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.3 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2687</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.88 [‐1.47, ‐0.30]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Fasting plasma glucose‐ random effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.1 Short term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1208</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.51 [‐2.20, ‐0.81]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.2 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2211</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.06 [‐1.99, ‐0.13]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3.3 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2182</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.81 [‐1.60, ‐0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ random effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>790</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.33 [‐0.73, 0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.1 Short term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>425</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.20 [‐0.68, 0.28]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.2 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>244</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.72 [‐2.97, 1.53]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4.3 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>121</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.5 [‐0.98, ‐0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Fasting blood glucose‐total‐ random effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5409</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.01 [‐1.31, ‐0.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Fasting plasma glucose‐ total‐ random effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4868</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.03 [‐1.66, ‐0.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">7 Percent of participating experiencing hypoglycemia‐ random effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7.1 Total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6131</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.97 [0.79, 1.19]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7.2 Severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5827</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.73 [0.61, 0.87]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7.3 Nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5406</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.67 [0.53, 0.84]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">8 Hypoglycemic events per 100 patient's days‐ random effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.1 Total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4704</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.42 [‐3.53, ‐1.30]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.2 Severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4564</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.01 [‐0.04, 0.05]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.3 Nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4971</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.25 [‐1.63, ‐0.87]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">9 Number of serious adverse events‐ random effect model <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4878</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.89 [0.65, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">10 Glycated haemoglobin‐ final values versus change from baseline <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10.1 Short term‐ final value</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1003</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.16 [‐0.28, ‐0.04]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10.2 Short term‐ change from baseline</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>256</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [‐0.12, 0.12]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10.3 Intermediate term‐ final value</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2724</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.17 [‐0.23, ‐0.10]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10.4 Long term‐ final value</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1834</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.20, 0.03]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10.5 Long term‐ change from baseline</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1468</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.07 [‐0.02, 0.16]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">11 Fasting blood glucose‐total‐ final values versus change from baseline <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5409</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.86 [1.00, ‐0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11.1 Fasting blood glucose‐total‐ final values</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3816</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.01 [‐1.19, ‐0.84]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11.2 Fasting blood glucose‐total‐ change from baseline</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1593</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.60 [‐0.82, ‐0.37]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">12 Fasting plasma glucose‐ total‐ final values versus change from baseline <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4868</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.63 [‐0.86, ‐0.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12.1 Fasting plasma glucose‐ total‐ final values</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3749</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.64 [‐0.89, ‐0.40]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12.2 Fasting plasma glucose‐ total‐ change from baseline</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1119</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.53 [‐1.20, 0.13]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">13 Glycated haemoglobin‐ long acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6666</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.12, ‐0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13.1 Glargine</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3249</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.07 [‐0.13, ‐0.01]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13.2 Detemir</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3095</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.11 [‐0.19, ‐0.04]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13.3 Ultralente</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>322</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.08 [‐0.17, 0.32]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">14 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ long acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>790</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.47 [‐0.58, ‐0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14.1 Glargine</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>540</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.49 [‐0.61, ‐0.38]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14.2 Detemir</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>118</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.10 [‐0.73, 0.53]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14.3 Ultralente</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>132</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.40 [‐0.43, 1.23]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">15 Fasting blood glucose‐total‐ long acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5409</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.86 [1.00, ‐0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15.1 Glargine</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2963</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.82 [‐0.99, ‐0.65]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15.2 Detemir</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2302</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.90 [‐1.15, ‐0.64]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15.3 Ultralente</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>144</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.17 [‐3.42, ‐0.91]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">16 Fasting plasma glucose‐ total‐ long acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4868</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.63 [‐0.86, ‐0.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16.1 Glargine</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2377</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.45 [‐0.73, ‐0.16]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16.2 Detemir</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2491</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.94 [‐1.31, ‐0.57]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">17 Percent of participating experiencing hypoglycemia‐ long acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17.1 Glargine‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2918</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.96 [0.79, 1.17]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17.2 Glargine‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2871</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.76 [0.58, 0.98]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17.3 Glargine‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2311</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.84 [0.70, 1.00]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17.4 Detemir‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3213</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.87 [0.69, 1.11]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17.5 Detemir‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2956</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.70 [0.54, 0.90]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17.6 Detemir‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3095</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.61 [0.52, 0.72]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">18 Number of serious adverse events‐ long acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4878</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.89 [0.66, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>18.1 Glargine</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2347</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.69 [0.46, 1.04]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>18.2 Detemir</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2531</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.27 [0.78, 2.05]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">19 Hypoglycemic events per 100 patient's days‐ long acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19.1 Glargine‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1675</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.41 [‐0.54, ‐0.27]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19.2 Glargine‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1614</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.00 [‐0.02, 0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19.3 Glargine‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1746</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.14 [‐0.21, ‐0.07]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19.4 Detemir‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2897</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.24 [‐2.51, ‐1.97]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19.5 Detemir‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2640</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.01 [‐0.04, 0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19.6 Detemir‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3213</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.89 [‐0.99, ‐0.79]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19.7 Ultralente‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>132</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.49 [‐0.36, 1.34]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19.8 Ultralente‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>310</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.20 [0.08, 0.32]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19.9 Ultralente‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.97 [‐4.49, ‐1.45]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">20 Glycated haemoglobin‐ intermediate acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6666</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.12, ‐0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20.1 NPH</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6522</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.13, ‐0.04]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20.2 Lente</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>144</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.01 [‐0.53, 0.51]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">21 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ intermediate acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>790</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.47 [‐0.58, ‐0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>21.1 NPH</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>658</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.48 [‐0.59, ‐0.37]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>21.2 Lente</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>132</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.40 [‐0.43, 1.23]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">22 Fasting blood glucose‐total‐ intermediate acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5409</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.86 [1.00, ‐0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22.1 NPH</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5265</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.84 [‐0.98, ‐0.70]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22.2 Lente</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>144</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.17 [‐3.42, ‐0.91]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">23 Hypoglycemic events per 100 patient's days‐ intermediate acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>23.1 NPH‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4572</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.80 [‐0.92, ‐0.68]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>23.2 NPH‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4432</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.00 [‐0.02, 0.01]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>23.3 NPH‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4959</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.39 [‐0.45, ‐0.33]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>23.4 Lente‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>132</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.49 [‐0.36, 1.34]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>23.5 Lente‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>132</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.98 [0.66, 1.30]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>23.6 Lente‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.97 [‐4.49, ‐1.45]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">24 Glycated haemoglobin‐ short acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6666</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.12, ‐0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>24.1 Porcine insulin</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.10 [‐1.75, 1.55]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>24.2 Human insulin versus insulin analogues</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>757</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.29 [‐0.41, ‐0.17]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>24.3 Human insulin</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2936</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.03 [‐0.04, 0.09]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>24.4 Insulin analogues</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2961</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.13 [‐0.20, ‐0.06]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">25 Fasting blood glucose‐total‐ short acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5409</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.86 [1.00, ‐0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>25.1 Human insulin</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3054</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.75 [‐0.92, ‐0.58]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>25.2 Insulin analogues</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2181</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.96 [‐1.22, ‐0.70]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>25.3 Porcine insulin</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐4.8 [‐7.78, ‐1.82]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>25.4 Human insulin versus insulin analogues</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>162</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.26 [‐1.75, ‐0.77]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">26 Fasting plasma glucose‐ total‐ short acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4868</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.63 [‐0.86, ‐0.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>26.1 Human insulin</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2455</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.13 [‐1.54, ‐0.72]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>26.2 Insulin analogues</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1768</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.62 [‐2.14, ‐1.11]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>26.3 Human insulin versus insulin analogues</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>645</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.07 [‐0.26, 0.39]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">27 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ short acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>790</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.47 [‐0.58, ‐0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>27.1 Human insulin</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>506</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.15 [‐0.26, 0.56]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>27.2 Insulin analogues</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>172</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.5 [‐0.61, ‐0.39]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>27.3 Human insulin versus insulin analogues</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>112</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.90 [‐3.01, ‐0.79]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">28 Percent of participating experiencing hypoglycemia‐ short acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>28.1 Human insulin versus insulin analogues‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>757</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.96 [0.57, 1.62]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>28.2 Human insulin versus insulin analogues‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>707</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.46 [0.34, 0.63]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>28.3 Human insulin‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2925</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.98 [0.80, 1.19]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>28.4 Human insulin‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2669</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.68 [0.52, 0.89]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>28.5 Human insulin‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2821</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.87 [0.74, 1.03]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>28.6 Insulin analogues‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3953</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.91 [0.74, 1.14]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>28.7 Insulin analogues‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2401</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.72 [0.54, 0.96]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>28.8 Insulin analogues‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2497</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.75 [0.63, 0.90]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">29 Number of serious adverse events‐ short acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4878</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.89 [0.66, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>29.1 Human insulin</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2925</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.73 [0.49, 1.09]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>29.2 Insulin analogues</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1196</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.18 [0.64, 2.17]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>29.3 Human insulin versus insulin analogues</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>757</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.16 [0.54, 2.51]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">30 Hypoglycemic events per 100 patient's days‐ short acting type <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>18</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30.1 Human insulin‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1531</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.42 [‐0.56, ‐0.28]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30.2 Human insulin‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1531</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.01 [‐0.03, 0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30.3 Human insulin‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1399</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.17 [‐0.25, ‐0.10]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30.4 Insulin analogues‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2416</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.07 [‐2.38, ‐1.75]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30.5 Insulin analogues‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2388</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.01 [‐0.01, 0.04]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30.6 Insulin analogues‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2803</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.63 [‐0.74, ‐0.52]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30.7 Human insulin versus insulin analogues‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>757</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.61 [‐2.02, ‐1.19]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30.8 Human insulin versus insulin analogues‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>645</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.02 [‐0.07, 0.03]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>30.9 Human insulin versus insulin analogues‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>757</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.94 [‐1.10, ‐0.77]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">31 Glycated haemoglobin‐ number of basal doses (long acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6666</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.12, ‐0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>31.1 Once daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3996</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.07 [‐0.13, ‐0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>31.2 Twice or more daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2145</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.13 [‐0.21, ‐0.05]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>31.3 According to glucose control</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>525</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.10 [‐0.10, 0.30]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">32 Fasting blood glucose‐total‐ number of basal doses (long acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5409</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.86 [1.00, ‐0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>32.1 Once daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3828</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.83 [‐0.98, ‐0.68]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>32.2 Twice or more daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1234</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.99 [‐1.38, ‐0.60]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>32.3 According to glucose control</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>347</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.20 [‐2.18, ‐0.22]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">33 Fasting plasma glucose‐ total‐ number of basal doses (long acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4868</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.63 [‐0.86, ‐0.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>33.1 Once daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3124</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.54 [‐0.81, ‐0.27]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>33.2 Twice or more daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1744</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.87 [‐1.31, ‐0.43]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">34 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ number of basal doses (long acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>790</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.47 [‐0.58, ‐0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>34.1 Once daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>607</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.35 [‐0.67, ‐0.03]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>34.2 Twice or more daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>183</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.48 [‐0.60, ‐0.37]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">35 Percent of participating experiencing hypoglycemia‐ number of basal doses (long acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>35.1 Once daily‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3783</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.01 [0.84, 1.21]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>35.2 Once daily‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3736</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.74 [0.59, 0.94]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>35.3 Once daily‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3058</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.86 [0.73, 1.00]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>35.4 Twice or more daily‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2001</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.78 [0.58, 1.04]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>35.5 Twice or more daily‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2491</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.69 [0.52, 0.93]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>35.6 Twice or more daily‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1576</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.53 [0.42, 0.65]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>35.7 According to glucose control‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>347</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.44 [0.09, 2.06]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>35.8 According to glucose control‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>347</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.76 [0.43, 1.35]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>35.9 According to glucose control‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>347</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.42 [0.22, 0.78]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">36 Number of serious adverse events‐ number of basal doses (long acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>15</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5303</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.81 [0.63, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>36.1 Once daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3212</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.75 [0.52, 1.09]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>36.2 Twice or more daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1744</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.86 [0.60, 1.23]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>36.3 ACcording to glucose control</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>347</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.99 [0.18, 5.49]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">37 Hypoglycemic events per 100 patient's days‐ number of basal doses (long acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>37.1 Once daily‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2540</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.45 [‐0.58, ‐0.31]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>37.2 Once daily‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2479</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.00 [‐0.02, 0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>37.3 Once daily‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2611</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.20 [‐0.26, ‐0.13]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>37.4 Twice or more daily‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1817</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.22 [‐2.51, ‐1.92]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>37.5 Twice or more daily‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1560</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.00 [‐0.04, 0.04]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>37.6 Twice or more daily‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2013</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.97 [‐1.09, ‐0.85]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>37.7 According to glucose control‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>347</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐3.30 [‐4.53, ‐2.07]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>37.8 According to glucose control‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>525</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.02 [‐0.07, 0.12]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>37.9 According to glucose control‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>347</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.11 [‐1.58, ‐0.64]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">38 Glycated haemoglobin‐ number of basal doses (intermediate acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>22</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6666</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.12, ‐0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>38.1 Once daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>922</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.15 [‐0.32, 0.03]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>38.2 Twice or more daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2431</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.19 [‐0.25, ‐0.12]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>38.3 According to glucose control</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3313</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.01 [‐0.05, 0.07]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">39 Fasting blood glucose‐total‐ number of basal doses (intermediate acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5409</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.86 [1.00, ‐0.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>39.1 Once daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1040</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.97 [‐1.26, ‐0.68]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>39.2 Twice or more daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1234</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.99 [‐1.38, ‐0.60]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>39.3 According to glucose control</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3135</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.79 [‐0.96, ‐0.62]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">40 Fasting plasma glucose‐ total‐ number of basal doses (intermediate acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4868</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.63 [‐0.86, ‐0.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>40.1 Once daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>797</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.03 [‐0.32, 0.38]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>40.2 Twice or more daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1744</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.87 [‐1.31, ‐0.43]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>40.3 According to glucose control</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2327</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.32 [‐1.73, ‐0.91]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">41 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ number of basal doses (intermediate acting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>790</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.47 [‐0.58, ‐0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>41.1 Once daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>118</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.10 [‐0.73, 0.53]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>41.2 Twice or more daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>304</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.48 [‐0.60, ‐0.37]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>41.3 According to blood glucose</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>368</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.35 [‐0.95, 0.25]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">42 Percent of participating experiencing hypoglycemia‐ number of basal doses (intermediate acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>42.1 Once daily‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>990</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.42 [0.90, 2.22]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>42.2 Once daily‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>915</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.68 [0.41, 1.15]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>42.3 Once daily‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>872</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.91 [0.67, 1.24]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>42.4 Twice or more daily‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2115</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.81 [0.61, 1.07]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>42.5 Twice or more daily‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2030</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.69 [0.50, 0.96]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>42.6 Twice or more daily‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1744</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.55 [0.45, 0.69]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>42.7 According to blood glucose‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3026</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.92 [0.75, 1.12]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>42.8 According to blood glucose‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2882</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.76 [0.59, 0.96]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>42.9 According to blood glucose‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2790</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.76 [0.64, 0.89]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">43 Number of serious adverse events‐ number of basal doses (intermediate acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4878</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.89 [0.66, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>43.1 Once daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1040</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.24 [0.56, 2.74]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>43.2 Twice or more daily</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1319</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.31 [0.74, 2.33]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>43.3 According to glucose control</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2519</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.67 [0.44, 1.00]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">44 Hypoglycemic events per 100 patient's days‐ number of basal doses (intermediate acting) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>44.1 Once daily‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1040</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.49 [‐0.97, ‐0.01]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>44.2 Once daily‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1040</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.00 [‐0.05, 0.04]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>44.3 Once daily‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1040</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.60 [‐0.79, ‐0.41]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>44.4 Twice or more daily‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2052</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐2.30 [‐2.58, ‐2.03]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>44.5 Twice or more daily‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1846</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.00 [‐0.03, 0.03]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>44.6 Twice or more daily‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2319</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.86 [‐0.97, ‐0.76]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>44.7 According to glucose control‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1612</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.40 [‐0.54, ‐0.26]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>44.8 According to glucose control‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1678</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.00 [‐0.02, 0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>44.9 According to glucose control‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1612</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.12 [‐0.19, ‐0.04]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">45 Glycated haemoglobin‐ diabetes status <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>21</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6633</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.13, ‐0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>45.1 Fare</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2167</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.04 [‐0.11, 0.03]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>45.2 Intermediate</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4138</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.11 [‐0.17, ‐0.05]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>45.3 Poor</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>328</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.06 [‐0.38, 0.25]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">46 Fasting blood glucose‐total‐ diabetes status <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5060</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.77 [‐0.91, ‐0.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>46.1 Fare</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1856</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.48 [‐0.69, ‐0.28]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>46.2 Intermediate</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3192</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.01 [‐1.21, ‐0.81]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>46.3 Poor</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐4.8 [‐7.78, ‐1.82]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">47 Fasting plasma glucose‐ total‐ diabetes status <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4868</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.63 [‐0.86, ‐0.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>47.1 Fare</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1738</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.07 [‐1.56, ‐0.58]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>47.2 Intermediate</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2814</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.51 [‐0.76, ‐0.25]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>47.3 Poor</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>316</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">48 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ diabetes status <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>790</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.47 [‐0.58, ‐0.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>48.1 Fare</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>290</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.49 [‐0.60, ‐0.38]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>48.2 Intermediate</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>500</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.09 [‐0.58, 0.40]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">49 Percent of participating experiencing hypoglycemia‐ diabetes status <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>49.1 Fare‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2113</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.94 [0.75, 1.19]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>49.2 Fare‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2028</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.69 [0.49, 0.98]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>49.3 Fare‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1995</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.88 [0.73, 1.07]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>49.4 Intermediate‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3353</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.90 [0.72, 1.13]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>49.5 Intermediate‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3134</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.77 [0.59, 0.99]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>49.6 Intermediate‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3095</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.60 [0.51, 0.70]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>49.7 Poor‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>316</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.97 [0.29, 3.24]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>49.8 Poor‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>316</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.60 [0.32, 1.10]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>49.9 Poor‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>316</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.67 [0.33, 1.35]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">50 Number of serious adverse events‐ diabetes status <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4529</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.06 [0.76, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>50.1 Fare</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1237</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.97 [0.57, 1.64]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>50.2 Intermediate</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2976</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.25 [0.76, 2.04]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>50.3 Poor</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>316</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.77 [0.29, 2.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">51 Hypoglycemic events per 100 patient's days‐ diabetes status <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>51.1 Fare‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1649</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.55 [‐0.69, ‐0.41]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>51.2 Fare‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1443</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.01 [‐0.03, 0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>51.3 Fare‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1720</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.19 [‐0.26, ‐0.12]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>51.4 Intermediate‐ total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3055</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.46 [‐1.71, ‐1.22]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>51.5 Intermediate‐ severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3121</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.00 [‐0.02, 0.03]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>51.6 Intermediate‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2923</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.69 [‐0.78, ‐0.59]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>51.7 Poor‐ nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>328</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.80 [‐2.29, ‐1.32]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span>&nbsp;<span class="table-title">Heterogeneity analyses</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-tbl-0007" class="tableList">Navigate to table in Review</a></div> </div> <div class="table"> <table data-id="CD006297-tbl-0008" class="comparison"> <div class="table-heading"><span class="table-label">Comparison 8.</span>&nbsp;<span class="table-title">Sensitivity analysis</span></div> <thead> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Outcome or subgroup title</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of studies</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>No. of participants</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Statistical method</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">1 Glycated haemoglobin‐ large trials ommited <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>20</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5300</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.12, ‐0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.1 Short term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>640</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.08 [‐0.18, 0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.2 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2105</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.18 [‐0.25, ‐0.10]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1.3 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2555</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.03 [‐0.05, 0.11]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">2 Glycated haemoglobin‐ low quality ommited <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>16</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6267</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.05 [‐0.10, ‐0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.1 Short term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>875</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.04 [‐0.13, 0.06]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.2 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2560</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.16 [‐0.23, ‐0.08]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2.3 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2832</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.04 [‐0.03, 0.12]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">3 Fasting blood glucose‐total‐ low quality ommited <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4559</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.75 [‐0.91, ‐0.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">4 Fasting plasma glucose‐ total‐ low quality ommited <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4485</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.07 [‐1.36, ‐0.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">5 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ low quality ommited <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>500</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.09 [‐0.58, 0.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.1 Short term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>256</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.30 [‐0.42, 1.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.2 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>244</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.43 [‐1.09, 0.24]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5.3 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">6 Percent of participating experiencing hypoglycemia‐ low quality ommited <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6.1 Total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5214</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.92 [0.77, 1.09]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6.2 Severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4688</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.71 [0.58, 0.88]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6.3 Nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5070</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.73 [0.64, 0.82]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">7 Hypoglycemic events per 100 patient's days‐ low quality ommited <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7.1 Total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4301</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.70 [‐0.82, ‐0.58]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7.2 Severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4110</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.00 [‐0.02, 0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7.3 Nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4497</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.38 [‐0.44, ‐0.32]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">8 Glycated haemoglobin‐ selection bias analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>4077</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.12 [‐0.18, ‐0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.1 Short term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>619</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.10 [‐0.27, 0.07]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.2 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2405</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.19 [‐0.27, ‐0.12]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8.3 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1053</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.02 [‐0.09, 0.14]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">9 Fasting blood glucose‐total‐ selection bias analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2628</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.72 [‐0.93, ‐0.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">10 Fasting plasma glucose‐ total‐ selection bias analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2632</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.92 [‐1.26, ‐0.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">11 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ selection bias analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>365</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.47 [‐0.86, ‐0.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11.1 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>244</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.43 [‐1.09, 0.24]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11.2 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>121</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.5 [‐0.98, ‐0.02]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">12 Percent of participating experiencing hypoglycemia‐ selection bias analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12.1 Total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3093</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.92 [0.73, 1.15]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12.2 Severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3326</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.77 [0.61, 0.98]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>12.3 Nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>7</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3091</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.74 [0.63, 0.86]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">13 Hypoglycemic events per 100 patient's days‐ selection bias analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>10</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13.1 Total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2873</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐1.82 [‐2.07, ‐1.56]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13.2 Severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2811</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.01 [‐0.01, 0.03]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>13.3 Nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2741</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.64 [‐0.74, ‐0.54]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">14 Glycated haemoglobin‐ attrition bias analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3919</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.10 [‐0.17, ‐0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14.1 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>5</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>1672</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.22 [‐0.31, ‐0.13]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>14.2 Long term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2247</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.01 [‐0.08, 0.11]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">15 Fasting blood glucose‐total‐ attrition bias analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2830</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.73 [‐0.94, ‐0.51]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">16 Fasting plasma glucose‐ total‐ attrition bias analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>6</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3025</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.98 [‐1.34, ‐0.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">17 Mean daily self measured blood glucose (SMBG) average (7‐8 points)‐ attrition bias analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>244</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.43 [‐1.09, 0.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>17.1 Intermediate term</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>2</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>244</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.43 [‐1.09, 0.24]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">18 Percent of participating experiencing hypoglycemia‐ attrition bias analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>18.1 Total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3497</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.79 [0.65, 0.97]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>18.2 Severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>8</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3484</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.68 [0.54, 0.87]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>18.3 Nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3609</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>0.62 [0.53, 0.73]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p class="subgroupTitle">19 Hypoglycemic events per 100 patient's days‐ attrition bias analysis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i class="fa fa-caret-down" aria-hidden="true"></i></span></p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>11</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"></td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19.1 Total episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3425</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.70 [‐0.83, ‐0.58]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19.2 Severe episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3491</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.01 [‐0.03, 0.01]</p> </td> </tr> <tr> <td data-title="Outcome or subgroup title" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>19.3 Nocturnal episodes</p> </td> <td data-title="No. of studies" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>9</p> </td> <td data-title="No. of participants" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>3609</p> </td> <td data-title="Statistical method" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td data-title="Effect size" align="" valign="" colspan="1" rowspan="1" bgcolor="#ffffff"> <p>‐0.38 [‐0.44, ‐0.32]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span>&nbsp;<span class="table-title">Sensitivity analysis</span></div> </div> <div class="tools"><a href="/cdsr/doi/10.1002/14651858.CD006297.pub2/references#CD006297-tbl-0008" class="tableList">Navigate to table in Review</a></div> </div> </div> <section class="translation-notes-modal" style="display: none" data-modal-title="Translation notes" data-modal-class="translation-notes" data-ok-btn-selector=".ok-btn"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="ja#CD006297-note-1201">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD006297-note-1203">Bahasa Malaysia</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" id="citeProcText" data-load-error="Unable to load citation data"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a href="#" class="addthis_button_citeulike at300b btn btn-link">CiteULike</a></li> <li><a href="#" class="addthis_button_mendeley at300b btn btn-link">Mendeley</a></li> <li><a href="#" class="citation-btn-refworks at300b btn btn-link" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <h4>Copy or download citation</h4> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button type="button" class="btn btn-link">Plain text</button></li> <li class="citation-option" data-option="endnote"><button type="button" class="btn btn-link">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button type="button" class="btn btn-link">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button type="button" class="btn btn-link">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button type="button" class="btn btn-link">BibteX</button></li> </nav> <div class="citation-content"> <pre id="citationContent" tabindex="0" data-load-error="Unable to load citation data"></pre> </div> <div class="clearfix"> <form class="download-citation-form" method="GET" target="citation-download-iframe" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=citation-citeproc&p_p_cacheability=cacheLevelPage&p_p_col_id=column-1&p_p_col_count=1"> <input type="hidden" id="siteId" name="siteId" value="" /> <input type="hidden" id="downloadType" name="downloadType" value="" /> <input type="hidden" id="style" name="style" value="" /> <input type="hidden" id="articleId" name="articleId" value="" /> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay" /><input name="p_p_lifecycle" type="hidden" value="2" /><input name="p_p_state" type="hidden" value="normal" /><input name="p_p_mode" type="hidden" value="view" /><input name="p_p_resource_id" type="hidden" value="citation-download" /><input name="p_p_cacheability" type="hidden" value="cacheLevelPage" /><input name="p_p_col_id" type="hidden" value="column-1" /><input name="p_p_col_count" type="hidden" value="1" /> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withAbstract"> <input class="checkbox" type="checkbox" name="withAbstract" /> <span class="checkbox-label">Include abstract</span> </label> </div> </form> <iframe title="Citation download frame" name="citation-download-iframe" src="" style="display: none; visibility: hidden" aria-hidden="true"></iframe> </div> </div> </div> </div> <div class="print-modal" style="display: none;" data-modal-title="Print this review"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input title="Select/deselect all" type="checkbox" class="print-options-select-all" checked="checked" /> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i class="fa fa-print" aria-hidden="true"></i> Print</button> </div> </div> <div class="download-stats-data-modal" style="display: none;" data-modal-title="Download statistical data"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <p> Downloaded data can only be viewed using <a class="external" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/tools/review-production-tools/revman-5" target="_blank">Review Manager software.</a> </p> <p> Please note that: <ul> <li>data are only available for Cochrane Reviews that contain one or more forest plots; and</li> <li>data in the downloaded RevMan file are editable and therefore the review data can be amended without warning.</li> </ul> </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input type="hidden" name="content-disposition" value="attachment" /> <input type="hidden" name="mime-type" value="application/octet-stream" /> <p class="print-options-controls"> <input type="checkbox" class="download-stats-data-toc-check-box" aria-label="I agree to these terms and conditions" /> <span class="checkbox-label" aria-hidden="true">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i class="fa fa-download" aria-hidden="true"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" style="display:none;" data-modal-title="Share this review"> <div class="add-this"> <div class="addthis_toolbox addthis_default_style addthis_32x32_style"> <nav class="stacked-nav-list"> <li> <a href="#" class="addthis_button_twitter at300b" title="Tweet">Twitter</a> </li> <li> <a href="#" class="addthis_button_mendeley at300b" target="_blank" title="Mendeley">Mendeley</a> </li> <li> <a href="#" class="addthis_button_facebook at300b" title="Facebook">Facebook</a> </li> <li> <a href="#" class="addthis_button_linkedin at300b" target="_blank" title="LinkedIn">LinkedIn</a> </li> <li> <a href="#" class="addthis_button_email at300b" target="_blank" title="Email">Email</a> </li> <li> <a href="#" class="addthis_button_whatsapp at300b" target="_blank" title="WhatsApp">WhatsApp</a> </li> <li class="clearfix"> <a href="#" class="addthis_button_more btn primary pull-right" target="_blank" title="View more"> <i class="fa fa-plus" aria-hidden="true"></i> View more</a> </li> </ul> </div> </div> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button type="button" class="btn btn-link" id="figureOptionBtn">Figures</button></li> <li class="table-options-btn-container"><button type="button" class="btn btn-link" id="tableOptionBtn">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div id="figureThumbnails" class="figure-thumbnails is-visible"></div> <div id="tableThumbnails" class="table-thumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a href="#" class="figure-viewer-menu-toggle"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-table-show-text="Show table list" data-table-hide-text="Hide table list" data-figure-show-text="Show thumbnails" data-figure-hide-text="Hide thumbnails">Hide thumbnails</span> </a> <a href="#" class="figure-viewer-zoomin"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a href="#" class="figure-viewer-zoomout"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a href="#" class="figure-viewer-nav previous"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a href="#" class="figure-viewer-nav next"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_  portlet-static portlet-static-end kaleo-designer-portlet " id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a title="Cochrane logo" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/">
<img class="footer-logo logo-part-1" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/footer-logo-part-1.png" alt="Cochrane logo" /> <img class="footer-logo logo-part-2" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/footer-logo-part-2.png" alt="" /> </a> </div> <nav class="footer-links"> <ul class="root"> <li class="footer-item"> <a class="footer-item-link" href="/about-cochrane1">About Cochrane</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/evidence" target="_blank">Cochrane.org</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us" target="_blank">Who we are</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NJYXT5SPMNYXG4DTMFYGKLUQPJUB/" target="_blank">Get involved</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX665WNWTYE63PMNYXG4DTMFYGKLUQPJUB/" target="_blank">Consumer Network</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us/our-funders-and-partners" target="_blank">Partners</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYXZ5DQPF4XT7LNF3SX8Z5IPJRX63JPN73GH/" target="_blank">Colloquium</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/news" target="_blank">In the news</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/publications">Publications</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="/library">Cochrane Library</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/" target="_blank">Library Homepage</a> </li> <li class="footer-item"> <a class="footer-item-link" href="cdsr/about-cdsr" target="_blank">Cochrane Reviews (CDSR)</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/central" target="_blank">Trials (CENTRAL)</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/cca/about" target="_blank">Cochrane Clinical Answers</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/about/cochrane-library-app" target="_blank">Cochrane Library App</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/cdsr/journal-club" target="_blank">Journal Club</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/about/podcasts" target="_blank">Podcasts</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/community">Community</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/" target="_blank">Community</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MF3GG4DJMVYGG55DNB3GC5UFF3YYE3D/" target="_blank">Archie log-in</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/PS3GC4LPNFYGPLUDN7SXR6UBN3TT655TMH/" target="_blank">Training and support</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/NWTYI4DQMS3T6Z5QMNVHEZLPMVYG86UH/" target="_blank">Methods</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/help" target="_blank">Software</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/news/jobs" target="_blank">Jobs and opportunities</a> </li> </ul> </li> <li class="footer-item"> <a class="footer-item-link" href="/contact-us">Contact Us</a> <ul class="child"> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/contact" target="_blank">General enquiries</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/help/contact-us" target="_blank">Cochrane Library support</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/organizational-info/people/central-executive-team/chief-executive-officers-office/team" target="_blank">Chief Executive Officer</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MNYX45LWN3VYI8JPMNYXG4DTMFYGKLUQPJUB/organizational-info/people/central-executive-team/editorial-methods/team" target="_blank">Editor in Chief</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TT655TMH/about-us/our-global-community" target="_blank">Cochrane groups</a> </li> <li class="footer-item"> <a class="footer-item-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/media" target="_blank">Media</a> </li> <li class="footer-item"> <a class="footer-item-link" href="/accessibility" target="_blank">Accessibility</a> </li> </ul> </li> </ul> </nav> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/advertisers">Advertisers & Agents</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NB4XELUYNFXGK8JPMNYXN/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/NB4XELUYNFXGK8JPMNYXN/community/support/cochrane-library">Help & Support</a></li> <li><a class="aux-footer-nav-link" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/terms-and-conditions">Terms & Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright &copy; 2000 - 2020 by <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUYNFXGK8JPMNYXN/" class="">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br /> Review our <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUYNFXGK8JPMNYXN/en-gb/privacy"><strong>Privacy Policy</strong></a> </p> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/MW4T675JNSTYTLUDN7XB/"><img class="logo" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/en-US_wiley-footer-logo.png" alt="Wiley logo" /></a> </div> </div> <span class="wiley-semi-circle"></span> </div> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" style="display: none" data-modal-title="Feature in English only" data-modal-class="english-only-modal"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1581423095000" type="text/javascript"></script> <!--<![endif]--> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/js/theme.js?t=1581423095000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX67DFN34C66UFMFTGG7LCMVYGG55N/cochrane/checkout.js"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MNYX67DFN34C66UFMFTGG7LCMVYGG55N/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MN3G865UNWRYE43NMNTG6LUDPJYYG65TMWUC655TMH/widget/v2.0/widget.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/MRZXE8DIHB4XC63SNWYHPN3PMNXG87LEM33G85UVF3YGK7A/assets/embed.js" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717691000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717708000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717777000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717709000" type="text/javascript"></script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581717714000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006297\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006297\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006297\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006297\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006297\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006297\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006297\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006297\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006297\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006297\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006297\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006297\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006297\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006297\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dreferences\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006297\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD006297\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dreferences\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD006297\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD006297\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1581423095000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a href="#" class="rh-nav-close-btn"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a href="#" class="rh-nav-open-btn"> <span>Review tools & navigation</span> </a> </div> <iframe title="Print frame" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" aria-hidden="true"></iframe> <div class="mobile-navigation"> <div class="close-container"> <a href="#" class="main-nav-back-btn" aria-label="Navigate back"><i class="fa fa-chevron-left"></i></a> <a href="#" class="main-nav-close-btn" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end " id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img id="ymag__null__null" src="/scolaris-search/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_auth=y8F68iId&p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=1&p_p_state=normal&p_p_mode=view&_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input type="hidden" name="searchType" value="basic" /> <input type="hidden" name="facetDisplayName" value="" /> <input type="hidden" name="facetQueryTerm" value="" /> <input type="hidden" name="facetQueryField" value="" /> <input type="hidden" name="facetCategory" value="" /> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select title="Search by options" aria-label="Search by options" name="searchBy" class="custom-select-enabled search-type"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" style="display: none;" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=topics-list&p_p_cacheability=cacheLevelPage"> <select class="search-select-topic-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input type="text" size="30" class="field browser-search search-text ui-autocomplete-input" value="" aria-label="Enter search term" id="searchText" name="searchText" placeholder="Search">
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button type="submit" class="searchByBtn" aria-label="Search">
<i class="fa fa-search" aria-hidden="true"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=references&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006297.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD006297.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<a href="/en/browse-by-topic" class="btn secondary">Browse </a>
<a href="/en/advanced-search" class="btn secondary advanced-search-button">Advanced search</a>
</div>
<div class="menu-items parent">
<ul>
<li class="nav-root-item parent">
<a href="#" title="Select language" class="language-selection-title-link">
<span class="mobile-nav-language-title">Select your preferred language</span><span class="icon fa fa-caret-down"></span>
<ul class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_  portlet-static portlet-static-end  " id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img id="fdkn__null__null" src="/scolaris-language-portlet/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hr, ja, ko, ms, pl, pt, ru, ta, th, zh, za]"> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-file-text"></i> English </a> <a title="Select your preferred language" class="language-select-mobile" href="#"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane Review language</h3> <p>Select your preferred language for Cochrane Reviews. You will see translated Review sections in your preferred language. Sections without translation will be in English.</p> <div id="active-content-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de" class="content-language-selector " data-languagecode="de">Deutsch</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en" class="content-language-selector is-active" data-languagecode="en">English</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es" class="content-language-selector " data-languagecode="es">Español</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa" class="content-language-selector " data-languagecode="fa">فارسی</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr" class="content-language-selector " data-languagecode="fr">Français</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr" class="content-language-selector " data-languagecode="hr">Hrvatski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja" class="content-language-selector " data-languagecode="ja">日本語</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko" class="content-language-selector " data-languagecode="ko">한국어</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms" class="content-language-selector " data-languagecode="ms">Bahasa Malaysia</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl" class="content-language-selector " data-languagecode="pl">Polski</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt" class="content-language-selector " data-languagecode="pt">Português</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru" class="content-language-selector " data-languagecode="ru">Русский</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta" class="content-language-selector " data-languagecode="ta">தமிழ்</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th" class="content-language-selector " data-languagecode="th">ภาษาไทย</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh" class="content-language-selector " data-languagecode="zh">简体中文</a> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage&_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=za" class="content-language-selector " data-languagecode="za">繁體中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div id="active-portal-language" class="dropdown-trigger"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a href="/en/cdsr/doi/10.1002/14651858.CD006297.pub2/references/en" class="portal-language-selector is-active" data-portallanguage="en">English</a> <a href="/es/cdsr/doi/10.1002/14651858.CD006297.pub2/references/es" class="portal-language-selector " data-portallanguage="es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=set-content-language&p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</ul>
</a>
</li>
<li class="parent">
<a class="mobile-link signin" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/c/portal/login?p_l_id=20757&redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD006297.pub2%2Freferences" data-redirect="false" rel="nofollow">
Sign In
</a>
</li>
</ul>
<div class="menu-items-footer">
<div class="utility-links">
<a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/http/P75YPLUDN7SXR6UBN3TT655TMH/" class="cochrane-link" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
<div class="basic-login-form-content" style="display: none;" data-modal-title="Sign in">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="dbam__null__null" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1583239527516" /> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x2f;references" /> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value="" /> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true" /> <input checked class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onClick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true" /> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> <a href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/N7YGZ4LPMWXGTZUTMF3HTLUYNFXGK8JPMNYXN/user-registration" target="_blank" class="btn secondary">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&p_p_lifecycle=0&p_p_state=normal&p_p_mode=view&_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" style="display: none;" data-modal-title="Institutional login">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="obft__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text">
</div>
<button class="btn primary" type="submit" name="button">Go</button>
</div>
<div id="institutionLookupErrorDiv" class="message error" style="display:none">
'<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
</div>
</div>
<input type="hidden" id="entityId" name="entityId" value="">
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_  portlet-static portlet-static-end portlet-login " id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img id="joiu__null__null" src="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/cochrane-theme/images/spacer.png" alt="" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;" /> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="http://eproxy2.lib.tsinghua.edu.cn:80/rwt/297/https/P75YPLUDN7SXR6UBN3TXZ4LCPJRYE8JPMNYXN/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" class="form sign-in-form " id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm" autocomplete="on"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1583239527520" /> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false" /> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="&#x2f;cdsr&#x2f;doi&#x2f;10&#x2e;1002&#x2f;14651858&#x2e;CD006297&#x2e;pub2&#x2f;references" /> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false" /> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value="" /> </div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value="" /> </div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true" /> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button type="submit" class="btn primary">Sign in</button> </div> </div> </fieldset> </form> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'>
<input type="hidden" name="openlabel" id="openlabel" value='Open access'>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" style="display: none;" data-modal-title="Unlock the potential of Cochrane evidence">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_  portlet-static portlet-static-end scolaris-content-display-portlet " id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img id="wpdq__null__null" src="/scolaris-content-display/icon.png" alt="" /> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class=" portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form method="post" action="/shibboleth" id="institutionLoginForm"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" name="institutionName" id="institutionName" value="" type="text"> </div> <button class="btn primary" type="submit" name="button">Go</button> </div> <div id="institutionLookupErrorDiv" class="message error" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input type="hidden" id="entityId" name="entityId" value=""> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input type="hidden" name="freelabel" id="freelabel" value='Free access'> <input type="hidden" name="openlabel" id="openlabel" value='Open access'> </div> </section> </div> </div>  <script>window.urlTitle="/cdsr/doi/10.1002/14651858.CD006297.pub2";addthis_config={pubid:"ra-593597d01cdf9a55",ui_508_compliant:true};addthis_share={url:window.location.href,title:document.title};</script> <script src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-593597d01cdf9a55"></script> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> </body> </html> 